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Tetraviruses are a family of small non-enveloped positive sense RNA viruses 
that exclusively infect members of the order Lepidoptera.  Their replication 
biology is poorly studied because, with the exception of Providence virus 
(PrV), tetraviruses are unable to replicate in tissue culture cells.  The overall 
aim of the research described in this thesis was to develop a fundamental 
understanding of the replication of tetraviruses, focussing on the site of 
replication within host cells and in particular, the subcellular localisation of the 
viral replicase. Helicoverpa armigera stunt virus (HaSV, Genus: 
Omegatetravirus) was chosen for this study because it is the only tetravirus 
for which the cDNAs have been shown to be infectious.   
 
In the absence of tissue culture cell lines susceptible to HaSV infection, the 
approach was to use confocal fluorescence microscopy to examine the 
subcellular localisation of the HaSV replicase fused to enhanced green 
fluorescent protein (EGFP) in mammalian and insect tissue culture cells.  The 
replicase (with EGFP fused at its C-terminus) localised to punctate structures 
throughout the cytoplasm of transfected HeLa and Sf9 cells.  These 
structures were then shown – using live cell imaging and time lapse 
photography – to behave similarly to cellular endocytic organelles and 
fluorescence partially overlapped with membranes containing the late 
endosomal marker protein CD63.  Biochemical fractionation of Sf9 cells 
expressing the replicase via a recombinant baculovirus (as well as 
transfected HeLa and Sf9 cells expressing EGFP-replicase fusion proteins) 
demonstrated that the replicase was strongly associated with detergent-
resistant membranes (DRMs) in these cells.  Deletion analysis of the 
replicase coding sequence revealed two regions involved in the generation of 
the punctuate structures.  Firstly, the C-terminal half of the replicase RNA-
dependant RNA polymerase domain was found to be essential for targeting 
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and the tight association with DRMs while the second region, within the N-
terminal 44 amino acids, enhanced localisation through a combination of 
secondary structural elements and sequence-specific functions.  A 
comparative immunofluorescence study on PrV, which replicates as a 
persistent infection in an insect midgut cell line, showed that the PrV 
replicase also localised to punctate structures in the cytoplasm.  Biochemical 
fractionation showed that the replicase was also strongly associated with 
DRMs.  This thesis describes the development of new experimental systems 
for the study of tetravirus replication biology and the data lead to the 
conclusion that the HaSV replicase associates with DRMs derived from 
alternate endocytic pathway organelles.   
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1.1 INTRODUCTION 
 
The major obstacle faced by all RNA viruses is that of genome replication.  
This requires RNA-dependent RNA replication in host cells that have DNA 
genomes and use DNA-dependent RNA polymerases for the production of 
RNA.  Thus no cellular machinery capable of genomic viral RNA (vRNA) 
replication is present in host cells.  Over fifteen years ago reports of RNA-
dependent RNA polymerase (RdRp) activity in plant cells began to emerge 
(Schiebel et al., 1993) and there is now evidence of non-viral RdRps in many 
eukaryotic cell types, some of which have a fidelity comparable to that of their 
viral equivalents.  It appears that these RdRps are involved in cellular 
processes such as RNA silencing and are unable to replicate the genomes of 
RNA viruses (Schiebel et al., 1998; Sijen et al., 2001; Ahlquist, 2002; Vaistij 
et al., 2002; Alder et al., 2003).  Thus RNA viruses carry their own RNA 
replication proteins, which in many cases function together with specific host 
and viral-encoded proteins to produce infectious vRNAs (Ahlquist 2002; Ortín 
and Parra, 2006).  Since this function is one of the fundamental differences 
between the virus and host cells, vRNA replication remains a key target for 
the development of antiviral therapies for treatment of diseases caused by 
RNA viruses (Ferrer-Orta et al., 2006). 
 
1.2 REPLICASES OF POSITIVE SENSE RNA VIRUSES 
 
Template-dependent polynucleotide polymerases (TDPPs) are responsible 
for the replication of cellular and viral genomes as well as cellular 
transcription.  Normal cellular functions in DNA repair or replication and RNA 
production are carried out by DNA-dependent DNA polymerases and DNA-
dependent RNA polymerases respectively.  However, the absence of host 
CHAPTER 1 
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cellular processes that can be exploited for genome-wide RNA replication 
has meant that all RNA viruses must carry their own RNA replication 
machinery, broadly referred to as viral replicases.  These replicases form 
RNA replication complexes in the host cell that may also contain host factors.  
Although there is some diversity in the number of replication proteins a 
particular virus produces and the additional functions that they perform, all 
positive sense (+ve) RNA viruses studied thus far have two characteristics in 
common:  they encode a highly conserved RdRp domain (Koonin, 1991; 
Ahlquist, 2002) and all are associated with host cellular membranes (Ortín 
and Parra, 2006). 
 
1.2.1. Structure and functional domains of RNA replicases 
 
The replication complexes produced by RNA viruses are multi-functional 
enzymes designed for the mass production of vRNA and range in complexity 
from a single protein encoding a single RdRp domain to an intricate 
assembly of viral and host encoded factors.  Many replicases carry other 
functional domains such as methyl- or guanyl-transferase (MT) domains 
responsible for attachment of 5' RNA caps, and helicase (HEL) domains that 
aid in the unwinding of double-stranded (ds) RNA replication intermediates 
(Van der Heijden and Bol, 2002).  In addition to the fundamental role they 
play in RNA replication, many also function in the recruitment of host factors 
required for viral replication and all replicases of (+ve) RNA viruses 
investigated to date have been shown to interact with host membranes . 
 
At the core of viral replication complexes is the RdRp domain, which has a 
high degree of structural conservation, not only among viral replicases, but 
also among all TDPPs, including cellular DNA and RNA replication proteins 
and reverse transcriptases (Ahlquist, 2002).  All TDPPs form a common 
tertiary structure that is often likened to a cupped right hand arranged with 
three distinct regions called the palm, thumb and fingers subdomains 
(Figure 1.1) (Ollis et al., 1985).  A conserved region of between 120 and 210 
Literature review 
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amino acids lies within the palm subdomain of all the RNA-dependent 
polymerases of retroviruses, retrotransposons, (+ve) and negative sense 
(-ve) single stranded (ss) RNA viruses, as well as some ds RNA viruses 
(Poch et al., 1989).   
 
 
The palm subdomain contains four highly conserved motifs named A, B, C 
and D (also known as motifs I, II, III and IV, Figure 1.1) that occur in an 
identical linear arrangement and which together contain 4 invariant and 18 
conserved amino acids (Poch et al., 1989).  These are assembled around 
motif C, which is the core catalytic domain containing the signature GDD box 
(Kamer and Argos, 1984; Argos, 1988).  Poch et al. (1989) hypothesised that 
the four motifs, separated by comparable numbers of amino acids, comprised 
a “polymerase module” or polymerase domain that is essential in template 
placement and nucleotide polymerisation.  A subsequent study identified a 
total of eight conserved motifs in RNA replicases even though only three, 
corresponding to motifs A, B and C, are universally conserved (Koonin, 
1991).  As there can be a large degree of variation over the full length of viral 
 
 
 
Figure 1.1:  Crystal structure of the Poliovirus replicase, 3Dpol, showing the thumb, 
fingers and palm subdomains.  A ribbon representation with the fingers (top left), palm 
(bottom) and thumb (top right) subdomains as indicated.  Motifs A to E are colour-coded as 
follows: A – red, B – green, C – yellow, D – violet and E – dark blue. Reproduced from 
Hansen et al. (1997). 
Literature review 
4 
replicase sequences, even among closely related viruses (Johnson et al., 
2001), these three motifs within the palm subdomain provide a useful means 
of comparison.   
 
As the catalytic core of the RdRp domain, motifs A to C are centred around 
the active site (Figure 1.1).  Motifs A (DX4-5D, where X is a non-conserved 
amino acid) and C (GDD) are spatially arranged with aspartic acid residues 
positioned for the binding of the divalent ions (Mn2+ or Mg2+) that are 
essential for the catalysis of the polynucleotide polymerisation reaction, while 
motif B ((S/T)GX3TX3N(S/T)) contains an essential asparagine residue that 
determines whether DNA or RNA is synthesised by discriminating between 
dNTPs and NTPs (Poch et al., 1989; Hansen et al., 1997).  Although these 
three motifs are typically present in a canonical A-B-C arrangement, 
Gorbalenya et al. (2002) identified an isolated group of replicases that carried 
a unique C-A-B permutation.  Originally this permutation was only identified 
in two ds RNA birnaviruses, Infectious pancreatic necrosis virus (IPNV) and 
Infectious bursal disease virus (IBDV), and two tetraviruses, Thosea asigna 
virus (TaV) and Euprosterna elaeasa virus (EeV) (Gorbalenya et al., 2002).  
However, more recently the permuted palm subdomain has also been 
observed in Drosophila A virus and Grapevine virus Q (Ambrose et al., 2009; 
Sabanadzovic et al., 2009).  Computational remodelling of the permutations 
into the three-dimensional structure of the Poliovirus (PV) replicase showed 
that this arrangement is compatible with the major secondary structural 
elements and would be capable of maintaining structural integrity 
(Gorbalenya et al., 2002).  
 
1.2.2. Classification of RNA-dependent RNA polymerases from 
positive sense RNA viruses 
 
Replicases provide a useful means of identification and classification of RNA 
viruses (Gorbalenya et al., 2002).  Phylogenetic analysis of the replicase 
sequences of (+ve) ss RNA viruses has enabled the classification of three 
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supergroups (I, II and III) of viral replicases based on differences in RdRp 
sequences, which is usually accompanied by the presence or absence of 
other associated domains and functions (Koonin, 1991; Van der Heijden and 
Bol, 2002).  This classification system takes into account three RdRp, three 
HEL, two MT and two proteinase domains and separates viruses into 
supergroup I (picorna-like), supergroup II (divided into the carmo-like and 
flavi-like lineages) or supergroup III (alpha-like) replicases (Table 1.1) 
(Gorbalenya et al., 1988, 1989, 1990; Koonin, 1991; Rozanov et al., 1992; 
Kadre and Haenni, 1997, Van der Heijden and Bol, 2002). 
 
Picorna-like replicases (supergroup I) encode a type I RdRp domain and a 
conserved cysteine proteinase motif required for post-translational 
processing of the replicase.  In addition, they may encode a type 1, 2 or 3 
HEL domain, but MT domains are absent because the majority of these 
viruses make use of VPgs (genome-linked virus proteins) to prime (+ve) and 
(-ve) RNA synthesis and stabilise vRNA (Table 1.1) (Wimmer et al., 1993).  
Supergroup II replicases are divided into two major lineages.  The first is the 
carmo-like replicases that carry a type II RdRp domain but lack HEL, MT and 
proteinase domains, while the second lineage, the flavi-like replicases, also 
utilise a type II RdRp domain but encode HEL (type 2), MT (type 2) and 
serine proteinase domains (Table 1.1).  Finally, supergroup III replicases 
comprise the alpha-like virus replicases named after the Alphavirus genus of 
 
 
Table 1.1: The conserved domains encoded by the replicases of each of the (+) RNA 
virus supergroups. Adapted from Van der Heijden and Bol (2002). 
 
Supergroup Type of domain 
 RdRp HEL MT Proteinase 
I: Picorna-like viruses I 1, 2 or 3 - Cys or Ser 
II: Carmo-like viruses* II - - - 
II: Flavi-like viruses* II 2 2 Ser 
III: Alpha-like viruses III 1 1 Cys or Papain-like 
*: The carmo-like and flavi-like viruses are two lineages within the supergroup II replicases. 
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the Togaviridae.  Type III RdRp, type 1 MT and type 1 HEL domains as well 
as cysteine or papain-like proteinase domains are characteristic of this group 
(Table 1.1) (reviewed in Van der Heijden and Bol, 2002).  The replicase 
encoded by Helicoverpa armigera stunt virus (HaSV), which is the subject of 
this study, falls within this last group (Gordon et al., 1995). 
 
The MT, HEL and RdRp domains conserved within the alpha-like superfamily 
are found in a linear arrangement with the MT domain closest to the N-
terminus followed by the HEL and the RdRp domains towards the C-terminus 
(Figure 1.2) (Rozanov et al., 1992).  In their study of alpha-like replicases, 
Rozanov et al. (1992) showed that the MT domain was unique among 
replicase proteins and identified a series of four motifs (I to IV) that contained 
four invariant amino acids.  Similar bioinformatic analysis of the HEL domains 
from various proteins involved in DNA and RNA unwinding revealed seven 
signature motifs, five of which are unique to the type 1 HEL domain found in 
alpha-like replicases (Gorbalenya et al., 1988, 1989; Kadre and Haenni, 
1997).  Motif B of the RdRp domain of alpha-like viruses contains a unique 
S/T pairing separated by nine amino acids (Koonin, 1991).  An additional “X” 
or macro domain of unknown function is found in alpha-like viruses infecting 
animals and cystein or papain-like proteases may be present and are 
involved in autoproteolytic cleavage (Table 1.1, Figure 1.2) (Van der Heijden 
and Bol, 2002). 
 
1.3 THE TETRAVIRIDAE 
 
The first tetravirus was isolated more than forty years ago from a South 
African population of pine emperor moth (Nudaurelia cytherea capensis) 
larvae (Hendry et al., 1968).  Nudaurelia capensis β virus (NβV) was among 
five small RNA viruses present in diseased larvae (Jukes, 1970) and analysis 
of virion structure revealed the characteristic T = 4 icosahedral capsid 
structure for which the family is now named (Finch et al., 1974; Sehnke et al., 
1988; Rossmann and Johnson, 1989; Olson et al., 1990).  The relative 
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abundance of NβV in infected insects ultimately resulted in it becoming the 
type member of a new group of viruses called the Nudaurelia β-like viruses 
(Reinganum et al., 1978; Mathews, 1982).   
 
In 1985, Hendry et al. isolated another small, non-occluded RNA virus co-
infecting diseased N. capensis larvae, which was designated Nudaurelia 
capensis ω virus (NωV).  While NωV had a number of biophysical 
 
 
 
Figure 1.2:  Schematic representation of the organisation of conserved functional 
domains of replicases within the alpha-like virus supergroup. Some of the genera (right) 
of viruses carrying alpha-like virus replicases, divided into animal, insect or plant viruses 
(left).  *: Nudaurelia capensis β virus is the only betatetravirus with an alpha-like replicase, 
MT: Guanyl/methyltransferase, HEL: Helicase, P: Papain-like protease, X: “X” or macro 
domain, RdRp: RNA-dependent RNA polymerase, : Known cleavage sites, : Read-
through stop codons.  Adapted from Van der Heijden and Bol (2002). 
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characteristics in common with NβV, there were differences in surface 
morphology and the two viruses were serologically unrelated (Hendry et al., 
1985).  Furthermore, NωV virions contained a bipartite ss RNA genome in 
contrast to the monopartite genome of NβV.  NωV became the first member 
of a second genus within the Tetraviridae called the ω-like tetraviruses, 
where it remained the sole member until the discovery of HaSV in a 
collapsed Helicoverpa armigera (cotton bollworm) colony (Hanzlik et al., 
1993).   
 
To date there are eleven assigned members of the Tetraviridae in addition to 
the fourteen members that remain as yet unassigned (Hanzlik et al., 2005; 
Walter et al., 2008).   All tetraviruses have capsids displaying the distinctive T 
= 4 icosahedral symmetry with an average diameter of approximately 40 nm 
encapsidating (+ve) RNA genomes.  The family is divided into two genera 
according to genomic organisation with NωV and NβV remaining the 
prototype viruses for what are now known as the bipartite Omegatetravirus 
and the monopartite Betatetravirus genera respectively (Dorrington and 
Short, 2010). 
 
1.3.1. Host range, pathology and virus-host interactions 
 
Tetraviruses are distinguishable from other insect viruses by their 
characteristic T = 4 icosahedral symmetry and their unusually narrow host 
range.  All tetraviruses are thought to infect the midgut cells of insects within 
the Order Lepidoptera with the host range of each virus generally being 
limited to one or a small group of species within a single family (Hanzlik et al., 
2005).  In some instances, most notably that of N. capensis, a number of 
tetraviruses can infect a single species (Jukes, 1979; Walter et al., 2008).  
With the exception of Providence virus (PrV), no tetraviruses have been 
found able to replicate in tissue culture cell lines (Bawden et al., 1999; 
Pringle et al., 2003).  In an effort to establish an infectious tissue culture 
system for HaSV, Bawden et al. (1999) attempted to induce HaSV replication 
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by infection of fourteen tissue culture cell lines with HaSV particles or 
transfection with genomic RNA.  None of the thirteen insect cell lines nor the 
one mammalian tissue culture cell line were found to be permissive for 
replication.  The authors suggested that this was most likely due to a lack of 
cell surface receptors suitable for the entry of HaSV particles and the 
absence of host factors essential for the replication of HaSV RNA.   
 
During infection, HaSV particles have been observed in the cytoplasm of 
columnar, goblet and basal regenerative cells, but not in endocrine cells 
(Brooks et al., 2002), indicating some degree of specificity even within the 
larval midgut.  Furthermore, Brooks et al. (2002) noted significant changes in 
the subcellular architecture of HaSV-infected cells, including an accumulation 
of lysosomes, increased cytosolic vacuolation and a concurrent increase in 
cell shedding to the midgut lumen.  Cell shedding was correlated with an 
increase in apoptosis (programmed cell death) in infected cells.  Subsequent 
studies have shown that there may be a correlation between the cytosolic 
acidification that occurs as a precursor of programmed cell death and the 
maturation of virus particles (discussed in detail below) (Matsuyama and 
Reed, 2000; Nilsson et al., 2006; Tomasicchio et al., 2007; Kirkegaard and 
Jäättelä, 2009). 
 
1.3.2. Capsid structure, assembly and maturation 
 
Three-dimensional reconstructions of electron micrographs of NβV particles 
revealed a novel T = 4 icosahedral symmetry and the presence of Y-shaped 
trimers on the capsid surface (Finch et al., 1974).  This was later confirmed 
when the structure of NβV virions was reconstructed to 32 Å by cryo-electron 
microscopy (Olson et al., 1990).  Since then the availability of a crystal 
structure for NωV at 2.8 Å resolution revealed similar core structures that are 
distinguishable by the presence of deeper grooves between Y-shaped trimers 
and prominent pits on each triangular face of NβV (Figure 1.3) (Finch et al., 
1974; Olson et al., 1990; Johnson et al., 1994; Munshi et al., 1996).  Cryo-
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electron microscopy structures are now available for HaSV and PrV 
(Figure 1.3) (Speir and Johnson, 2008) and the crystal structure of PrV has 
recently been solved at a resolution of 3.8 Å (Speir et al., 2010). 
 
Capsids are assembled from 240 identical capsid protein precursors (VCAP), 
each with an internal helical domain, a core β-barrel domain and an external 
Ig-like domain (Figure 1.4, Panel A), the former two regions displaying 
significant structural similarity to the T = 3 nodaviruses (Finch et al., 1974; 
Fisher and Johnson, 1993; Munshi et al., 1996; Speir et al., 2010).  The Ig-
like domain, unique among non-enveloped viruses, is inserted between the E 
and F strands of the β-barrel domain and is the dominant structure on the 
exterior of the virus capsid (Munshi et al., 1996; Speir and Johnson, 2008; 
Speir et al., 2010).  Furthermore, it is the least conserved region of VCAP 
 
 
 
Figure 1.3: Three-dimensional representations of cryo-electron microscopy 
reconstructions of NβV, PrV, NωV and HaSV.  All four reconstructions are resolved to 
below 30 Å and are viewed down their two-fold icosahedral axis.  Reproduced from Speir 
and Johnson (2008). 
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and, along with the different orientation of the Ig-like domain that creates the 
distinct surface morphologies of ω- and β-like viruses, is thought to enable 
virus-specific interactions with different hosts (Munshi et al., 1996; Helgstrand 
et al., 2004; Speir et al., 2010).  As in all icosahedral viruses, the β-barrel 
domain is the core around which the capsid assembles (Munshi et al., 1996; 
Helgstrand et al., 2004; Speir et al., 2010).  The internal helical domain, 
formed by the N- and C-termini of VCAP, has been implicated in capsid 
 
 
 
Figure 1.4:  The tertiary structure and quasi-equivalence of the NωV capsid displaying 
the three distinct capsid protein domains.  Panel A shows a ribbon diagram of the C 
subunit of NωV with the positions of the three structural domains.  The internal helical 
domain with N570/F571 autoproteolytic cleavage site is enlarged.  Panel B shows a schematic 
diagram of the positions of the four quasi-equivalent capsid subunits in T = 4 viruses: A 
(blue), B (red), C (green) and D (yellow).  White pentagons, ellipses and triangles represent 
5-fold, 2-fold and 3-fold icosahedral axes, while black ellipses and triangles represent quasi-
2-fold and quasi-3-fold axes.  The flat conformation at quasi-2-fold axes is stabilised by 
ordered C-terminal helices.  Taken from Speir and Johnson (2008). 
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assembly, RNA binding and stabilisation during encapsidation, as well as the 
translocation of vRNA into the cell during infection (Sehnke et al., 1988; 
Munshi et al., 1996; Helgstrand et al., 2004; Speir et al., 2010).   
 
Assembly of the tetravirus capsid is proposed to start with the self-
association of structurally equivalent trimers, each subunit assuming one of 
the four slightly different quasi-equivalent conformations, A, B, C and D, after 
the assembly into procapsids (Figure 1.4, Panel B) (Finch et al., 1974; Olson 
et al., 1990; Johnson et al., 1994).  NωV procapsids (48 to 49 nm in 
diameter) are larger and more rounded in shape than mature virus-like 
particles (VLPs) (42 nm in diameter) (Figure 1.5) and are thought to mature 
as the result of conformational changes driven by electrostatic interactions 
(Canady et al., 2000, 2001).  The rearrangements occur rapidly (in the sub-
second range) and are reversible until approximately 15 % of the capsid 
protein precursors have undergone autoproteolytic cleavage at their C-
termini (Canady et al., 2001; Tang et al., 2009).   
 
Cleavage of VCAP produces the large (β) (56 to 64 kDa) and small (γ) (6 to 8 
kDa) capsid proteins observed in all tetravirus particles studied so far 
(Hanzlik et al., 2005; Yi et al., 2005; Zeddam et al., 2010), with the γ 
polypeptide of NωV acting as a molecular switch determining the quasi-
symmetry of each subunit (Munshi et al., 1996).  In the C and D subunits, the 
γ polypeptide is ordered and, through interactions between the ABC and 
DDD morphological units, creates a flat contact, preventing excess curvature 
(Figure 1.4, Panel B) (Munshi et al., 1996).  In PrV, however, the N-terminal 
helices of the β polypeptide fulfil this function, with the γ polypeptide possibly 
bracing the N-terminal helices in their position in an arrangement similar to 
that observed in nodaviruses (Fisher and Johnson, 1993; Speir et al., 2010).  
Autoproteolytic cleavage occurs between a conserved 
asparagine/phenylalanine pair (N570 and F571 in NωV, N575 and F576 in HaSV 
and N556 and F557 in PrV) in a reaction that is inhibited by N570T, E103Q and 
E103S mutations in NωV (Taylor et al., 2002; Taylor and Johnson, 2005; 
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Speir et al., 2010).  Little is known about what promotes the conformational 
changes leading to particle maturation in vivo, but exposing procapsids to a 
pH below 5.8 has been shown to induce maturation (Canady et al., 2000, 
2001; Taylor et al., 2002).  This observation, along with the correlation 
between VLP maturation and apoptosis has led to the hypothesis that 
cytosolic acidification may play a role in virus maturation in vivo (Tomasicchio 
et al., 2007).  
 
 
 
 
 
 
 
 
 
 
Figure 1.5:  Three-dimensional reconstructions of full and sectioned HaSV procapsid 
and capsid structures including their packaged RNA.  Sectioned particles in are 
sectioned down the 2-fold axis of symmetry.  Reproduced from Speir and Johnson (2008). 
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1.3.3. Genomic organisation 
 
Tetraviruses are classified according to their respective genome organisation 
with the betatetraviruses being monopartite and the omegatetraviruses 
bipartite (Hanzlik et al., 2005).  At present, the full genome sequences of six 
tetraviruses have been determined, including four betatetraviruses (NβV, 
TaV, EeV and PrV) and two omegatetraviruses (HaSV and Dendrolimus 
punctatus tetravirus (DpTV)) (Table 1.2).  The cDNA sequence of NωV RNA2 
has also been reported (Du Plessis et al., 2005). 
 
The betatetraviruses encode both the replicase and VCAP on a single 
genomic RNA that ranges from 5714 and 5698 nucleotides (nts) (TaV and 
EeV respectively) to 6625 nts (NβV) in length (Figure 1.6) (Gordon et al., 
1999; Pringle et al., 2003; Zeddam et al., 2010).  In NβV, the two open 
reading frames (ORFs) overlap substantially with the replicase ORF proximal 
to the 5' end and VCAP at the 3' end (Gordon et al., 1999; Pringle et al., 
1999, 2003; Zeddam et al., 2010).  VCAP is translated from a subgenomic 
RNA that, in NβV and TaV, originates just upstream of the VCAP ORF 
(Gordon et al., 1999; Pringle et al., 1999).  Both TaV and EeV encode 
 
Table 1.2:  Members of the Tetraviridae for which nucleotide sequences are available. 
Modified from Dorrington and Short (2010). 
 
Virus Acronym GenBank 
Acc. No. 
References 
Genus: Betatetravirus    
        Euprosterna elaeasa virus EeV AF461742 Gorbalenya et al. (2002) 
        Nudaurelia capensis β virus NβV AF102884 Gordon et al. (1999) 
        Providence virus PrV NC014126 Pringle et al. (2003) 
        Thosea asigna virus TaV 
 
AF282930 
AF062037 
Pringle et al. (1999) 
Genus: Omegatetravirus    
        Helicoverpa armigera stunt virus HaSV U18246 
EU345431 
L37299 
Gordon et al. (1995) 
Hanzlik et al. (1995) 
        Nudaurelia capensis ω virus NωV DQ054400 Du Plessis et al. (2005) 
        Dendrolimus punctatus tetravirus DpTV AY594352 
AY594353 
Yi et al. (2005) 
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N-terminal extensions to VCAP that are processed from the nascent protein 
via the action of a 2A-like cleavage site to generate an additional 17 kDa 
polypeptide (p17) of unknown function (Pringle et al., 1999; Zeddam, et al., 
2010).  As opposed to the tRNA-like structure at the 3’ end of NβV RNA 
(Gordon et al., 1999), both the genomic and subgenomic TaV and EeV RNAs 
are thought to terminate in 3' pseudoknots and the TaV and EeV replicase 
sequences suggest that the genomic RNAs may carry a 5' VPg (Zeddam et 
al., 2010).   
 
PrV has an atypical genomic organisation encoding an additional 5'-proximal 
ORF of unknown function (p130) that encodes a 2A-like processing site 
predicted to generate 17 and 113 kDa polypeptides (p17 and p113 
respectively) (Walter et al., 2010).   The replicase ORF is unique among 
tetraviruses in that it generates two overlapping replication proteins through 
the function of a read-through stop signal, the N-terminal region of the larger 
 
 
 
Figure 1.6:  The genomic organisation of the tetraviruses.  The top panel shows the 
genomic organisation of HaSV, a typical omegatetravirus, while the bottom panel shows the 
genomic organisation of the Betatetravirus type member NβV.  The name of the protein 
translated from each ORF is indicated inside the open blocks.  Molecular masses for each 
protein is indicated in kDa by the value following the p.  Conserved replicase domains are 
indicated by hatched blocks above the respective replicase ORFs in HaSV.  MT: 
Guanyl/methyltransferase domain, HEL: Helicase domain, RdRp: RNA-dependent RNA 
polymerase domain, gRNA: genomic RNA, sgRNA: subgenomic RNA. 
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replication protein, p104, corresponding directly to the early termination 
product (p40) (Walter et al., 2010).  Finally, two 2A-like processing sites are 
present upstream of the VCAP ORF and are predicted to generate 
polypeptides of 7 and 8 kDa (Walter et al., 2010).   
 
Both the omegatetraviruses sequenced to date encode VCAP on a distinct 
genomic RNA (RNA2, approximately 2500 nts) (Figure 1.6).  The larger RNA 
(RNA1, 5312nts in HaSV and 5492 nts in DpTV) encodes the replicase (189 
and 180 kDa in HaSV and DpTV respectively), in addition to three small 
ORFs for proteins of 8, 11 and 15 kDa at the 3' end (Gordon et al., 1995; Yi 
et al., 2005).  It is unknown whether the three small proteins are expressed 
(Gordon et al., 1995; Yi et al., 2005).  The smaller of the RNAs carries two 
ORFs, with VCAP overlapping with the 5' proximal ORF that encodes a 17 
kDa non-structural protein thought to be an RNA binding protein (Hanzlik et 
al., 1995; Du Plessis et al., 2005; Yi et al., 2005; Zhou et al., 2008).  Both 
HaSV genomic RNAs are capped at their 5' ends and terminate in 3' tRNA-
like structures that can be charged with valine in vitro (unpublished data cited 
in Gordon et al., 1999). 
 
1.3.4. Tetravirus replication  
 
The replication of tetraviruses is thought to occur in the midgut cells of the 
insects they infect (Moore et al., 1985; Bawden et al., 1999; Brooks et al., 
2002).  The only tetravirus that has been shown to replicate in tissue culture 
is PrV, which exists as a persistent infection of a Helicoverpa zea midgut-
derived cell line (MG8) although it is also able to infect H. zea FB33 and 
Spodoptera exigua Se-1 cells (Pringle et al., 2003).  In the first study on 
tetravirus replication, particles of the betatetravirus, Trichoplusia ni virus 
(TnV), were detected in midgut cells of Trichoplusia ni larvae during the early 
stages of infection and later during development in immature sex bodies 
(Greenwood and Moore, 1984).  Transmission electron microscopy analysis 
of cells infected with PrV and TnV showed virions organised in crystalline 
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arrays associated with cytoplasmic vesicles (Greenwood and Moore, 1984; 
Pringle et al., 2003).   Bawden et al. (1999) analysed HaSV-infected H. 
armigera larvae for the presence of vRNAs over time following infection with 
wild-type virus.  RNA1 was first detected three days after infection with RNA2 
appearing two days later.  This suggested that RNA1, encoding the viral 
replicase, was preferentially replicated early during the infection cycle.  No 
subgenomic RNA was detected in the infected larvae (Bawden et al., 1999).  
A similar observation has been made for PrV where replication of the 
genomic RNA precedes that of the subgenomic RNA (Pringle et al., 2003).  In 
general it is held that the betatetravirus subgenomic RNA is not replicated 
(Hanzlik et al., 2005), although Pringle et al. (2003) observed negative sense 
vRNA corresponding in size to the subgenomic RNA. 
 
1.3.5. The tetravirus replicase 
 
Tetravirus replicases can be clustered into three distinct groups, with each 
bearing similarities to a different superfamily of virus replicases (Section 
1.2.2) (Gordon et al., 1995; Walter et al., 2010; Zeddam et al., 2010).  The 
first group contains the replicases encoded by NβV, HaSV and DpTV, all of 
which have replicases related to those of the alpha-like superfamily of 
replicases (Gordon et al., 1995; Gordon et al., 1999; Yi et al., 2005).  Each 
replicase contains the characteristic modular N- to C-terminal arrangement of 
the conserved MT, HEL and RdRp domains (reviewed in Van der Heijden and 
Bol, 2002).  Over these three regions, HaSV and DpTV show a high degree 
of sequence similarity with 67 %, 63 % and 76 % amino acid sequence 
identity over the three domains respectively (Gordon et al., 1995; Yi et al., 
2005).  Although this is significantly higher than the sequence similarity 
observed between NβV and either HaSV or DpTV, more than one third of the 
amino acids over each of the domains that have been compared are identical 
between all three viruses (Gordon et al., 1995; Gordon et al., 1999; Yi et al., 
2005).  The DpTV RdRp domain, expressed as a recombinant polypeptide in 
Escherichia coli, is capable of primer-independent initiation of vRNA 
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synthesis in vitro (Zhou et al., 2006).  Interestingly, the tetraviruses are the 
only insect-specific alpha-like viruses, although there are a number of insect 
borne animal (alphaviruses) and plant (marafiviruses) viruses within the 
group (Van der Hiejden and Bol, 2002).  HaSV, DpTV and NβV replicases 
lack any signs of co- or post-translational processing (Gordon et al., 1995; 
Gordon et al., 1999; Yi et al., 2005), a characteristic shared with only a small 
group of plant viruses that includes the unclassified Foveavirus and 
Potexvirus genera (Van der Heijden and Bol, 2002). 
 
A second group of tetravirus replicases comprises those encoded by TaV and 
EeV.  Over the full length of their replicase sequences they share 68 % 
identity and together with the ds RNA birnaviruses, IPNV and IBDV, and 
Drosophila A virus, form a cluster distantly related to members of the picorna-
like virus superfamily of viral replicases and are distinct from other (+ve) ss 
RNA viruses (Gorbalenya et al., 2002; Ambrose et al., 2009; Zeddam et al., 
2010).  Characteristic of this cluster is the unique internally permuted C-A-B 
arrangement of the canonical A, B and C motifs conserved in the palm 
subdomain of all TDPPs (Section 1.2.1) (Poch et al., 1989; Gorbalenya et al., 
2002; Ambrose et al., 2009; Zeddam et al., 2010).  Another unusual feature 
of these replicases is the lack of discernible MT and HEL domains, unlike 
other picorna-like viruses which typically encode a HEL domain (Gorbalenya 
et al., 2002; Van der Heijden and Bol, 2002).  Both TaV and EeV replicases 
encode conserved sequences that, in birnaviruses, are responsible for the 
addition of 5’ VPgs to genomic RNAs, leading Zeddam et al. (2010) to 
suggest a similar function in these two tetraviruses.  The significant 
differences in replicase sequence and genomic organisation has led to the 
proposal that TaV and EeV be classified in a separate family called the 
Permutotetraviridae (Zeddam et al., 2010). 
 
The final group contains PrV as the sole member, with a replicase that is 
significantly different from the other tetraviruses.  Phylogenetic analysis using 
the PrV sequence groups it along with (+ve) RNA plant viruses like the 
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tombus- and umbraviruses, which belong to the carmo-like virus lineage of 
supergroup II (Walter et al., 2010).  The absence of MT and HEL domains in 
the PrV replicase is consistent with other carmo-like replicases (Walter et al., 
2010).  The PrV replicase is unique among the tetravirus replicases in that it 
undergoes co-translational modification via the action of a read-through stop 
codon that results in the production of a major (p40) and minor (p104) 
replication protein, with p104 carrying the RdRp domain (Walter et al., 2010). 
 
1.4 SUBCELLULAR REPLICASE-HOST INTERACTIONS 
 
1.4.1. Replicase-host interactions and viral replication complexes 
 
The RdRp activity of many replicases is dependent on the assembly of vRNA 
replication complexes that often require specific interactions with cellular 
proteins and/or self-association of viral proteins (Buck, 1996; O'Reilly et al., 
1998; Dye et al., 2005; Wileman, 2006).  Three of the best studied (+ve) ss 
RNA replicases in terms of replicase-host interactions are protein A of Flock 
House virus (FHV) (Nodaviridae), 3Dpol from PV and Foot-and-mouth disease 
virus (FMDV) (Picornaviridae) and proteins 1a and 1b from the alpha-like 
virus Brome mosaic virus (BMV) (Bromoviridae), all of which have been 
shown to self-associate and/or interact with host proteins. 
 
Protein A of FHV is the sole viral protein required for replicase activity (Ball, 
1995) and has been shown to self-associate through the function of several 
non-overlapping internal sequences (Dye et al., 2005).  The importance of 
this self-interaction is demonstrated in that protein A deletion mutants with 
diminished self-interaction also show reduced RNA replication ability, 
indicating that multimerisation of protein A is essential for the efficient 
replication of FHV RNA (Dye et al., 2005).  Efficient RNA replication is also 
dependent on virus-encoded factors such as cis-acting elements within vRNA 
(Ball and Li, 1993) and host factors such as glycerophospholipids (Wu et al., 
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1992) and heat shock protein 90, which is essential for the accumulation of 
FHV replication complexes in mitochondria of infected Drosophila 
melanogaster cells (Miller et al., 2001; Kampmueller and Miller, 2005). 
 
Analysis of the crystal structure of 3Dpol from PV revealed several protein-
protein interactions that produce higher order structures, which Hansen et al. 
(1997) suggested were important for RdRp activity.  This was in agreement 
with previous observations of 3Dpol self-interaction using glutaraldehyde 
cross-linking and the observation that the binding of a single synthetic 
template requires replicase multimers (Pata et al., 1995).  In terms of 
interactions with host proteins, the formation of FMDV replication complexes 
has recently been shown to occur in the presence of viral encoded 2C and 
3A proteins as well as the host poly(A) binding protein and RNA helicase A 
(Lawrence and Reider, 2009).  
 
Self-association of the BMV replication protein 1a, containing MT and HEL 
domains, is important for the recruitment of the RdRp domain (encoded by 
protein 2a) and the development of the replication complex (O'Reilly et al., 
1998).  A comprehensive study of BMV-infected yeast cells by Kushner et al. 
(2003) showed that there were approximately 100 genes that, when deleted, 
increased or decreased BMV replication by more than 3-fold, demonstrating 
the complexity of virus-host interactions during RNA replication.  The genes 
identified included those involved in membrane and chromatin remodelling, 
endocytosis, osmoregulation and ubiquitination.  Although the exact functions 
of these genes in viral replication remain to be identified, the large number of 
host factors affecting vRNA production underscores the importance of host 
factors in the BMV life cycle in yeast cells.  Other sources have identified 
further examples of host protein requirements for BMV replication including 
the yeast decapping activator complex Lsm1p-7p/Pat1p/Dhh1p, which is 
required for recruitment of vRNA for replication (Díez et al., 2000; Mas et al., 
2006).  Mas et al. (2006) suggested that this cellular function may be a key 
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regulator of the switch between translation and replication of BMV RNA, 
which is also dependent on specific cellular fatty acids (Lee et al., 2001). 
 
1.4.2. Subcellular localisation of replicases and anchoring to 
specific membranes 
 
The various viral and host protein components involved in the formation of 
virus replication complexes have been shown to be associated with host-
derived membranes in all (+ve) RNA viruses studied thus far, which is 
thought to concentrate the required viral and host factors and to create a 
localised site of replication (Netherton et al., 2007).  Additional functions such 
as avoidance of host anti-viral defence systems like proteolytic degradation 
of the viral replicase and/or RNAi-mediated degradation of ds RNA 
intermediates, have also been suggested (Jonczyk et al., 2007). 
 
RNA viruses have been shown to replicate their RNA in association with a 
wide variety of cellular membranes and are directed to their cellular location 
by various signals located within the replicase sequence.  For example, FHV 
protein A is targeted to the mitochondria in infected Drosophila DL-1 and 
yeast cells by a target sequence within the N-terminal 46 amino acids (Miller 
et al., 2001; Miller and Ahlquist, 2002).  A similar localisation is seen in the 
type member of the alphanodaviruses, Nodamura virus, in both the greater 
wax moth (Galleria mellonella) and suckling mice (Garzon et al., 1990).  In 
the betanodavirus, Atlantic halibut nodavirus, protein A carries two 
mitochondrial localisation signals, one in the N-terminal 40 amino acids and 
another a further 225 amino acids downstream, either of which are capable 
of targeting enhanced green fluorescent protein (EGFP) to the mitochondria 
(Mézeth et al., 2007).  Interestingly, in FHV, vRNA replication is not 
dependent on mitochondrial localisation (Miller et al., 2003).  Retargeting of 
FHV protein A to the endoplasmic reticulum (ER) results in replicase activity, 
implying that specific membranes are not required for vRNA production 
(Miller et al., 2003).  In the first study on the three-dimensional structure of 
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replicase-membrane associations, Kopek et al. (2007) showed that 
approximately 100 copies of FHV protein A reside in invaginations of the 
outer mitochondrial membranes, approximately 50 nm in diameter and 
located in the inter-membrane space.  These spherules also contained on 
average, three RNA replication intermediates and had a necked channel of 
approximately 10 nm, allowing for the export of vRNA and the import of 
nucleotides.   
 
In contrast to FHV, the Tomato ringspot virus replication complex is anchored 
to the ER by a C-terminal transmembrane helix and an N-terminal 
amphipathic helix present in the nucleoside triphosphate-binding protein 
(NTB) as well as by a multipass transmembrane protein called X2 (Han and 
Sanfaçon, 2003; Wang et al., 2004; Zhang et al., 2005; Zhang and Sanfaçon, 
2006).  Immunofluorescence analysis of the BMV replication proteins 1a and 
2a in infected barley protoplasts has shown that 1a is capable of localisation 
to the ER independent of other viral proteins (Restrepo-Hartwig and Ahlquist, 
1996; Restrepo-Hartwig and Ahlquist, 1999).  This localisation is directed via 
a peripheral membrane association within the N-terminal MT domain of 1a 
(Den Boom et al., 2001).  
 
PV-induced vesicles have been shown by electron microscopy to be formed 
from ER membranes and contain the COPII protein complex (Bienz et al., 
1987; Rust et al., 2001).  Later in the infectious cycle, PV proteins colocalise 
with Golgi marker proteins, consistent with the function of COPII in ER-Golgi 
transport (Bolten et al., 1998).  The same is true for FMDV, with the non-
structural proteins 2B and 2C associating with the ER and Golgi when 
expressed alone in cells (Moffat et al., 2005).  However, in FMDV-infected 
cells replication complexes do not overlap with markers of the ER or Golgi 
leading Knox et al. (2005) to hypothesise that it may exclude host proteins 
from the membranes it sequesters.  Although the studies on PV and FMDV 
indicate a stringent localisation, biochemical studies conducted by Schlegel 
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et al. (1996) indicated that membranes may be derived from the lysosomes in 
addition to the Golgi and the ER.   
 
The togaviruses Semliki Forest virus (SFV), Sindbis virus (SIN) (both in the 
genus Alphavirus) and Rubella virus (RV) (Genus: Rubivirus) replicate their 
RNA in association with cytopathic vacuoles that are derived from 
endosomes and lysosomes (Grimley et al., 1968; Froshauer et al., 1988; 
Magliano et al., 1998; Kujala et al., 1999, 2001; Matthews et al., 2009).  In 
both SFV and SIN, the replicase complexes are also associated with fibrous 
structures that appear to form bonds between the cytopathic vesicles and the 
rough ER (Froshauer et al., 1988).  In a recent study by Matthews et al. 
(2009) the N-terminus of the RV replication protein P150 and its precursor 
P200 was shown to be essential for fibre formation and the subcellular 
location of replication complexes, which replicate vRNA at cellular sites that 
partially overlap with endocytic and lysosomal membranes (Matthews et al., 
2009). 
 
To date, no studies have been conducted regarding the subcellular 
interactions of tetravirus replicases.  Tomasicchio et al. (2007) demonstrated 
that the induction of apoptosis in yeast cells expressing VCAP resulted in the 
spontaneous maturation of VLPs.  This, coupled with the acid maturation of 
VLPs and the cytosolic acidification caused during apoptosis, led 
Tomasicchio et al. to hypothesise that the viral replicase could associate with 
either the mitochondria or lysosomes due to their role in the induction of 
apoptosis (Matsuyama and Reed, 2000; Nilsson et al., 2006).  This was 
further supported by experiments demonstrating an increased incidence of 
apoptosis in HaSV-infected cells, suggesting that virus replication may induce 
apoptosis in vivo (Brooks et al., 2002).  Capsid maturation through cytosolic 
acidification could therefore be the result of the replicase-dependent 
induction of apoptosis (Tomasicchio et al., 2007).  Tetraviruses preferentially 
infect highly endocytic midgut cells and the observation that HaSV infection 
results in the accumulation of lysosomes (Brooks et al., 2002) suggests a 
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possible association of replication and endocytic organelles in host cells.  
The potential association of tetraviral replication, and the viral life cycle, with 
endocytic organelles warrants a discussion of cellular endocytosis, which will 
enable the comparison of the data obtained during the course of this study 
with the various organelles of cellular endocytic pathways.  A significant 
proportion of the data discussed in this thesis is suggestive of interactions 
between these organelles and the HaSV replicase.  Therefore, a full 
understanding of the cellular processes involved will greatly aid in the 
interpretation of these data. 
 
1.5 CLASSICAL AND ALTERNATE ENDOCYTIC PATHWAYS 
 
The endocytic pathway comprises a series of morphologically heterogeneous 
compartments designed for uptake of extracellular components.  These are 
largely destined for lysosomes, where they are degraded and the 
constituents (amino acids, nucleotides, lipids, cholesterol, etc.) made 
available for metabolism elsewhere in the cell (Gruenberg and Maxfield, 
1995; Fielding and Fielding, 1997; Gu and Gruenberg, 1999; Mullins and 
Bonifacino, 2001).  Since many viruses and a number of plant and toxic 
bacterial proteins exploit normal endocytic pathways to gain entry into their 
host cells, much of what we now know about the cellular processes involved 
in endocytosis is the direct result of studies aimed at understanding specific 
virus- and toxin-host interactions (reviewed in Johannes and Goud, 1998; 
Lord and Roberts, 1998; Pelkmans and Helenius, 2003).  Ultimately, the 
progression of the extracellular cargo through the endocytic pathway is 
achieved through a combination of vesicular transport and maturation that is 
further complicated by the continuous retrograde recycling of components to 
the plasma membrane and trans Golgi network, as well as the infrequent 
removal of undigested material from the cell upon fusion of lysosomes with 
the plasma membrane.   
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There is evidence that there may be a number of different endocytic 
pathways that a given cell may utilise and that different cells (and viruses) 
may utilise them to different extents and for different functions (Pelkmans and 
Helenius, 2003).  In addition, some proteins, such as 
glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) and (under 
certain conditions) tetraspannins cluster within distinct but overlapping 
regions of the plasma membrane and are endocytosed and trafficked along 
with detergent-resistant membranes (DRMs), the function of which is still 
largely unclear (Berditchevski, 2001; Claas et al., 2001; Levy and Shoham, 
2005; Hein et al., 2009; Zheng and Foster, 2009). 
 
1.5.1. Classical or clathrin-dependent endocytosis 
 
The uptake of extracellular macromolecules at the plasma membrane occurs 
primarily through receptor mediated endocytosis, allowing the cell to 
selectively bind and internalise components from the surrounding 
environment (summarised in Figure 1.7, Centre) (Gruenberg and Maxfield, 
1995).  For this purpose, transmembrane receptor proteins are displayed on 
the outer surface of the plasma membrane where they bind to their 
respective ligands.  After binding between the receptor and an appropriate 
ligand (or virus particle) has occurred, the receptor associates with transient 
invaginations of the plasma membrane caused by clathrin polymerisation, 
where it interacts with clathrin-associated sorting proteins and adaptor 
proteins, such as AP-2 (adaptor protein complex 2) and arrestin (Zaremba 
and Keen, 1983; Matsui and Kirchhausen, 1990; Trowbridge el al., 1993; 
Shih et al., 1995; reviewed in Robinson 1994; Mousavi et al., 2004; Traub 
2009).  This results in the stabilisation and formation of a clathrin-coated pit 
and the specific accumulation of virus- and/or ligand-bound receptors.  The 
clathrin-coated pit is then closed and pinched off to form a clathrin-coated 
vesicle by dynamin and its associated proteins (reviewed in Schmid et al., 
1998) and will transport the virus particle through the endocytic pathway until 
a virus-specific acidic pH triggers the next stage of infection (Helenius et al., 
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Figure 1.7:  Cellular endocytic pathways.  Schematic representations of caveolae (left), 
classical clathrin-dependent (centre) and lipid raft-dependent (right) endocytosis as 
described in text.  The table (top) indicates which major factors are required for each 
endocytic pathway.  Organelle names are in italics and examples of cargo carried by specific 
organelles are in brackets.  Normal text indicates selected factors present as organelle-
specific markers.  In the distinct early endosomes and caveosomes, notable markers that are 
absent are indicated with a cross before the marker name. 
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1980).  Since the lumen of the clathrin-coated vesicle contains fluid from 
outside the cell, it will also contain unbound extracellular components, which 
are taken up via fluid-phase endocytosis.  These vesicles are short-lived 
(approximately 1 minute) and shed their coat within seconds of being formed, 
rendering them competent for fusion with the early endosomes (Aniento et 
al., 1993).  
 
Within a few minutes endocytosed material is found in early endosomes, 
which are characteristically small (0.3 to 0.4 μm in diameter), tubulo-vesicular 
organelles with an internal pH of approximately 6.0 (Dunn and Maxfield, 
1992; Thilo et al., 1995; reviewed in Gruenberg and Maxfield, 1995).  These 
then undergo fusion events with newly endocytosed material from the plasma 
membrane at a rate that declines with age (Ajioka and Kaplan, 1986; Ward et 
al., 1990; Dunn and Maxfield, 1992).  The fusion events require the activity of 
protein phosphatases as well as the small GTPase Rab5, Syntaxin 13 and 
the tethering factor, early endosomal autoantigen 1 (EEA1) (Gorvel et al., 
1991; Bucci et al., 1992; Woodman et al., 1992; Clauge, 1999; McBride et al., 
1999; Luzio et al., 2000).  Rab5 functions as an important kinetic regulator of 
the transport of newly endocytosed material from the plasma membrane to 
the early endosomes, specifically with regard to vesicle fusion (Bucci et al., 
1992). 
 
The accumulation of lysosome-targeted constituents is further facilitated by 
the recycling of the receptors to the plasma membrane by recycling 
endosomes that bud from early endosomes, which at this point can be 
termed sorting endosomes (Dunn et al., 1989).  This sorting process allows 
for receptors to follow a number of different paths from the early endosomes.  
For example, transferrin is recycled back to the plasma membrane along with 
its receptor via recycling endosomes (Dautry-Varsat et al., 1983; Klausner et 
al., 1983), while EGF (epidermal growth factor) is routed through the 
endocytic pathway to the lysosomes where it is degraded along with its 
receptor (Carpenter and Cohen, 1979).  LDL (low density lipoprotein) is 
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transported for degradation, as opposed to the receptor which is recycled 
back to the plasma membrane (Goldstein et al., 1979).  Furthermore, studies 
showing that lipids (Puri et al., 2001) and proteins, such as Shiga toxin 
produced by Shigella dysenteriae and TGN38 (Ghosh et al., 1998; Mallard et 
al.. 1998), were sorted from this point to the Golgi, revealed the presence of 
a retrograde post-Golgi pathway for the recovery of secretory/biosynthetic 
pathway constituents (Mallard et al., 2002).  In some cases toxins, and 
probably host proteins, are further transported to the ER (reviewed in 
Johannes and Goud, 1998; Lord and Roberts, 1998).  Hence, the early 
endosome forms the major point for the sorting of proteins to be recycled or 
degraded (Gruenberg et al., 1989).  It appears that the recycling pathway is 
regulated by another small GTPase, Rab4, which plays a similar role to that 
of Rab5 in the early endosomes (Van Der Sluijs et al., 1992).  In addition to 
the functions relating to the movement of receptors, a number of lipids have 
been shown to follow the endocytic pathway to the lysosomes where they are 
further shuttled to the Golgi apparatus (Koval and Pagano, 1990; Chen et al., 
1998; Pagano et al., 1999; Pagano, 2003). 
 
With time, early endosomes become resistant to fusion with newly 
endocytosed material as they mature to form late endosomes via 
multivesicular bodies (MVBs) (reviewed in Gruenberg and Maxfield, 1995; 
Piper and Luzio, 2001).  Although dependent on cell type, maturation typically 
takes between 4 and 30 minutes in mammalian cells (Dunn and Maxfield, 
1992; Thilo et al., 1995).  This process proceeds in the absence of homotypic 
fusion in vitro, which is in contrast to both the early and late endosomes 
(Gruenberg et al., 1989; Bomsel et al., 1990; Aniento et al., 1993).  MVBs 
function as a means of transport and maturation from early to late 
endosomes, which is demonstrated by the observation that although the 
protein composition of the early and late endosomes are distinct, there is a 
large degree of overlap between the protein content of both endosomal 
compartments and MVB's (Aniento et al., 1993; Emans et al., 1993).   
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As MVBs mature, they are transported towards the late endosomes by an 
active process requiring intact microtubules and the motor proteins dynein 
and kinesin (Gruenberg et al., 1989; Bomsel et al., 1990; Aniento et al., 1993, 
Bananis et al., 2004).  This maturation into late endosomes coincides with an 
increase in the ability of these vesicles to fuse with traffic from the Golgi 
apparatus, which contain lysosomal enzymes targeted to the late endosomes 
by the mannose-6-phosphate receptor (Griffiths et al., 1988; Geuze et al., 
1988).  As is the case with early endosomes, a retrograde post-Golgi 
recovery pathway retrieves secretory pathway components from the late 
endosomes in a Rab9-dependent manner (Lombardi et al., 1993; Itin et al., 
1997; Carrol et al., 2001).   
 
Experimental evidence suggests that late endosomes then transfer their 
cargo to lysosomes in a combination of “fusion-fission” and “kiss-and-run” 
events (Bright et al., 2005; reviewed in Mullins and Bonifacino, 2001).  Bright 
et al. (2005) found that the majority of content-mixing in live rat kidney cells 
was the result of “kiss-and-run” or “kiss-and-linger” events where the content 
in the late endosome is delivered to the lysosome through brief contact that 
does not result in fusion.  This allows for the mixing of the contents of the two 
organelles without direct fusion, although a late endosome may subsequently 
fuse with a different lysosome (Bright et al., 2005).  It has also been observed 
that microtubule-dependent tubules may form over relatively large distances 
to facilitate content-mixing as well.  Bright et al. (2005) describe one such 
tubule that protruded from a lysosome and connected with a late endosome 
at a distance of over 13 μm.   
 
Fusion events also occur as late endosomes fuse with lysosomes to form late 
endosome-lysosome hybrid organelles that contain marker proteins from 
both organelles and are less electron dense than lysosomes.  The 
mechanism is not dependent on phosphorylation or microtubules (as is the 
case with early and late endosomal fusion events respectively), but is reliant 
on the activity of a Rab protein (Mullock et al., 1994, 1998; Bright et al., 2005; 
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reviewed in Luzio et al., 2000).  This late endosome-lysosome hybrid 
organelle then matures to reform a lysosomal compartment, apparently due 
to a combination of digestive processes and a membrane and late 
endosome-specific protein recovery system to remove late endosomal 
components (Bright et al., 1997; Mullock et al., 1998; Luzio et al., 2000; 
Bright et al., 2005). 
 
Maturation of the late endosome-lysosome hybrid therefore reforms the 
lysosome by a combination of degradation and membrane recycling 
processes.  At the end of the maturation process, the lysosomes are 
characterised by their acidic pH (approximately 4.5), the presence of acid 
hydrolases and specific integral membrane glycoproteins, an absence of 
mannose 6-phosphate receptors and recycling cell surface receptors and a 
perinuclear distribution that is dependent on Rab7 (Mellman et al., 1986; 
Feng et al., 1995; Bucci et al., 2000; Luzio et al., 2002). 
 
1.5.2. Detergent-resistant membranes, lipid rafts, caveolae and 
clathrin-independent endocytosis 
 
The membrane compartmentalisation model states that membrane 
microdomains are areas of biological membranes with different protein and/or 
lipid composition to the regions surrounding them, which are able to function 
in biosynthetic processes and endocytic transport or as specialised reaction 
centres and enzyme, substrate and/or adaptor concentration sites (Simons 
and Ikonen, 1997).  DRMs represent a subset of membrane fractions that are 
insoluble in cold, non-ionic detergents and have a low buoyant density, which 
is largely due to their association with high concentrations of cholesterol, 
sphingomyelin and glycolipids (reviewed in Anderson and Jacobson, 2002; 
Zheng and Foster, 2009).  Although they have often been associated with 
specific membrane microdomains, it has been argued that DRMs more 
accurately represent the incomplete solubilisation of membranes under the 
specified conditions and only exist as a result of the detergent treatments 
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(Lichtenberg et al., 2005).  Nevertheless, differential solubility in various 
detergents remains an important means of studying lipid-protein interactions, 
especially those associated with genuine in vivo lipid microdomains.   
 
In a number of cases, DRM isolation has been important for the isolation and 
characterisation of previously unidentified components of both the secretory 
and endocytic pathways in the cell, including the recently discovered 
clathrin-independent endocytic components (Figure 1.7, Left and Right).  For 
example, Lamaze et al. (2001) showed that interleukin 2 receptors, ultimately 
destined for the lysosomes, associate with DRMs on the cell surface and 
internally after dynamin-dependent and clathrin-independent endocytosis.  In 
Madin Darby Canine Kidney (MDCK) cells, the GPI anchor of membrane 
dipeptidase is important for maturation in the Golgi apparatus (Hein et al., 
2009) and Triton X-100-insoluble monocyte lipid rafts contain proteins from 
the ER and the endocytic pathway as well as proteins involved in vesicular 
fusion and actin-based vesicular transport (Li et al., 2003).  Interestingly, 
these non-classical pathways seem to be able to deliver their cargo to a 
number of different cellular destinations including lysosomes, the ER and the 
Golgi apparatus (Nichols and Lippincott-Schwartz, 2001).   
 
A number of viruses and bacterial toxins make use of these pathways to 
enter cells (Figure 1.7) including Simian virus 40 (SV40), targeted to the ER 
via caveosomes, and Cholera toxin, which is taken up by numerous cellular 
processes but requires clathrin-independent endocytosis to gain access to 
the Golgi apparatus for it to be toxic (Tran et al., 1987; Norkin, 1999).  These 
non-classical pathways also appear to play an important role in the regulation 
and transport of intracellular cholesterol (Fielding and Fielding, 1997) and are 
thought to play a role in Plasmodium falciparum infection of human 
erythrocytes (Murphy et al., 2004).  Studies such as these are revealing that 
the inner complexity of both the secretory and endocytic pathways goes 
beyond the well-defined classical pathways and are identifying a number of 
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previously unacknowledged pathways (reviewed in Nichols and Lippincott-
Schwartz, 2001; Johannes and Lamaze, 2002; Pelkmans and Helenius, 
2003; Mayor and Pagano, 2007). 
 
Although there are several clathrin-independent endocytic pathways, 
unambiguous classification of these pathways is somewhat difficult.  In broad 
terms, these alternative pathways are generally dependent on dynamin, 
caveolin or lipid rafts with the classical endocytic pathway dependent on 
clathrin and dynamin (Section 1.5.1). The caveolae pathway is dependent on 
caveolin-1 and dynamin, while lipid-raft dependent endocytosis may or may 
not be dynamin dependent (Figure 1.7) (Pelkmans and Helenius, 2003; 
Mayor and Pagano, 2007).  Since there appears to be some plasticity in 
terms of function and the uptake of different cargo in different cells, this 
survey will discuss lipid rafts and caveolae in terms of what is known in 
general and will attempt to avoid cell- or tissue-specific functions. 
 
Lipid rafts 
Lipid rafts have been defined as “dynamic assemblies of cholesterol and 
glycosphingolipids that are present in the lateral plane of membranes” 
(Johannes and Lamaze, 2002) with sphingolipids acting as spacers due to 
their relatively large head groups (Simons and Ikonen, 1997).  This 
cholesterol-lipid interaction results in a tightly packed structure that differs 
significantly from the surrounding membrane.  The structure and function is 
maintained by lipid-lipid interactions, associations of lipids and proteins that 
are recruited through their high affinity for lipid rafts (such as GPI-APs) and 
protein-protein interactions, which can result in large protein complexes.  The 
concentration and partition of specific proteins onto the distinct lipid rafts 
produces membrane reaction centres that are especially active in cellular 
signalling and trafficking (Simons and Ikonen, 1997; Foster et al., 2003; Li et 
al., 2003; Botto et al., 2004). 
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In addition to functions in signal transduction, a number of vesicular transport 
pathways are associated with lipid rafts.  For example, it has been 
hypothesised that they are involved in post-Golgi retrograde secretory 
pathway transport that runs parallel to that observed in the classical 
endocytic pathway (Simons and Ikonen, 1997).  This pathway provides an 
alternative route for the recovery of ER and Golgi proteins mis-transported 
towards the cell surface along the secretory pathway.  While low levels of 
EGF stimulate receptor-mediated endocytosis almost exclusively via the 
classical pathway, higher concentrations of EGF result in the ubiquitination of 
the EGF receptor, which is sufficient to stimulate internalisation by a lipid raft-
dependent route (Sigismund et al., 2005).  In addition there are dynamin-
independent pathways that appear to require the small GTPases CDC42, 
ARF6 or RhoA (Mayor and Pagano, 2007), both the CDC42- and ARF6-
dependent pathways require sphingomyelin-associated proteins but not 
glycosphingolipids (Cheng et al., 2006).  The CDC42 pathway is also 
reported to be involved in the uptake of a large proportion of GPI-APs (Kalia 
et al., 2006).  In contrast, the Herpes simplex virus (HSV) protein VP22 is 
internalised via an ARF6-dependent pathway that is also dynamin-dependent 
(Nishi and Saigo, 2007).  The complexity in terms of the small GTPases that 
are required and the observation of dynamin-dependent and -independent 
pathways for many of them means that it is difficult to know what differences 
are the result of cell type as opposed to changes in experimental methods.  
However, what is clear is that there are a rapidly increasing number of 
reports of endocytosis by lipid raft-associated mechanisms that are both 
clathrin- and caveolin-independent. 
 
Caveolae 
Many cell types have flask-shaped, stable invaginations on the plasma 
membrane called plasmalemmal vesicles or caveolae (in reference to their 
cave-like appearance when viewed by electron microscopy) (reviewed in 
Stan, 2005).  These invaginations typically have an outer diameter of 
approximately 70 nm and can occur in a number of distributions across the 
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cell surface.  Although discovered by electron microscopy over half a century 
ago, the first protein component, caveolin (now caveolin-1), was only 
discovered in 1992 (Palade, 1953; Rothberg et al., 1992).  Since then further 
caveolins (caveolin-2 and caveolin-3) and a number of other lipid and protein 
components such as sphingolipids, glycosphingolipids, fatty acids, 
cholesterol, signalling proteins and GPI-APs have been shown to be involved 
in the formation of caveolae – although protein-protein interactions are the 
determining factor for formation (Simons and Ikonen, 1997; Aboulaich et al., 
2004; Sprenger et al., 2004; Cheng et al., 2006; Zheng and Foster, 2009).   
 
Caveolae are multi-functional membrane domains utilised in the up- or down-
regulation of enzyme activity through the compartmentalisation of enzymes, 
endocytosis, cholesterol transport and homeostasis, signal transduction and 
cell signalling (Fielding and Fielding, 1997; Henley et al., 1998; Kurzchalia 
and Parton, 1999; Sowa et al., 2001; Sandvig et al., 2008).  Although 
caveolae have been thought of as specialised lipid rafts and the majority of 
data available appears to confirm this, their association with cholesterol has 
been questioned (Foster et al., 2003).  However, in contrast to lipid rafts there 
are a number of distinct molecules associated with caveolae, most notably 
the caveolins (Rothberg et al., 1992; Liu et al., 1997; Sowa et al., 2001).  
Additionally, cholesterol and an association with intact actin cytoskeletal 
elements are required for their formation while internalisation is dynamin-
dependent and is a triggered event (Parton et al., 1994; Thomsen et al., 
2002).  Internalisation via caveolae is also very slow with only around 2 % of 
caveolin-1-positive vesicles budding from the plasma membrane per minute 
in mouse embryonic fibroblasts (Kirkham et al., 2005).  In SV40-infected 
cells, phosphorylation of caveolae-associated proteins is required for the 
extensive actin rearrangements necessary for internalisation (Pelkmans et 
al., 2001).  In contrast to the other endocytic pathways described above, 
internalisation by caveolae does not appear to be involved in constitutive or 
fluid-phase endocytosis (Pelkmans et al., 2001). 
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Destinations of material internalised by clathrin-independent endocytosis 
Although there are a number of different mechanisms available to cells for 
internalisation, it appears that the majority of endocytosed material is 
ultimately transported into Rab5- and EEA1-positive early endosomes, where 
normal sorting processes direct cargo to the degradative pathway, the 
secretory pathway or back to the plasma membrane (Figure 1.7) (Hansen et 
al., 1993; Mayor and Pagano, 2007).  However, there are alternate routes 
and intermediate compartments associated with each of the pathways that 
are different from those observed in the classical pathway (Figure 1.7). 
Endocytosis by lipid raft-dependent pathways usually bud into distinct early 
endosome-like compartments.  Clathrin-, caveolin-1- and dynamin-
independent carrier vesicles bud directly from tubular invaginations of the 
plasma membrane containing GPI-APs (Kirkham et al., 2005).  Naslavsky et 
al. (2003) reported that the interleukin 2 receptor, internalised by AFR6-
associated endocytosis, enters endosomes distinct from those containing 
cargo from the classical pathway.  The same has been observed for GPI-APs 
from a CDC42-dependent, dynamin-, AFR6- and RhoA-independent pathway 
(Sabharanjak et al., 2002; Kalia et al., 2006) and the VacA cytotoxin 
produced by Helicobacter pylori (Gauthier et al., 2005).  These endosomes 
are acidic structures devoid of EEA1, Rab4 and Rab5 (Kalia et al., 2006).  
Later they acquire EEA1 and Rab5 and undergo homotypic fusion with other 
ARF6-associated GPI-AP-enriched early endosomal compartments (GEECs) 
and heterotypic fusion with early endosomes from the classical pathway, 
ultimately resulting in an overlap with typical endocytic cargo like LDL 
(Radhakrishna and Donaldson, 1997; Naslavsky et al., 2003; Kalia et al., 
2006).  Following convergence, cargo from both the lipid raft-associated and 
classical pathways are transported together to the lysosomes in a Rab7-
dependent manner (Naslavsky et al., 2003) or sorted by normal cellular 
processes to the Golgi or the plasma membrane.   
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Caveolae deliver their cargo to caveosomes (Pelkmans et al., 2001), which 
are pre-existing, static, stable and cholesterol-enriched structures that have 
neutral luminal pH and are devoid of Rab4, Rab5, Rab7, Rab9 and Rab11 
(Thomsen et al., 2002; Pelkmans and Helenius, 2003).  From here cargo can 
be transported to early endosomes (Gagescu et al., 2000) or the smooth ER 
(Kartenbeck et al., 1989).  However, caveosomes appear to function in 
specific sorting of only the cargo derived from caveolae-associated 
endocytosis since they do not seem to receive cargo from the classical 
endocytic pathway, as demonstrated by the absence of classical markers or 
ligands (Pelkmans et al., 2001).  This is further substantiated by the 
observation that they do not accumulate fluid-phase markers such as 
fluorescent-labelled dextran, even in the presence of cargo known to be 
internalised via caveolae (Pelkmans et al., 2001). 
 
In addition to alphaviruses (SFV and SIN) and RV, all of which form 
replication complexes that associate at least in part with classical endocytic 
organelles (Froshauer et al., 1988; Matthews et al., 2009), alternate 
endocytic pathways are involved in the life cycles of viruses such as SV40 
and HSV (Norkin, 1999; Nishi and Saigo, 2007).  Since all the tetraviruses 
studied thus far have been shown to infect the midgut cells of their hosts, it is 
possible that the well developed endocytic systems present in these cells are 
important in one or more stages in the tetravirus life cycle. 
 
1.6 PROBLEM STATEMENT 
 
Very little is known about tetravirus replication biology and to date there is no 
literature available on the subcellular site of tetravirus replication.  Their 
unusually narrow host range and tissue tropism as well as the absence of an 
in vitro cell culture system has hampered the study of the replication and 
expression strategies of the Tetraviridae (Bawden et al., 1999).  Thus, the 
broad aim of the research described in this thesis was to develop new 
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experimental systems for studying tetravirus replication, focusing on the 
subcellular localisation of the HaSV replicase. 
 
1.7 SIGNIFICANCE OF UNDERSTANDING HaSV REPLICATION 
BIOLOGY 
 
Besides contributing to knowledge about tetravirus replication, studies on the 
replication biology of the replicase from HaSV has the potential to impact the 
understanding of RNA replication in other viruses.  HaSV relies on a single 
virus encoded protein for vRNA replication and, as a result, represents one of 
the simplest viruses known.  This simplicity means that auxiliary functions, 
encoded by additional viral proteins in more complex viruses, must, in the 
case of HaSV, be supplied by host proteins.  As a result, understanding 
gained from the analysis of the replication biology of HaSV could shed light 
on host functions essential for virus replication and thus identify auxiliary 
processes supplied by the host cell.  In addition, the results obtained from 
this “basic” viral unit could be extrapolated to larger viruses with more 
complicated genomes and protein production strategies, enabling an 
increased understanding of the reasons behind the greater complexity and 
the ways in which different replication strategies are suited to particular 
cellular environments. 
 
1.8 OBJECTIVES 
 
1. To develop experimental systems for studying tetravirus replication 
2. Analysis of the cellular distribution and subcellular localisation of the 
HaSV replicase in tissue culture cell lines 
3. Identification and characterisation of HaSV replicase membrane 
targeting domains 
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2.1 INTRODUCTION 
 
The discovery of HaSV by Hanzlik et al. in 1993 resulted in significant 
advances in the knowledge of the Tetraviridae.  This was because, unlike 
many tetravirus hosts, H. armigera can be reared in laboratory colonies, and 
as a result HaSV has proven to be an important tool in understanding some 
of the common features found in the broader virus family.  However, at the 
outset of the research described in this thesis, the replication biology of HaSV 
was essentially unknown.  This was due to the absence of a replication-
competent tissue culture system, as well as the inability to detect HaSV 
replicase in infected cells because of the unavailability of replicase-specific 
antiserum.  Thus the first objective of this study was to identify potential 
antigenic regions of the HaSV replicase, to overexpress them in E. coli and to 
use purified protein to raise polyclonal anti-replicase antiserum. 
 
2.2 MATERIALS AND METHODS 
 
Unless otherwise indicated, recombinant DNA methods were generally as 
described in Sambrook et al. (1989).  The E. coli strain DH5α (F- endA1 
glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK- mK+), λ–) (Hanahan, 1983) was used to propagate 
recombinant plasmids and E. coli BL21 (DE3) (B F- dcm ompT hsdS(rB- mB-) 
gal λ(DE3)) (Studier and Moffatt, 1986; Studier et al., 1990) was used for the 
overexpression of polypeptide fragments.   
 
CHAPTER 2 
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2.2.1. Bioinformatic analysis of the HaSV replicase and selection of 
 fragments for bacterial expression 
 
Potentially hydrophilic domains of the HaSV replicase were identified by 
bioinformatic analysis according to Kyte and Doolittle (1982), generated by 
online submission of the HaSV replicase amino acid sequence (cDNA 
GenBank accession number EU345431) to the ProtScale program (Gasteiger 
et al., 2005) hosted by the Expert Protein Analysis System (ExPASy) 
(ProtScale last accessed at http://au.expasy.org/tools/protscale.html on 
29/03/2010). 
 
2.2.2. Recombinant plasmids for the overexpression of HaSV 
 replicase protein fragments in E. coli 
 
Basic restriction maps of the recombinant expression vectors used in the 
experiments described in this chapter are shown in Figure 2.1 and their 
construction is described in detail in Appendix A.  The bacterial expression 
vector pT7-7_6xHis –Xba I (referred to as pT7-7_6xHis) contains the T7 RNA 
polymerase promoter, ribosome binding site (RBS) and a hexa-histidine 
(6xHis) sequence following the methionine residue which is directly upstream 
of a multiple cloning cassette (Figure 2.1).  Both pJRS17 and pJRS19 were 
derived from pT7-7_6xHis and contain the 5' fragments of the HaSV 
replicase CDS corresponding to the N-terminal 150 or 218 amino acids 
respectively, fused in frame with the 3' end of the 6xHis CDS for the 
production of His-REP1-150 and His-REP1-218.  A recombinant plasmid for the 
expression of a glutathione S-transferase (GST)-tagged HaSV replicase 
fragment, pJRS23, was also constructed.  Derived from the commercially 
available pGEX-4T-2 (GE Healthcare), pJRS23 contains the sequence 
coding for the carboxy-terminal 564 amino acids of the HaSV replicase fused 
at its N-terminus to the C-terminus of GST, with expression under the control 
of an inducible tac promoter.  
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Figure 2.1:  Restriction maps of the recombinant bacterial expression vectors used in 
the overproduction of HaSV replicase fragments in E. coli cells. Amp R: β-lactamase, 
GST: glutathione S-transferase, laclq: lac operon repressor protein, T7 Promoter: T7 
bacteriophage RNA polymerase promoter, tac Promoter: hybrid bacterial promoter.  The 
cloning strategy used to generate these plasmids can be found in Appendix A. 
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2.2.3. Overexpression of HaSV replicase fragments in E. coli BL21 
 (DE3) cells 
 
Recombinant constructs pJRS17, pJRS19 or pJRS23 were transformed into 
competent E. coli BL21 (DE3) cells, with 1 ml of an overnight culture 
inoculated into 100 ml Luria-Bertani (LB) broth (containing 125 μg/ml 
ampicillin) and grown at 37 °C with shaking until the cultures reached an 
OD600 nm of between 0.4 and 0.6.  Protein expression was induced by adding 
isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1 μM 
and cultures were then grown further until cultures had reached an OD600 nm 
of between 0.8 and 1.0.  Cells were harvested by centrifugation at 10 000 x g 
at 4 °C for 10 minutes and samples analysed by sodium dodecyl sulphate 
(SDS) polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970).  
SDS-PAGE was conducted using discontinuous glycine/polyacrylamide gels 
with 4 % stacking and 7.5 % or 15 % resolving gels for GST-REP1140-1704 and 
the His-tagged replicase fragments (His-REP1-150 and His-REP1-218) 
respectively.  E. coli cell-free extracts were generated by centrifuging 1 ml of 
an overnight culture at 16 000 x g for 1 minute in a bench-top microfuge and 
resuspending the resulting pellet in 100 μl of 1 x sample buffer (10 % 
glycerol, 125 mM Tris-Cl pH 6.8, 4 % SDS, 10 % β-mercaptoethanol, 0.01 % 
bromophenol blue) per 1 OD600 nm unit followed by boiling for 5 minutes. 
 
2.2.4. Solubility of HaSV replicase fragments 
 
Cells expressing HaSV replicase fragments were harvested as in Section 
2.2.3 and resuspended in 2 ml lysis buffer (50 mM NaH2PO4 (pH 8.0), 
300 mM NaCl, 10 mM imidazole) in the case of pJRS17 and pJRS19, or 2 ml 
phosphate buffered saline (PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2PO4, 1.8 mM KH2PO4, pH 7.4) for pJRS23, after which 20 μg lysozyme 
was added to each sample.  Cells were incubated on ice for 30 minutes 
before being sonicated using a hand-held 3 mm probe (Vibra CellTM) at 40 % 
power for ten 10 second cycles.  Soluble and insoluble fractions were 
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separated by centrifugation of sonicated extracts at 10 000 x g at 4 °C for 30 
minutes.  Proteins were resolved by SDS-PAGE and detected using 
coomassie staining. 
 
2.2.5. Purification of recombinant replicase polypeptides and 
antiserum production 
 
Gel-purification of HaSV replicase polypeptides 
Insoluble replicase polypeptides were purified by gel-purification from SDS-
polyacrylamide gels (Method provided by Dr. Sharon Braunagel, Department 
of Biochemistry and Biophysics, Texas A and M University, College Station, 
Texas, USA).  Following SDS-PAGE using a 15 % polyacrylamide resolving 
gel, the resolving gel was incubated in 100 ml ice-cold 100 mM KCl for 5 
minutes to visualise protein bands.  The appropriate protein band (visible as 
an opaque white band) was then excised from the resolving gel and finely 
diced into small pieces before incubation at 4 °C in PBS (pH 7.4) overnight.  
The extracts were then passed through a glass wool plug placed at the 
bottom of a disposable 2 ml plastic syringe to remove the acrylamide gel and 
the eluted protein concentrated by ethanol precipitation by adding 
1.6 x volume ice cold 95 % ethanol.  Samples were incubated on ice for 1 
hour with occasional inversion before centrifugation at 10 000 x g for 5 
minutes at room temperature.  Pellets were dried and then incubated in 
100 μl PBS per gel on ice for 2.5 hours.  Finally, the resuspended protein was 
resolved using SDS-PAGE and detected by coomassie staining.  
 
Denaturing nickel-affinity purification of His-REP1-218 
Cells expressing His-REP1-218 (pJRS19) were harvested as described in 
Section 2.2.3 before being resuspended in buffer B (8 M urea, 0.1 M 
NaH2PO4, 0.01 M Tris-Cl, pH 8).  The 25 kDa 6xHis-tagged polypeptide was 
purified using the denaturing nickel-affinity protocol for Ni-NTA spin columns 
(Qiagen) according to the manufacturer's directions.  The resulting fractions 
were analysed by SDS-PAGE using a 12 % resolving polyacrylamide gel.  
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Elution fractions were pooled, concentrated and exchanged into buffer B 
without urea by dialysis using Amicon Ultra-15 centrifugal filter units (10 kDa 
cut-off) (Millipore). 
 
Expression and solubility of GST-REP1140-1704 
The expression of GST-REP1140-1704 was induced in cells transformed with 
pJRS23 by the addition of 1 μM IPTG once the cells had reached an OD600 nm 
of between 0.4 and 0.6.  They were grown further with shaking at 37 °C and 
harvested in PBS (pH 7.4) as described in Section 2.2.3.  Crude extracts 
were obtained by sonication of the cells on ice as described in Section 2.2.4.  
Soluble and insoluble fractions were obtained by centrifugation of the crude 
extracts at 10 000 x g for 30 minutes at 4 °C, analysed by SDS-PAGE and 
the proteins visualised using coomassie staining. 
 
Production of rabbit polyclonal antiserum directed against His-REP1-218 
Approximately 1 mg of purified protein was used to raise a rabbit polyclonal 
antiserum against different regions of the HaSV replicase (produced by Prof. 
D. U. Bellstedt, Department of Biochemistry, University of Stellenbosch, 
Stellenbosch, South Africa).  The specificity and optimal concentration of the 
antiserum generated against the His-REP1-218 polypeptide were tested using 
crude extracts of E. coli BL21 (DE3) cells transformed with pT7-7_6xHis, 
pJRS17 or pJRS19 and/or mock- and HaSV-infected H. armigera larvae.  H. 
armigera midgut cell-free extracts were produced by homogenising a single 
mock- or HaSV-infected larva in 1.5 ml centrifuge tubes using a glass rod in a 
small volume of PBS.  The homogenate was then diluted with an equal 
volume of 2 x sample buffer and boiled for 5 minutes.  Proteins in the cell-free 
extracts were resolved using 12 % or 15 % polyacrylamide resolving gels and 
transferred to HybondTM-C extra nitrocellulose membrane (GE Healthcare) 
using the Biorad® Mini Trans-blot electrophoretic transfer cell system as 
recommended by the manufacturer.  Antibodies were diluted in Tris-buffered 
saline (150 mM NaCl, 50 mM Tris-Cl, pH 7.6) containing 0.1 % Tween-20 and 
1 % BSA, fraction V (Roche Applied Biosciences) for western analyses. 
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2.3 RESULTS 
 
Hydropathy plots (Kyte and Doolittle, 1982) were used to identify regions of 
the HaSV replicase with relatively high levels of predicted hydrophilicity 
(Figure 2.2).  Two regions that might serve as antigens for antibody 
production were selected for expression in heterologous expression systems 
because they represented the regions with the highest probability of being 
soluble.  The first region included the N-terminal 150 amino acids of the 
replicase (REP1-150).  As this fragment ended within the replicase MT domain, 
a second fragment including the entire MT domain (REP1-218) was also 
selected.  Secondly, the C-terminal 564 amino acids were chosen 
(REP1140-1704) based on the high proportion of predicted hydrophilic regions 
(Figure 2.2).  
 
 
 
Figure 2.2:  Schematic representation of the regions of the HaSV replicase selected for 
overexpression in bacterial cells and their corresponding hydropathy plots.  The 
expression plasmids pJRS17, pJRS19 and pJRS23 encode His-REP1-150, His-REP1-218 and 
GST-REP1140-1704 respectively.  The native replicase is shown with the methyltransferase 
(MT), helicase (HEL) and RNA-dependent RNA polymerase (RdRp) domains indicated by 
black boxes.  Kyte and Doolittle hydropathy plots (Kyte and Doolittle, 1982) are shown below 
the N- and C-terminal fragments. 
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2.3.1. Expression and purification of replicase polypeptides 
His-REP1-150 and His-REP1-218 
 
The first HaSV replicase fragment to be expressed in E. coli cells was 
His-REP1-150.  Crude extracts derived from E. coli cells transformed with 
pJRS17 and pT7-7_6xHis were compared using SDS-PAGE analysis, 
showing the expression of a polypeptide of approximately 17.5 kDa, 
corresponding to the predicted size of His-REP1-150 (Figure 2.3, Panel A, 
Lanes 7 to 10), which was not present in cells transformed with the control 
vector plasmid, pT7-7_6xHis (Figure 2.3, Panel A, Lane 6).  This 17.5 kDa 
polypeptide appeared to be largely insoluble since it was not detected in the 
supernatant fractions of solubility experiments but was only visible in pellet 
fractions following SDS-PAGE (Figure 2.3, Panel B, Lane 6 vs Lane 8).  
Attempts to gel-purify the polypeptide from the insoluble fraction using the 
acrylamide gel purification protocol (Section 2.2.5) were unsuccessful (data 
not shown).  It was concluded that His-REP1-150 was insoluble when 
expressed in E. coli cells and could not be solubilised for use in antiserum 
production. 
 
Next the N-terminal replicase polypeptide was extended to include the entire 
MT domain.  It was thought that the presence of the full MT sequence would 
aid in the proper folding of the polypeptide since this domain constitutes a 
functionally distinct portion of the full length HaSV replicase.  Initial 
SDS-PAGE analysis of crude extracts of E. coli cells transformed with 
pJRS19 indicated that a protein of approximately 25 kDa was overexpressed 
in cells cultured in the presence of IPTG (Figure 2.4, Lane 4).  This 
polypeptide was absent in cells transformed with pT7-7_6xHis (Figure 2.4, 
Lane 2).  As was the case with His-REP1-150, the 25 kDa polypeptide was 
largely insoluble, with the majority of the polypeptide being detected in pellet 
fractions while remaining undetectable in supernatant fractions of solubility 
experiments (Figure 2.4, Lane 5 vs Lane 6).  However, in contrast 
His-REP1-150, it was possible to gel-purify His-REP1-218 (Figure 2.4, Lane 7).  
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Approximately 1.2 mg of His-REP1-218 was purified, concentrated and 
dialysed for use in raising rabbit polyclonal anti-replicase antiserum 
designated anti-REP1-128(a).  
 
 
Figure 2.3:  Overexpression and solubility of His-REP1-150 in E. coli BL21 (DE3) cells.  
A: SDS-PAGE analysis of cell-free extracts of E. coli BL21 (DE3) cells transformed with 
pT7-7_6xHis or pJRS17 plasmid isolates showing uninduced cells (Lanes 1 to 5) or cells 
induced with IPTG (Lanes 6 to 10).  B: SDS-PAGE analysis showing IPTG-induction and 
solubility of His-REP1-150 expression.  Crude extracts of uninduced (Lanes 1 and 2) and 
induced (Lanes 3 and 4) E. coli BL21 (DE3) cells transformed with pT7-7_6xHis or pJRS17 
are shown.  Pellet (Lanes 5 and 6) and supernatant (Lanes 7 and 8) fractions, representing 
insoluble and soluble protein fractions respectively, were derived from the IPTG-induced 
cells.  Molecular mass standards are indicated in kDa on the left of each image and the 
arrows on the right indicate the recombinant 17.5 kDa His-REP1-150 polypeptide. 
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2.3.2. Validation of anti-REP1-218(a) polyclonal antiserum 
 
The suitability of the anti-REP1-218(a) antiserum for western analysis was 
determined using varying amounts of E. coli cell-free extracts expressing N-
terminal HaSV replicase fragments and homogenised HaSV-infected H. 
armigera larvae.  The antiserum was able to detect His-REP1-218 in crude 
protein extracts derived from E. coli cells transformed with pJRS19, even 
when these protein extracts were diluted 100-fold (Figure 2.5, Lanes 3 
and 5).  This band was not detected in crude extracts derived from cells 
transformed with the control vector plasmid, pT7-7_6xHis (Figure 2.5, 
Lane 1).  Detection of His-REP1-150 was far less sensitive.  The 17.5 kDa 
protein was only weakly detected at a dilution of 1:10 (Figure 2.5, Lane 2).  
Longer exposure of the X-ray film resulted in the detection of a stronger 
signal that was also absent from cells transformed with pT7-7_6xHis (data 
 
 
 
Figure 2.4:  Overexpression, solubility and gel-purification of His-REP1-218.  SDS-PAGE 
analysis of crude extracts of E. coli cells transformed with pT7-7_6xHis and pJRS19 showing 
uninduced cells (Lanes 1 and 3) and cells induced with IPTG (Lanes 2 and 4).  Pellet 
(Lane 5) and supernatant (Lane 6) fractions, representing insoluble and soluble protein 
fractions respectively, were derived from the induced cells transformed with pJRS19.  
His-REP1-218 following gel-purification, concentration and dialysis is shown in lane 7.  
Molecular mass standards are indicated on the left in kDa and the 25 kDa His-REP1-218 
polypeptide is indicated on the right. 
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not shown).    Non-specific proteins of approximately 60, 36 and 27 kDa were 
detected in all three E. coli extracts (Figure 2.5, Lanes 1 to 3).  No HaSV-
specific proteins were detected by this antiserum in crude extracts derived 
from infected H. armigera larvae (Figure 2.5, Lanes 8 and 9). 
 
 
2.3.3. Denaturing nickel affinity purification of His-REP1-218 
 
The poor specificity and low sensitivity of the anti-REP1-218(a) antiserum 
meant that the antibodies would be unsuitable for use in western analysis 
and further biochemical analysis of the HaSV replicase.  As a result, it was 
 
 
 
 
 
Figure 2.5:  The affinity of anti-REP1-128(a) antiserum tested against crude extracts of E. 
coli cells transformed with pT7-7_6xHis, pJRS17 and pJRS19.  Western analysis of 
varying dilutions of cell free extracts of E. coli BL21 (DE3) cells transfected with pT7-7_6xHis 
(Lane 1), pJRS17 (Lanes 2, 4 and 6) or pJRS19 (Lanes 3, 5 and 7) as well as undiluted 
crude extracts derived from uninfected (Lane 8) and HaSV-infected (Lane 9) H. armigera 
larvae using anti-REP1-218(a) antiserum at a dilution of 1:12 000.  The ratios 1:10, 1:100 and 
1:1000 represent 10-fold serial dilutions of the transformed E. coli cell free extracts.  
Molecular mass standards are indicated on the left in kDa.  Asterisks (“*”) represent distinct 
E. coli and H. armigera proteins detected by the REP1-218(a) antiserum and are indicated on 
the right in addition to His-REP1-218 (25 kDa) and His-REP1-150 (17.5 kDa) polypeptides.  His-
REP1-150 was only detectable as a faint band in lane 2. 
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decided to purify the REP1-218 polypeptide, which carries an N-terminal 6xHis 
tag, using nickel affinity chromatography to generate a polypeptide of higher 
purity, less likely to produce an antiserum that would cross react with E. coli 
proteins.  Native nickel affinity purification was unsuccessful (data not 
shown), so His-REP1-218 was purified using a denaturing nickel affinity 
purification protocol.  This proved to be more efficient than the gel purification 
and approximately 1.6 mg of His-REP1-218 was purified, with 1.3 mg being 
used to generate anti-REP1-218(b) antiserum.  SDS-PAGE analysis showed 
that His-REP1-218 was successfully purified using the Ni-NTA matrix 
(Figure 2.6, Lanes 9 to 11).  Although the purified polypeptide (Figure 2.6, 
Lane 12) contained a small amount of contaminating E. coli protein detected 
between 40 and 50 kDa (also faintly visible in Figure 2.6, Lanes 9 to 11), it 
was used to raise rabbit polyclonal antibodies.  
 
 
 
 
 
 
 
Figure 2.6:  Denaturing nickel affinity purification of His-REP1-218.  SDS-PAGE analysis 
of fractions collected during the nickel affinity purification of His-REP1-218 from E. coli BL21 
(DE3) cells transformed with pJRS19 under denaturing conditions.  The cleared lysate (“CL”, 
Lane 1), flow-through (“FT”, Lane 2), wash (Lanes 3 to 8), elution (Lanes 9 to 11) and final, 
purified, dialysed and concentrated (“Conc”, Lane 12) fractions are shown.  Molecular mass 
standards are indicated on the left of the gel in kDa and the arrowhead on the right indicates 
the 25 kDa His-REP1-218. 
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2.3.4. Validation of rabbit anti-REP1-218(b) polyclonal antiserum 
 
The specificity and sensitivity of the antiserum raised against His-REP1-218 
was tested using various dilutions of E. coli cells transformed with pJRS19 
and purified His-REP1-218.  In contrast to the antiserum raised against 
gel-purified antigen, the anti-REP1-218(b) antiserum (raised against affinity-
purified REP1-218) appeared to be both more sensitive and more selective for 
the detection of His-REP1-218.  The 25 kDa recombinant polypeptide was 
detected in cells transformed with pJRS19 and not in cells transformed with 
pT7-7_6xHis (Figure 2.7, Lane 2 vs Lane 1).  A number of cross-reacting 
proteins were detected in the undiluted E. coli extracts (Figure 2.7, Lanes 1 
and 2) but were only weakly detected at a dilution of 1:10 (Figure 2.7, Lane 
3).  Purified His-REP1-218 was detectable at below 50 ng (Figure 2.7, Lane 6). 
 
 
 
 
 
 
 
Figure 2.7:  The affinity of anti-REP1-218(b) antiserum tested using E. coli crude extracts 
and purified His-REP1-218.  Western analysis of varying dilutions of cell free extracts of cells 
transformed with pT7-7_6xHis (Lane 1) and pJRS19 (Lanes 2 to 4) purified His-REP1-218 
(Lanes 5 and 6) using anti-REP1-218(b) antiserum at a dilution of 1:15 000.  The ratios 1:1, 
1:10 and 1:100 represent 10-fold serial dilutions of the E. coli crude extracts and the mass of 
purified His-REP1-218 loaded is indicated in lanes 5 and 6.  Molecular mass standards are 
indicated on the left of each blot in kDa and His-REP1-218 (25 kDa) is indicated on the right of 
the blot. 
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2.3.5. Expression and purification of GST-REP1140-1704 
 
In order to generate an antiserum directed against the C-terminus of the 
replicase for use in co-immunoprecipitation experiments, it was decided to 
use the second hydrophilic replicase fragment (amino acid residues 1120 to 
1704) with a GST tag that might facilitate solubility of the fusion protein.  The 
expression of GST-REP1140-1704 in E. coli cells transformed with pJRS23 
resulted in the overproduction of a protein with an estimated molecular mass 
of 87 kDa upon induction of expression with IPTG that was absent in 
uninduced cells (Figure 2.8, Lane 1 vs Lane 2).  However, the fusion protein 
was not soluble, consistently appearing in the pellet fraction during solubility 
experiments (Figure 2.8, Lane 3 vs Lane 4).  Attempts to increase the 
solubility of GST-REP1140-1704 using detergents such as Triton X-100 and 
N-lauroylsarcosine were unsuccessful (data not shown), precluding the use 
of the fusion polypeptide for antibody production. 
 
 
 
 
Figure 2.8:  Overexpression and solubility of GST-REP1140-1704 expressed in E. coli 
cells.  SDS-PAGE analysis of cell free extracts of E. coli BL21 (DE3) cells transformed with 
pJRS23 showing uninduced cells (Lane 1) and cells induced with IPTG (Lane 2). Pellet 
(Lane 3) and supernatant (Lane 4) fractions were obtained from IPTG-induced cells 
expressing GST-REP1140-1704.  Molecular mass standards are indicated on the left in kDa and 
the arrowhead on the right indicates the 87 kDa GST-REP1140-1704. 
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2.4 DISCUSSION 
 
The absence of suitable antibodies for the detection of the HaSV replicase by 
western analysis and immunofluorescence microscopy has prevented the 
biochemical characterisation and in vivo detection of the viral replicase.  
During the course of this study, four attempts were made to express HaSV 
replicase fragments in E. coli cells using three different polypeptides 
identified as REP1-150, REP1-218 and REP1140-1704.  Ultimately two anti-
replicase antisera were produced, both of which were raised against 6xHis 
tagged polypeptide consisting of the N-terminal 218 amino acids (His-REP1-
218), including the entire MT domain of the replicase.  Validation of the 
antibodies raised against His-REP1-218 showed that both anti-REP1-218(a) and 
anti-REP1--218(b) were able to detect similar amounts of E. coli-expressed 
polypeptide fragments, but that the anti-REP1-218(b) antiserum was somewhat 
more sensitive and selective.  Although the full-length wild-type HaSV 
replicase was not detected, the anti-REP1-218(b) antiserum might be suitable 
for the detection of the HaSV replicase by western blot, provided that 
sufficient replicase could be produced. 
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3.1 INTRODUCTION 
 
Replication complexes of (+ve) RNA viruses have thus far all been found to 
associate with host-derived membranes.  The specific site of virus replication 
is often determined as a result of the trafficking of the viral replicase, a 
process that is usually sufficient for the generation of vRNA replication 
factories.  Localisation of the viral replicase, and the concurrent formation of 
replication complexes, typically results in the modification of host-derived 
membranes in order to concentrate viral and host factors into a localised 
replication site and to avoid host defence mechanisms (Jonczyk et al., 2007; 
Netherton et al., 2007). 
 
The subcellular location of vRNA replication is important since there is often a 
coupling of the location of the viral replicase and other stages in the viral life 
cycle.  One such example is that of the alphaviruses, which make use of the 
mildly acidic environment of the early endosomes during virus entry and 
uncoating before targeting vRNA replication to endocytic and lysosomal 
membranes (Schlesinger and Schlesinger, 2001).  The location of viral 
replication within host cells may play additional roles in virus replication 
beyond multiplication of vRNA.  Thus, identifying the location of the HaSV 
replicase in cells represents the first step towards understanding the most 
fundamental aspects of tetravirus replication biology and may shed light on 
other aspects of the virus life cycle.   
 
At present, very little is known about the cellular location of tetravirus 
replication, largely due to the absence of experimental systems for the study 
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of their replication biology.  Other than PrV, none of the tetraviruses have 
been found to replicate in tissue culture cell lines and no replication-
competent ex vivo experimental system for HaSV exists (Bawden et al., 
1999; Pringle et al., 2003).  This study of HaSV replication in vivo was 
hampered by both the absence of suitable antiserum directed against the 
HaSV replicase and a lack of antibodies against insect cellular markers.  As a 
result a novel experimental system for the study of HaSV replication biology 
needed to be developed. 
  
This chapter describes the use of fluorescence microscopy to examine the 
subcellular localisation of HaSV replicase fused to EGFP (REP1-1704-EGFP) 
in mammalian (HeLa) and Spodoptera frugiperda pupal ovarian (Sf9) cells.  
The distribution of EGFP fluorescence was compared to that of known 
organelle markers in mammalian cells and live cell imaging techniques were 
used to characterise the dynamics of replicase-associated structures.  
Selected data presented here has been published (Short et al., 2010) and 
are reproduced with permission from the publisher. 
 
3.2 MATERIALS AND METHODS 
 
Unless otherwise stated, tissue culture cell lines were maintained as 
described in Appendix C. 
 
3.2.1. Recombinant plasmids used for expression of replicase-EGFP 
fusion proteins 
 
Restriction maps of recombinant plasmids used in the experiments described 
in this chapter are shown in Figure 3.1 and their construction outlined in 
Appendix A.  The mammalian expression construct pJRS7 (Appendix A.4) 
contains a full length copy of the HaSV replicase CDS, with a mutated stop 
codon cloned into the BamHI site of pEGFP-N1, such that the replicase ORF 
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Figure 3.1:  Plasmid maps of the recombinant expression vectors used in the 
expression of HaSV replicase-EGFP fusion proteins in tissue culture cells. Amp R: β-
lactamase, CMV Promoter: Human cytomegalovirus immediate early promoter, EGFP: 
enhanced green fluorescent protein, hr/AcMNPV Promoter: hybrid insect promoter, Kan/Neo 
R: neomycin phosphotransferase.  The cloning strategy used to generate these plasmids 
can be found in Appendix A. 
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is fused at its C-terminal end with the N-terminus of EGFP (REP1-1704-EGFP).  
Expression of REP1-1704-EGFP is controlled by a human cytomegalovirus 
(CMV) immediate early promoter.  The plasmid pJRS8 (Appendix A.5) carries 
the full length replicase ORF fused at its N-terminus to the C-terminus of 
EGFP (EGFP-REP1-1704) expressed from the same CMV promoter.  Finally, 
pJRS26 (Appendix A.6) encodes the same REP1-1704-EGFP CDS as pJRS7, 
under the control of a hybrid hr/AcMNPV promoter consisting of the 
Autographa californica multiple nuclearpolyhedrovirus (AcMNPV) hr5 
enhancer fused to the AcMNPV immediate early promoter (obtained from 
Prof. Vernon Ward, University of Otago, New Zealand). 
 
3.2.2. Transfection of tissue culture cells 
 
Monolayers of HeLa cells were transfected in 24 well plates on 13 mm glass 
cover slips for immunofluorescence, or in glass bottomed 35 mm Petri dishes 
(Asahi Techno Glass Corporation) for live cell imaging using Fugene® HD 
(Roche) according to an optimised protocol based on the manufacturer’s 
instructions.  Cells were seeded to approximately 60 % confluence and 
incubated in complete Dulbecco's modified Eagle medium (DMEM) overnight 
before transfection.  Monolayers were transfected at about 80 % confluence 
as follows (quantities indicated are those for a single well in a 24 well plate, 
this to be multiplied by a factor of five for 35 mm Petri dishes).  For small 
plasmids (such as the 4.7 kilobase (kb) pEGFP-N1 control plasmid, lacking 
the HaSV replicase sequence), 100 ng of plasmid DNA (purified using 
QIAprep Spin Miniprep Kit (Qiagen)) was added to 19 μl serum-free DMEM 
followed by 0.5 μl of Fugene® HD transfection reagent to produce the 
Fugene:DNA complex.  For larger plasmids (such as the 9.8 kb pJRS7 
containing the full length HaSV replicase CDS), 300 ng of DNA and 3 μl 
Fugene® HD were diluted to a total of 20 μl with serum-free DMEM as above.  
The Fugene:DNA complex was briefly mixed and complex formation was 
allowed to proceed at room temperature for 30 minutes.  The medium was 
Subcellular localisation of the HaSV replicase 
57 
 
aspirated from each well and the complex added directly to cells in a drop-
wise manner, before the addition of a further 80 μl of serum free DMEM.  
Cells were incubated as normal for three hours followed by the addition of 
900 μl complete DMEM.  Thereafter the cells were incubated at 37 °C with 
10 % CO2 for between 16 and 24 hours depending on the experiment.  Sf9 
cells were transfected as for HeLa cells with the exception that cells were 
initially seeded at approximately 70 % and transfected at 85 % confluence. 
 
3.2.3. Immunofluorescence staining of HeLa cells 
 
Following transfection, cells intended for immunofluorescence staining were 
briefly rinsed three times in PBS (pH 7.5) before being fixed with 4 % 
paraformaldehyde in PBS for 15 minutes.  Cells were again rinsed twice in 
PBS and then subjected to immunofluorescence microscopy according to 
one of the following protocols depending on the primary antibody used. 
 
Triton X-100-based permeabilisation protocol 
Immunofluorescence detection of the ER and Golgi apparatus (method 
provided by Dr. Caroline Knox, Department of Biochemistry, Microbiology and 
Biotechnology, Rhodes University, Grahamstown, South Africa) was done 
using polyclonal rabbit antibodies directed against ERp60 and β-COP (both 
obtained from Prof. Tom Wileman, University of East Anglia, Norwich, UK) as 
follows.  After fixing, cells were incubated in 400 μl permeablisation buffer 
(5 % normal goat serum, 1 % Triton X-100, 10 % sucrose in PBS, pH 7.5) for 
20 minutes with gentle shaking.  Primary antibody was then added to cells at 
a dilution of 1:400 for β-COP or 1:8 000 for ERp60 in permeabilisation buffer 
with gentle shaking for one hour.  Cells were then briefly rinsed three times in 
PBS-Tween (1 % Tween 20 in PBS, pH 7.5) before the addition of secondary 
antibody (Alexa Fluor 546-conjugated goat anti-rabbit, Invitrogen) diluted 
1:500 in permeablisation buffer.  Following a 30 minute incubation, cells were 
briefly rinsed three times in PBS-Tween followed by three 10 minute washes, 
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also in PBS-Tween.  DAPI (4',6-diamidino-2-phenylindole) (500 μg.ml-1) was 
added to the second wash to visualise nuclei.  Coverslips were mounted on 
glass slides using Fluorescent Mounting Medium (DakoCytomation). 
 
Saponin-based permeabilisation protocol 
Immunofluorescence detection of the early and late endosomes (method 
provided by Dr. Kristine Schauer, Molecular Mechanisms of Intracellular 
Transport group, Institut Curie, Paris, France) was done using goat 
anti-EEA1 (Santa Cruz Biotechnology, Inc., sc-6415) and mouse anti-CD63 
(Invitrogen, 187300) antibodies as follows.  After fixing, cells were quenched 
for 10 minutes in 50 mM NH4Cl in PBS (pH 7.5) before being permeabilised 
in saponin buffer (0.2 % BSA, 0.05 % saponin in PBS, pH 7.5) for 15 
minutes.  Coverslips were then inverted into 25 μl droplets of saponin buffer 
containing primary antibodies (anti-EEA1 (1:200) or anti-CD63 (1:35)) on 
parafilm.  After 30 minutes cells were briefly rinsed three times in saponin 
buffer before being incubated in 400 μl saponin buffer containing a 1:500 
dilution of secondary antibody (Alexa Fluor 546-conjugated donkey anti-goat 
or Alexa Fluor 546-conjugated goat anti-mouse, both from Invitrogen) for 30 
minutes in the 24 well plate.  Cells were then rinsed and mounted as for 
Triton X-100-permeabilised cells. 
 
3.2.4. Organelle specific staining of live HeLa and Sf9 cells 
 
Both HeLa and Sf9 cells were grown and transfected (Section 3.2.2) in glass 
bottomed 35 mm Petri dishes (Asahi Techno Glass Corporation).  Cells were 
incubated in the presence of 200 nM MitoTracker® Red 580, 50 nM 
LysoTracker® Red DND-99 or 100 nM ER-TrackerTM Blue-White DPX 
(Invitrogen) for 30 minutes prior to imaging according to an optimised 
protocol derived from the manufacturer’s instructions.  Both LysoTracker® 
and MitoTracker® have been used in previous studies to visualise lysosomes 
(Kawar and Jarvis, 2001, Kawar et al., 2001, Aumiller et al., 2006) and 
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mitochondria (Chow et al., 2009) in Sf9 cells and, as a result, both were used 
to stain Sf9 cells.  However, ER-TrackerTM does not stain the ER in insect 
cells and could therefore not be used in Sf9 cells.  Cascade Blue®-
conjugated dextran (10,000 Da) (Invitrogen) was added to complete growth 
medium at the time of transfection in order to allow for maximal loading of the 
endocytic pathway prior to imaging.  Cells were incubated for up to 24 hours 
according to manufacturer's instructions before being rinsed and incubated in 
complete growth medium prior to imaging (mammalian cells were incubated 
in complete DMEM without phenol red for live cell imaging). 
 
3.2.5. Confocal laser scanning microscopy, image analysis and image 
editing 
 
All images were obtained using a Zeiss LSM 510-META confocal microscope 
with a live cell imaging facility.  Unless otherwise indicated all images 
represent 0.8 μm thick optical slices that were scanned at optimal x,y 
resolution, as determined by the proprietary Zeiss Scanning Microscope LSM 
510 software (release version 4.2), using 63x oil immersion objective lenses.  
Sequential time-lapse images of live cells (t-stacks) each represent 1 μm 
optical slices.  Blue diode (405 nm), argon (488 nm) and helium/neon 
(543 nm) laser lines were used to image the respective fluorophores using 
standard filter sets with laser attenuation modified for each sample to obtain 
maxium light intensity resolution.  Images were viewed and/or analysed using 
the Zeiss LSM 5 Image Browser (v 4.2.0), ZEN 2008 Light Edition (both Carl 
Zeiss), ImageJ 1.42o (http://rsb.info.nih.gov/ij/) or GIMP 2.6.6 
(www.gimp.org).  Time-lapse imaging was performed on cells from 16 hours 
after transfection for 6 to 8 hours and the image series analysed using 
ImageJ 1.42o and a manual particle tracking plug-in (Sbalzarini and 
Koumoutsakos, 2005) for the analysis of particle movements. 
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3.3 RESULTS 
 
3.3.1. Subcellular distribution of HaSV replicase-EGFP fusion  proteins 
in fixed and live tissue culture cells 
 
The transfection protocols for HeLa and Sf9 cells were optimised using 
control plasmids expressing EGFP (pEGFP-N1 or pCW56 in HeLa and Sf9 
cells respectively) and experimental plasmids expressing REP1-1704-EGFP 
(pJRS7 and pJRS26 in HeLa and Sf9 cells respectively) (Figure 3.1).  Using 
the optimised protocol, transfection frequencies of 8 % (for pJRS7) and 
between 40 % and 50 % (for pEGFP-N1, pCW56 and pJRS26) were 
reproducibly achieved as evidenced by EGFP fluorescence.   
 
Plasmids expressing REP1-1704-EGFP (pJRS7 or pJRS26), EGFP-REP1-1704 
(pJRS8) and EGFP (pEGFP-N1 or pCW56) were transfected into HeLa and 
Sf9 cells and the subcellular distribution of the proteins determined by 
fluorescence microscopy.  Native EGFP fluorescence was observed 
throughout the cytoplasm of transfected cells with some accumulation of 
fluorescence in the nucleus (Figure 3.2, Panel B, Images a and e).  
EGFP-REP1-1704-associated fluorescence was also present throughout the 
cytoplasm of transfected cells but, in contrast to native EGFP the fusion 
protein was excluded from the nucleus (Figure 3.2, Panel B, Image d) either 
due to its large size or because the replicase carries a nuclear export signal.  
Fluorescence associated with REP1-1704-EGFP was concentrated in small 
cytoplasmic structures in both cell lines (Figure 3.2, Panel B, Images b and f).  
The same punctate distribution was also observed in live cells eliminating the 
possibility that the punctate structures were experimental artefacts produced 
by the fixation process (Figure 3.2, Panel B, Images c and g).  The difference 
in distribution between REP1-1704-EGFP and EGFP-REP1-1704 suggested that 
the N-terminus of the replicase may be important in targeting of the protein to 
the punctate structures.  Although the size, shape and location of the 
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punctate structures do not share definitive characteristics with any major 
cellular organelles, the structures were clearly excluded from the nucleus.  
The characteristic perinuclear distributions associated with the ER and Golgi 
apparatus were not observed.  The mitochondria typically form reticular 
structures that are spread throughout the cytoplasm of cells and could have 
accounted for the structures observed, as could the organelles of either the 
endocytic or secretory pathways.  Another possibility was that the 
morphology could be caused by the modification of host organelles.   
 
3.3.2. Subcellular localisation of REP1-1704-EGFP by 
immunofluorescence 
 
Following the observation that the full length HaSV replicase fused to the 
N-terminus of EGFP was located in small punctate structures within the 
cytosol of both Sf9 and HeLa cells, further investigation into the origin of 
those structures was necessary.  Firstly, REP1-1704-EGFP-associated 
fluorescence in HeLa cells was compared with that of marker proteins for the 
major organelles by immunofluorescence microscopy.  The paucity of 
appropriate antibodies directed against marker proteins in insect cells 
precluded similar immunofluorescence studies in the Sf9 cells.  In HeLa cells, 
the punctate structures were examined in relation to the peripheral Golgi, ER, 
early endosomes and late endosomes.  HeLa cells transfected with pJRS7 
(REP1-1704-EGFP) were incubated for 16 to 24 hours before being fixed and 
stained with antibodies directed against β-COP (Golgi), ERp60 (ER), EEA1 
(early endosomes) or CD63 (late endosomes) respectively.  Cells were then 
examined by confocal fluorescence microscopy to determine the extent of co-
localisation. 
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As expected, staining of HeLa cells with β-COP produced the distinctive 
perinuclear staining pattern of the peripheral Golgi, with the majority of the 
signal being detected in a defined location to one side of the nucleus 
(Figure 3.3, Image a).  ERp60-associated signal was observed in a typical 
reticular pattern throughout the cytosol with characteristic fluorescence 
visualisation of the nuclear envelope (Figure 3.3, Image d).  Both EEA1    
 
 
 
Figure 3.2:  The distribution of EGFP and full-length HaSV replicase-EGFP fusion 
proteins in fixed and live HeLa and Sf9 cells.  Panel A shows schematic representations 
of EGFP and N- or C-terminal fusions of EGFP to the HaSV replicase and Panel B contains 
images of the typical distribution of EGFP fluorescence observed in cells expressing each 
protein.  Fixed cells expressing EGFP (a and e), REP1-1704-EGFP (c and g) or 
EGFP-REP1-1704 (d) as well as live cells expressing REP1-1704-EGFP (b and f) were imaged 
using confocal fluorescence microscopy.  Scale bars represent 10 μm. 
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(Figure 3.3, Image g) and CD63 (Figure 3.3, Images j and m) were observed 
in punctate structures distributed throughout the cytosol.  Importantly, no 
significant differences in morphology or distribution of any of these organelles 
was observed in cells transfected with pJRS7 as compared with 
untransfected cells, indicating that substantial remodelling of these 
membranes by the replicase-EGFP fusion protein was unlikely.  
 
Comparison of the distribution of the Golgi- and ER-specific marker proteins 
with the EGFP fluorescence associated with REP1-1704-EGFP revealed a 
marked difference in the distribution of the two signals indicating that neither 
the Golgi apparatus nor the ER were the site of REP1-1704-EGFP localisation 
(Figure 3.3, Images a to c and d to f respectively).  There was significant 
similarity between the subcellular distribution patterns of REP1-1704-EGFP and 
both CD63 and EEA1 suggesting that endocytic organelles might be 
candidate sites to which the HaSV replicase is targeted in HeLa cells.  Initial 
experiments involving both marker proteins with cells fixed 20 to 24 hours 
after transfection showed no overlap between EGFP fluorescence and the 
markers of either organelle (Figure 3.3, Images g to i and m to o).  However, 
when cells were fixed and stained 16 hours post-transfection, some overlap 
was observed with the late endosomes (Figure 3.3, Images j to l).  There was 
approximately 20 % overlap between the REP1-1704-EGFP-derived punctate 
structures and late endosomes defined by the CD63 marker in 10 % of the 
transfected cells imaged on each cover slip.  These data suggested that the 
HaSV replicase may be associated with the late endosomes during the early 
stages of subcellular localisation in HeLa cells.  The lack of complete overlap 
could indicate that REP1-1704-EGFP is later moved to a different cellular 
location or that accumulation of the protein results in late endosome 
modification to the extent that CD63, and probably other host proteins, are no 
longer present.  Alternatively, the replicase-EGFP fusion protein could be 
present in cytosolic aggregates, though the cytosolic distribution of 
EGFP-REP1-1704 suggests that this is less likely.  
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3.3.3. Subcellular localisation of REP1-1704-EGFP in live cells 
 
Tomasicchio et al. (2007) hypothesised that the destabilisation of acidic 
subcellular organelles (lysosomes or mitochondria) and subsequent 
acidification of the cytoplasm may be involved in the tetravirus lifecycle.  The 
results of co-localisation experiments in this study suggested that the 
endocytic compartment might be the site for targeting of the viral replicase.  
To further investigate the role of acidic organelles in the localisation of the 
HaSV replicase, live HeLa and Sf9 cells expressing REP1-1704-EGFP were 
stained with commercially available stains which label the lumens of 
lysosomes, mitochondria and fluid-phase endocytic organelles.   Cells were 
also stained with ER-TrackerTM, which specifically labels the ER membranes 
of mammalian cells, to further exclude the organelles of the secretory 
pathway.  
 
Validation of the staining protocols showed that the mitochondrion-specific 
MitoTracker® Red 580 displayed a typical mitochondrial staining pattern in 
both HeLa and Sf9 cells (Figure 3.4, Panel A, Left Column).  Similarly, 
LysoTracker® Red DND-99 produced the normal punctate cytosolic 
distribution, comparable to that of the late endosomal marker protein CD63, 
in both cell types (Figure 3.4, Panel B, Left Column).  The incubation of cells 
in the presence of Cascade Blue®-conjugated dextran (10 000 Da) also 
resulted in punctate cytosolic structures associated with the dextran 
(Figure 3.4, Panel C, Left Column.  While the use of these stains in insect 
cells had previously been described (Entchev et al., 2000; Kawar and Jarvis, 
Figure 3.3 (page 64):  Comparison of the distribution of REP1-1704-EGFP with that of 
cellular organelles in HeLa cells by confocal immunoflourecence microscopy.  HeLa 
cells expressing REP1-1704-EGFP were stained with antiserum against the specific organelle 
marker proteins β-COP (Golgi) (a – c), ERp60 (ER) (d – f), EEA1 (early endosomes) (g – i) 
and CD63 (late endosomes) after 16 (j – l) or 24 (m – o) hours.  Primary antibodies were 
detected using species specific secondary antibodies conjugated to Alexa Fluor 546.  Areas 
of partial overlap (l) are magnified approximately 3-fold. Scale bars represent 10 μm. 
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2001; Kawar et al., 2001; Kurisu et al., 2003; Aumiller et al., 2006; Sasamura 
et al., 2007; Chow et al., 2009), ER-TrackerTM Blue-White DPX concentrates 
in the ER of mammalian cells via a lipid-based transport mechanism that 
does not have the same effect in insect cells, preventing the use of ER-
TrackerTM in Sf9 cells.  HeLa cells stained with ER-TrackerTM did however 
result in the visualisation of the nuclear envelope along with a reticular 
morphology in the cytoplasm of HeLa cells, as expected (Figure 3.4, Panel D, 
Left Column).  As was the case for cells subjected to immunofluorescence, 
no significant differences were observed between transfected and 
untransfected cells, supporting the suggestion that REP1-1704-EGFP does not 
cause significant remodelling of the organelles tested.   
 
 
 
 
Figure 3.4 (Here and page 67):  Comparison of the distribution of REP1-1704-EGFP with 
that of organelle-specific stains in live HeLa and Sf9 cells by confocal fluorescence 
microscopy.  Cells expressing REP1-1704-EGFP were stained with MitoTracker
® Red 580 
(mitochondria) (Panel A), Lysotracker® Red DND-99 (lysosomes) (Panel B), Cascade Blue-
conjugated dextran (classical endocytic pathway) (Panel C) or ET-TrackerTM Blue-White DPX 
(ER) (Panel D).  HeLa cells are shown in the top row of each panel and Sf9 cells are 
displayed in the bottom row, except in panel D, which shows only HeLa cells since the ER of 
Sf9 cells cannot be stained using ER-TrackerTM.  Scale bars represent 10 μm. 
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Figure 3.4: Figure legend on page 66. 
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Following validation of the live cell stains, co-localisation experiments were 
conducted to determine the site of REP1-1704-EGFP localisation in both the 
HeLa and Sf9 cells.  Comparisons with the MitoTracker® signal showed no 
overlap with REP1-1704-EGFP fluorescence in either cell type, excluding the 
mitochondria as a potential site of replicase localisation (Figure 3.4, Panel A).  
The same was true for cells stained with ER-TrackerTM (Figure 3.4, Panel D), 
confirming previous immunofluorescence data obtained using ERp60 that 
excluded the ER as the site of REP1-1704-EGFP-association.   
 
No significant overlap was seen with either LysoTracker®, specific for 
lysosomes and acidic organelles, or endocytosed dextran (Figure 3.4, 
Panels B and C).  This was the case even when dextran uptake was allowed 
proceed throughout the endocytic pathway to the point of delivery to the 
lysosomes, as shown by the overlap of the two signals after approximately 24 
hours (Figure 3.5).  These results indicated that, while there was some 
interaction between REP1-1704-EGFP and endocytic organelles, this 
interaction did not occur through, nor migrate along, the classical endocytic 
pathway.  Rather this interaction might proceed via an alternate pathway that 
intersects with the clathrin-dependent pathway at the late endosomes, as is 
the case for some of clathrin-independent endocytic pathways.  Alternatively, 
the data could indicate a replicase-dependent means of excluding the 
organelle marker proteins that were used in the immunofluorescence studies 
and the fluorescence-conjugated dextran, possibly through membrane 
permeabilisation or destabilisation.  The latter explanation is less likely since 
no evidence for the large-scale remodelling of endocytic membranes was 
observed in transfected cells.  
 
3.3.4. Time-lapse imaging of REP1-1704 EGFP in live cells 
 
In order to clarify the location of REP1-1704-EGFP-containing structures, time-
lapse imaging was employed to analyse the sub-cellular dynamics of the 
Subcellular localisation of the HaSV replicase 
69 
 
punctate structures.  Since the subcellular movements of major organelles 
have been described in some detail, the data obtained from time-lapse 
imaging were compared to the flux of replicase-associated structures.  Live 
cells, expressing REP1-1704-EGFP, were imaged over time with successive 
images being taken at various intervals over a 6 to 8 hour period starting at 
16 hours after transfection.  Consecutive images were analysed as “t-stacks” 
to follow general movements and dynamics.  
 
 
REP1-1704-EGFP-associated punctate structures were highly dynamic 
(Supplementary data, videos S1a and S1b) and varied significantly in size, 
with the majority of the structures detected measuring between 0.2 and 
4.0 μm in diameter.  The rate and type of movement associated with each 
structure was generally size dependent with smaller vesicles (< 0.8 μm) 
being more mobile than the larger ones (> 2 μm) and in the majority of cases, 
 
 
Figure 3.5:  Comparison of the distribution of Cascade Blue®-conjugated dextran and 
LysoTracker®.  Live HeLa (top) and Sf9 (bottom) were stained first with Cascade 
Blue®-conjugated dextran (for 23 hours) before LysoTracker® Red DND-99 was added for 30 
minutes prior to imaging by confocal fluorescence microscopy.  Yellow areas in the merged 
images (right) indicate areas of overlap.  Scale bars represent 10 μm. 
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the movements appeared to be random.  Interestingly, a number of structures 
moved large distances across the cell at speeds significantly higher than the 
random movements (> 2 μm.s-1).  Furthermore, in these cases the structures 
moved in a more directed manner, possibly along defined cellular pathways 
(Figure 3.6, Panel A).  In one case, two vesicles were observed to traverse a 
similar region of the cell in the same direction and within a short space of 
time (Supplementary data, Video 2).  Both of these structures dissociated at 
a similar position, at which point they again displayed random movements.  
Taken together, these data suggested that the REP1-1704-EGFP-associated 
punctate structures might be transported within cells along defined pathways, 
most likely along the microtubule network, as is the case for endocytic 
vesicles between the early and late endosomes (Gruenberg et al., 1989).  
 
 
 
Figure 3.6 (Here and page 71):  Transport, fusion and fission of REP1-1704-EGFP 
containing structures in live HeLa and Sf9 cells.  HeLa and Sf9 cells expressing REP1-
1704-EGFP were imaged between 16 and 24 hours after transfection using time-lapse 
confocal fluorescence microscopy.  Analysis of time-lapse image series' from both cell types 
revealed structures associated with EGFP fluorescence that were transported along defined 
pathways (Panel A) and capable of fusion (Panel B) and fission (Panel C).  All images 
represent 1 μm optical slices and scale bars represent 5 μm. (Additional data showing the 
transport of vesicles is available on the supplementary data CD as video S2.) 
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Further analysis of “t-stacks” also revealed other interesting characteristics.  
In addition to transport along defined pathways, some EGFP-containing 
structures appeared to undergo both fusion (Figure 3.6, Panel B) and fission 
 
 
 
 
Figure 3.6:  Figure legend on page 70. 
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(Figure 3.6, Panel C) reactions as well as a few instances of a combination of 
the two, called “kiss-and-run” events.  Fusion was observed more frequently 
than fission and appeared to occur more readily between smaller structures, 
with vesicles less than 1 μm in diameter more likely to undergo fusion events 
than their larger counterparts.  This fusion activity is likely to give rise to the 
higher proportion of larger structures (> 2 to 5 μm) at later time points (20 to 
24 hours).  Fission events, although less frequently observed, were noted for 
vesicles regardless of size.  These characteristics are, as was the case with 
transport along cellular pathways, consistent with an association of 
REP1-1704-EGFP with endocytic organelles (Bright et al., 2005).  
 
3.4 DISCUSSION 
 
The aim of the experiments described in this chapter was to determine the 
subcellular localisation of replicase-EGFP fusion proteins in mammalian and 
insect tissue culture cells.  The data represent the first experimental evidence 
of the targeting of a tetravirus replicase to a subcellular location and was 
obtained by studying the subcellular localisation of the HaSV replicase fused 
to EGFP in tissue culture cells. This system offered several advantages: first, 
EGFP fluorescence could be used to detect the presence and location of the 
replicase and second, EGFP provided the additional advantage of being 
detectable in live cells without the requirements of cell fixation and detection 
by immunofluorescence or the use of expensive substrates, as is the case for 
tetra-cysteine tags.  Similar use of EGFP as a tag, fused to either the 
replicase or the capsid genes, has been employed in the generation of 
genetically stable and infectious recombinant SFV, Hepatitis E virus and 
Equine arteritis virus (Thakral et al., 2005; Tamberg et al, 2007; Van den Born 
et al., 2007) and in the analysis of various aspects of Hepatitis C virus, 
Rabies virus and Vesicular stomatitis virus life cycles in live cells (Kien et al., 
2003; Finke et al., 2004; Das et al., 2006). 
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Initial analysis of full-length HaSV replicase-EGFP fusion proteins revealed 
that both N- and C-terminal fusions to EGFP resulted in a subcellular 
distribution of fluorescence that was different from cells expressing the 
untagged marker protein.  Most significant was the observation that small 
punctate structures were produced when cells expressed REP1-1704-EGFP.  
The cytosolic distribution of EGFP-REP1-1704 suggested that the N-terminus 
of the replicase may be important in the development of these structures.  
The absence of other viral proteins also suggested that the localisation was 
likely to be solely dependent on factors present within the viral replicase and 
host factors present within both HeLa and Sf9 cells.  Comparison of these 
structures with those of cellular organelles demonstrated a possible 
association with endocytic organelles, although overlap was only observed 
with the late endosomal marker protein, CD63, and only at certain time points 
was this overlap significant.  Unexpectedly, no overlap was observed with 
endocytosed dextran as it traversed the classical endocytic pathway into the 
lysosomes.  Possible reasons for this include the active exclusion of certain 
host proteins from REP1-1704-EGFP-containing vesicles, the permeabilisation 
of REP1-1704-EGFP-containing vesicles in a replicase-dependent manner or 
the association of the HaSV replicase with non-clathrin-dependent endocytic 
pathways that do not incorporate dextran and intersect with the classical 
pathway at the late endosomes.  These data suggested an atypical 
association with endocytic organelles, most likely those directly or closely 
associated with the late endosomes.   
 
To further characterise this association, time-lapse imaging of cells 
expressing REP1-1704-EGFP was conducted.  Analysis of the resulting 
“t-stacks” also showed similarities to endocytic organelles, with both being 
capable of cellular transport, fusion and fission, strengthening the argument 
for the localisation of REP1-1704-EGFP to the endocytic pathway in transfected 
tissue culture cells.  Furthermore, these data suggest that continued 
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accumulation of replicase-associated structures within the cell through 
continued protein production and fusion reactions gradually sequesters 
increasing amounts of cellular membrane that must either be replaced by 
increased lipid production or adversely affect cellular processes, especially 
those reliant on the organelles targeted by the replicase.  Similar punctate 
structures have also been observed in PrV-infected MG8 cells stained with 
anti-p40 antibodies (Walter, 2008).  This suggests the possibility of a 
common cellular location of vRNA production among tetraviruses, even 
though the replicases differ significantly in amino acid sequence.  
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4.1 INTRODUCTION 
 
Proteins that associate with cellular membranes are grouped into three major 
classes according to the type and strength of the interaction involved.  (1) 
Transmembrane proteins may be strongly associated with membranes 
through one or more hydrophobic domains that span the entire width of the 
lipid bilayer resulting in a protein with regions present on both membrane 
surfaces;  (2) Integral membrane proteins may interact with membranes 
through amphipathic helices that are embedded into a single leaflet of the 
lipid bilayer and/or covalent lipid attachments, both of which produce 
interactions that are generally weaker than that of transmembrane proteins;  
(3) Electrostatic and hydrophobic protein-protein interactions with other 
membrane-associated proteins result in the relatively weak interactions of 
peripheral membrane proteins (Alberts et al., 2002). 
 
Confocal fluorescence microscopy studies to determine the subcellular 
localisation of replicase-EGFP fusion proteins provided evidence for an 
association between the HaSV replicase and the endocytic organelles of 
mammalian (HeLa) and insect (Sf9) cells (Chapter 3).  Biochemical 
fractionation of cellular membranes and associated proteins is frequently 
used to confirm protein-membrane interactions and to characterise the type 
of association involved.  This chapter describes the use of such fractionation 
to characterise the interaction between the HaSV replicase and cellular 
membranes.  Anti-REP1-218(b) and anti-EGFP antisera were unable to detect 
the expression of replicase-EGFP fusion proteins in tissue culture cells due to 
the low transfection efficiencies associated with the full length replicase 
CHAPTER 4 
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expression vectors.  Consequently, a recombinant baculovirus was 
developed for high level expression of the full-length HaSV replicase with an 
N-terminal 6xHis tag and a C-terminal V5 epitope tag, to facilitate detection of 
the recombinant protein.  Subcellular fractionation of baculovirus-infected 
cells suggests that the HaSV replicase associates with cellular DRMs. 
 
4.2 MATERIALS AND METHODS 
 
All SDS-PAGE analyses were conducted using discontinuous 
glycine/polyacrylamide gels with 4% stacking gels.  Analysis of His-REP-V5 
was done using 7.5% resolving gels and the separation of the 
transmembrane protein control, voltage-dependent anion channel (VDAC), 
was done using 15% resolving gels.  Western analysis was carried out as 
described in Section 2.2.5 using monoclonal mouse anti-His (Roche Applied 
Biosciences), rabbit anti-REP1-218(b), monocolonal mouse anti-V5 (obtained 
from Richard Randall, School of Biology, University of St. Andrews, St. 
Andrews, Scotland, UK) or monocolonal mouse anti-VDAC (Santa-Cruz 
Biotechnology). 
  
4.2.1. Construction of recombinant baculovirus JRS BV1 expressing 
 recombinant HaSV replicase 
 
The recombinant baculovirus for the expression of the full length HaSV 
replicase with N-terminal 6xHis and C-terminal V5 epitope tags (His-REP-V5) 
was generated using the Bac-to-Bac® Baculovirus Expression System 
(Invitrogen).  The plasmid pJRS42 was constructed as described in Appendix 
A.7 and consists of the commercial vector, pFastBacTM Dual (Invitrogen), with 
the His-REP-V5 CDS inserted for expression under the control of the 
polyhedrin (PolH) promoter (Figure 4.1).  The recombinant bacmid was 
generated by transforming pJRS42 into competent E. coli DH10Bac cells (F– 
mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 endA1 araD139 
Δ(ara leu) 7697 galU galK λ– rpsL nupG/ pMON14272/pMON7124) 
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(Invitrogen).  Bacmid DNA was purified and screened by polymerase chain 
reaction (PCR) amplification using the insert- (JRS2 and JRS13R) and 
bacmid-specific (M13F and M13R) primers as per manufacturer's 
recommendations (primer sequences are shown in Appendix B).  
Recombinant bacmid DNA was then transfected into Sf9 cells as follows.  Sf9 
cells were seeded at a density of 8 x 105 cells per well of a 6 well plate and 
allowed to settle for 30 to 60 minutes.  During that time the transfection 
mixture consisting of approximately 800 ng purified bacmid DNA, 12 μl 
Fugene® HD and serum-free Grace's insect medium (200 μl total volume) 
was prepared, mixed and incubated at room temperature for 30 minutes.  
The medium was then aspirated and the DNA-lipid complex was added drop-
wise with an additional 200 μl serum-free medium.  Following incubation at 
28 °C for 2 hours, 1 ml complete Grace's insect medium was added to each 
well and the cells incubated at 28 °C for four days before the supernatant 
was harvested as a passage 1 virus stock.  This stock was then propagated 
and plaque-purified. 
 
 
 
 
pJRS42
10407 bp
Amp R
Gent R
His-REP1-1704-V5
Polh Promoterp10 Promoter
Hind III (5026)Hind III (5392)
Pvu II (3640)
Pvu II (10226) Pst I (233)
Pst I (1198)
Pst  I (3639)
Pst I (4458)
Pst I (5157)Pst I (5383)  
 
 
Figure 4.1:  Plasmid map of the recombinant plasmid used in the production of 
JRS BV1, the recombinant baculovirus for the expression of His-REP-V5.  Amp R: β-
lactamase, Gent R: gentamicin acetyl transferase , PohH Promoter: AcMNPV polyhedrin 
promoter. 
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4.2.2. Plaque-purification of recombinant baculoviruses 
 
Plaque-purification was conducted using 6 well tissue culture dishes.  Each 
well was seeded with 8.5 x 105 Sf9 cells, which were allowed to settle for 30 
to 60 minutes at 28 °C in complete Grace's insect medium.  The medium was 
aspirated from the cells and each well infected with 500 μl of a 10-fold serial 
dilution of the passage 1 virus stock (10-1 to 10-6) in complete Grace's insect 
medium.  Cells were then incubated at 28 °C for 1 hour with very gentle 
agitation. 
 
Tissue culture grade agarose (Sigma), at a concentration of 2 % (w/v), was 
dispersed in chilled sterile double distilled water before being heated to just 
below boiling point and shaken until the agarose was dissolved.  Both the 
2 % agarose and an equivalent volume of 2 x complete Grace's insect 
medium were then incubated in a water bath at 40 °C until needed.  
Following infection, the medium was aspirated from the cells and a 1:1 
mixture of 2 % agarose and 2 x Grace's insect medium was prepared before 
2 ml was added to each well.  The agarose was allowed to set at room 
temperature for 10 to 20 minutes and the cells were then incubated at 28 °C 
for 6 days.  After 5 days, 500 μl thiazolyl blue tetrazolium bromide 
(0.1 % (w/v) in PBS, pH 7.4) was added to each well to stain live cells and 
incubated at 28 °C overnight.  Individual plaques visible after staining were 
then “picked” using sterilised disposable P1000 pipette tips and resuspended 
in 500 μl complete Grace's insect medium.  Plaques purified in this manner 
were used to infect each of the wells of the freshly seeded 6 well plate as 
detailed below.   
 
Each well of a fresh 6 well plate was seeded with 2 x 106 cells per well and 
allowed to settle for 30 to 60 minutes in complete Grace's medium at 28 °C.  
Each well was infected with 500 µl of the resuspended virus at 28 °C with 
very gentle agitation before a further 3 ml complete medium was added.  
Cells were incubated at 28 °C for 4 days before harvesting at which point the 
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cells were resuspended in the spent medium and pelleted by centrifugation at 
5 000 x g for 5 minutes.  The supernatant was retained as the passage 3 JRS 
BV1 virus stock while the cells were resuspended in 100 μl 1 x sample buffer 
and the crude protein extracts resolved by SDS-PAGE.  Western analysis 
was used to confirm recombinant protein expression. 
 
4.2.3. Calculation of virus infectivity 
 
In order to determine the concentration of infectious virus particles in a 
particular virus stock, 8.5 x 105 Sf9 cells were seeded into each well of a 6 
well plate and allowed to settle for 30 to 60 minutes in complete Grace's 
insect medium.  Each well was then infected with 10-fold serial dilutions of 
each respective virus passage stock as described in Section 4.2.2.  Agarose 
overlays were prepared and, after staining, the concentration of infectious 
virus particles (plaque-forming units (pfu).ml-1) was calculated using the 
following formula provided by the manufacturer: 
 
 pfu.ml-1 = (1/dilution factor) x no. plaques x (1/ml inoculum) 
 
where the “dilution factor” is associated with the well in which between 2 and 
20 plaques were observed and the “ml inoculum” is the volume of the dilution 
used in the infection. 
 
4.2.4. Optimisation of His-REP-V5 expression 
 
Once the expression of His-REP-V5 had been confirmed by SDS-PAGE 
analysis, a baculovirus stock (JRS BV1 (3), referred to as JRS BV1 hereafter) 
was selected for further use.  The expression levels of His-REP-V5 were then 
optimised with respect to multiplicity of infection (MOI) (in pfu.cell-1) and 
length of time for maximum expression.  First, the optimal MOI for protein 
expression was determined by infecting 2 x 106 cells in each well of a 6 well 
plate with MOI's of 0.1, 1, 2, 5 and 10.  After 4 days cells were harvested in 
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the spent medium and pelleted by centrifuging at 13 000 x g for 2 minutes 
before being resuspended in 100 μl 1 x sample buffer.  Crude protein extracts 
were then resolved by SDS-PAGE and the proteins visualised by coomassie 
staining.  Once the optimal MOI for protein expression had been determined, 
4 wells of a 6 well plate were infected with JRS BV1 at an MOI of 5 and the 
cells harvested after 24, 48, 72 and 96 hours respectively.  Cells were 
pelleted, resuspended in 1 x sample buffer, resolved by SDS-PAGE and the 
proteins visualised by coomassie staining. 
 
4.2.5. Solubility of His-REP-V5 
 
T25 (25 cm2) and T75 (75 cm2) flasks (Corning) were seeded with 4.5 x 106 
or 1.4 x 107 cells, respectively, before being infected at an MOI of 5 for 72 
hours.  Once the expression of His-REP-V5 had been confirmed using SDS-
PAGE followed by coomassie staining, the solubility of the recombinant HaSV 
replicase was determined.  JRS BV1-infected cells from a T75 flask were 
harvested by centrifugation at 5 000 x g for 5 minutes.  These cells were 
resuspended in 750 μl lysis buffer (50 mM Tris, 300 mM NaCl, 10 mM 
Imidazole, 1 % (v/v) Nonidet P40, pH 8.0, containing EDTA-free protease 
inhibitor cocktail, set III (Calbiochem)) and incubated on ice for 10 minutes in 
preparation for Ni-affinity chromatography.  The lysate was then centrifuged 
at 10 000 x g for 10 minutes at 4 °C to obtain soluble (supernatant) and 
insoluble (pellet) protein fractions for analysis by SDS-PAGE. 
 
The insolubility of His-REP-V5 produced in cells grown in Grace's insect 
medium led to the investigation of other insect growth media, including 
serum-free ExCell 420 medium (Sigma).  Cells grown in either complete TC-
100 (Lonza), Grace's or ExCell 420 insect media were infected with 
recombinant baculovirus at an MOI of 5 as before, and incubated in the 
respective media before being harvested after 4 days.  Soluble and insoluble 
fractions were subjected to SDS-PAGE analysis and coomassie staining, as 
described above. 
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4.2.6. Subcellular fractionation of baculovirus-infected Sf9 cells 
 
Subcellular fractionation of virus-infected cells was carried out according to a 
modified protocol originally provided by Prof. Tom Wileman (School of 
Medicine, Health Policy and Practice, University of East Anglia, UK).  Virus-
infected cells from a T75 tissue culture flask were harvested, pelleted at 
5 000 x g for 5 minutes and resuspended in 800 μl chilled fractionation buffer 
(50 mM Tris, 1 mM Na2EDTA, 8 % sucrose (w/v), pH 7.5, containing EDTA-
free protease inhibitor cocktail, set III).  Cells were lysed by 20 passes 
through a 25 gauge syringe needle and lysates were centrifuged at 3 300 x g 
for 2 minutes at 4 °C to pellet large cell debris, nuclei and whole cells.  The 
supernatant was retained and the pellet re-extracted in 400 μl fractionation 
buffer, followed by pelleting of cell debris and nuclei as described above.  The 
supernatants were pooled as the “post nuclear supernatant” (PNS) (used to 
generate the subsequence fractions) and 200 μl was retained for further 
analysis.   
 
The remaining PNS was divided equally between three 1.5 ml centrifuge 
tubes (approximately 330 μl in each) and the membrane fraction pelleted at 
17 000 x g for 20 minutes at 4 °C.  The resulting supernatants were pooled 
as the soluble fraction while the pellets were resuspended in 330 μl of 
100 mM NaCO3 (pH 11.1) in distilled water or fractionation buffer containing 
either 1 M NaCl or 1 % Triton X-100 and incubated on ice for 15 minutes.  
These fractions were again centrifuged at 17 000 x g for 20 minutes at 4 °C.  
The soluble fractions were retained and diluted 4:1 with 5 x sample buffer, 
while the pellets were resuspended in 410 μl 1 x sample buffer.  Equivalent 
volumes of each sample were resolved using SDS-PAGE and protein 
detected by western analysis. 
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4.3 RESULTS 
 
4.3.1. The expression of His-REP-V5 in JRS BV1-infected Sf9 cells 
 
The recombinant baculovirus JRS BV1 encodes the full length HaSV 
replicase with 6xHis (N-terminal) and V5 epitope (C-terminal) tags.  Passage 
1 virus was plaque-purified and cells infected, with each of six isolates 
analysed for His-REP-V5 expression.  Cells infected with recombinant 
JRS BV1 isolated expressed a dominant protein band with a molecular mass 
of between 150 and 200 kDa, which correlated to the predicted molecular 
mass of 190 kDa for His-REP-V5 (Figure 4.2, Lanes 1 to 6).  This band was 
not present in cells infected with wild-type baculovirus (Figure 4.2, Lanes 7 
and 8) or mock infected cells (Figure 4.2, Lane 9).   
 
 
 
 
 
 
Figure 4.2:  The expression of His-REP-V5 in Sf9 cells infected with various JRS BV1 
isolates. SDS-PAGE analysis of crude extracts of Sf9 cells infected with six plaque-purified 
JRS BV1 isolates for the expression of His-REP-V5 (Lanes 1 to 6), two plaque-purified 
wild-type (“wt”) baculovirus isolates (Lanes 7 and 8) and mock-infected Sf9 cells (Lane 9).  
Molecular mass standards are indicated on the left of the gel in kDa and His-REP-V5 is 
indicated on the right. 
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To confirm that the JRS BV1-specific protein band was His-REP-V5, cell-free 
extracts obtained from each of the sets of virus-infected cells were subjected 
to western analysis using anti-His, anti-REP1-218(b) and anti-V5 epitope 
antisera to conclusively identify His-REP-V5.  All three western blots 
confirmed the identity of the recombinant HaSV replicase with a distinct band 
being detected at the expected molecular mass (190 kDa) in cells infected 
with the JRS BV1 (Figure 4.3, Panels A, B and C).   
 
 
 
 
 
 
Figure 4.3:  Specific detection of His-REP-V5 in Sf9 cells infected with JRS BV1 
isolates.  His-REP-V5 detected in crude extracts obtained from mock-infected Sf9 cells 
(“Mock”) or Sf9 cells infected with six recombinant baculovirus isolates for the production of 
His-REP-V5 (“JRS BV1”) or wild-type baculovirus (“wt”) as detected by western analysis.  
Membranes were probed using anti-His (Panel A), anti-REP1-218(b) (Panel B) or anti-V5 
(Panel C) antisera at dilutions of 1:500, 1:15 000 and 1:1 000 respectively.  Molecular mass 
standards are indicated on the left of the gel in kDa and His-REP-V5 is indicated on the right. 
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4.3.2. Optimisation of His-REP-V5 expression 
 
The optimal MOI for the expression of His-REP-V5 was determined by 
infecting Sf9 cells with JRS BV1 at MOIs of 0.1, 1, 2, 5 or 10.  SDS-PAGE 
analysis of crude protein extracts showed that His-REP-V5 production was 
maximal when cells were infected at an MOI of 5 pfu.cell-1 (Figure 4.4, 
Lane 7).  A small increase in His-REP-V5 expression was observed when the 
MOI was increased from 1 to 2 and again from 2 to 5 (Figure 4.4, Lanes 5 
to 7).  However, a further increase in virus load (MOI = 10) resulted in a 
decrease in His-REP-V5 expression (Figure 4.4, Lane 8) as well as a 
decrease of approximately 25 % in the overall biomass harvested. 
 
The effect of incubation time on protein expression was also investigated.  
Cells infected at the optimal MOI of 5 were harvested after 24, 48, 72 or 96 
hours and crude protein extracts analysed by SDS-PAGE.  No His-REP-V5 
 
 
 
Figure 4.4:  Optimisation of infection of Sf9 cells with the recombinant baculovirus, 
JRS BV1, expressing His-REP-V5.  SDS-PAGE analysis of crude extracts of Sf9 cells 
harvested 4 days after infection with different multiplicities of infection (MOI's) of wild-type 
(“wt”) baculovirus (Lanes 1 and 2) or JRS BV1 (Lanes 3 to 8).  The MOI used in each 
infection (in pfu.cell-1) is indicated above each lane.  Molecular mass standards are indicated 
on the left in kDa and the recombinant HaSV replicase, His-REP-V5, is indicated on the 
right. 
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was observed after 24 hours, but only after 48 hours (Figure 4.5, Lanes 1 
and 2).  A significant increase in His-REP-V5 expression levels was observed 
after 72 hours (Figure 4.5, Lane 3) and although expression levels were 
relatively stable after this point, maximum production was observed when 
cells were harvested after 96 hours (Figure 4.5, Lane 4). 
 
4.3.3. Solubility of His-REP-V5 
 
Differential centrifugation was used to separate soluble and 
insoluble/membrane-associated protein fractions.  A significant amount of 
His-REP-V5 was observed in the pellet fraction obtained from 
JRS BV1-infected cells (Figure 4.6, Lane 4), but none was detected in the 
supernatant fraction (Figure 4.6, Lane 3).  This indicated that the recombinant 
HaSV replicase was present in the baculovirus-infected cells either as a 
membrane-associated protein or in insoluble aggregates.  Sf9 cells grown in 
 
 
 
Figure 4.5:  Optimisation of time for expression of His-REP-V5 following infection of 
Sf9 cells with JRS BV1.  SDS-PAGE analysis of crude extracts of Sf9 cells infected with the 
recombinant baculovirus, JRS BV1, to determine the time following infection at which the 
maximum expression of His-REP-V5 was achieved.  Cells were infected at the optimal MOI 
of 5 and harvested after 24, 48, 72 or 96 hours (Lanes 1 to 4 respectively).  Molecular mass 
standards are indicated on the left and His-REP-V5 is shown on the right. 
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TC-100 and serum-free ExCell 420 media were also infected with JRS BV1 
in order to determine whether the growth medium and/or foetal calf serum 
could have an effect on solubility of the recombinant protein, However, the 
analysis of soluble and insoluble protein fractions by SDS-PAGE showed no 
change in the solubility of His-REP-V5 in either medium (Figure 4.7, Lanes 1 
to 3 vs Lanes 4 to 6).  Attempts at solubilisation and purification of 
His-REP-V5 using denaturing Ni-affinity purification (in the presence of 8 M 
urea) were equally unsuccessful (data not shown). 
 
 
4.3.4. Subcellular fractionation of His-REP-V5 
 
To determine whether His-REP-V5 was associated with cellular membranes, 
a subcellular fractionation protocol able to distinguish between the major 
groups of membrane-associated proteins was used.  Validation of the 
fractionation protocol was done using VDAC, a ubiquitous transmembrane, 
pore-forming protein present in all eukaryotic mitochondria (Blachly-Dyson et 
al., 1993).  Small amounts of VDAC were detected in soluble/cytosolic 
fractions but the protein was mostly present in membrane-associated 
fractions (Figure 4.8, Panel A, Lanes 4 and 6).  As expected, incubation of 
membrane-associated fractions in solutions of high ionic strength buffer (1 M 
 
 
Figure 4.6:  The solubility of His-REP-V5 expressed in Sf9 cells infected with JRS BV1.  
SDS-PAGE analysis of soluble (“Sup”, Lanes 1 and 3) and insoluble (“Pel”, Lanes 2 and 4) 
protein fractions from Sf9 cells infected with wild-type (“wt”) baculovirus (Lanes 1 and 2) or 
the recombinant JRS BV1 (Lanes 3 and 4).  Molecular mass standards are indicated on the 
left while His-REP-V5 is indicated on the right. 
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NaCl) or alkaline pH (11.1) did not release VDAC from membrane fractions, 
where it remained in the pellet fractions representing unliberated membrane 
proteins and insoluble aggregates (Figure 4.8, Panel A, Lanes 4 and 6).  By 
contrast, the presence of the non-ionic detergent Triton X-100 resulted in the 
complete solubilisation of VDAC from the membrane-associated fraction 
(Figure 4.8, Panel A, Lane 7).   
 
Western analysis of JRS BV1-infected cells showed that the full length 
His-REP-V5 pelleted with membrane-associated/insoluble proteins when 
incubated at an alkaline pH (11.1) (Figure 4.8, Panel B, Lane 6).  Similar 
results were also obtained following incubation in buffer containing 1 M NaCl 
or 1 % Triton X-100 (Figure 4.8, Panel B, Lanes 4 and 8).  In addition to the 
full length His-REP-V5, three degradation products of approximately 90, 110 
and 150 kDa in size were detected (Figure 4.8, Panel B).  While His-REP-V5 
and the largest degradation product (150 kDa) were exclusively present in 
the respective pellet fractions, a small amount of the 90 and 110 kDa 
 
 
Figure 4.7:  The effect of growth medium on the solubility of His-REP-V5 in Sf9 cells 
infected with JRS BV1.  SDS-PAGE analysis of the soluble (Lanes 1 to 3) and insoluble 
(Lanes 4 to 6) protein fractions of Sf9 cells infected with JRS BV1 and grown in complete 
Grace's (Lanes 1 and 4), complete TC-100 (Lanes 3 and 6) or serum free ExCell 420 (Lanes 
2 and 5) insect tissue culture media.  Molecular mass standards are indicated on the left and 
His-REP-V5 is indicated on the right. 
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polypeptides were detected in the soluble fraction (Figure 4.8, Panel B, 
Lane 2).  The remainder were present with membrane-associated/insoluble 
protein fractions and remained in the pellet fractions (Figure 4.8, Panel B, 
Lanes 4, 6 and 8), with the exception of the smallest degradation product (90 
kDa), the majority of which was detected in the fraction of membrane proteins 
solubilised by Triton X-100 (Figure 4.8, Panel B, Lane 7).  This suggests that 
the proteolytic degradation of C-terminal region of His-REP-V5 affects the 
association of the polypeptide with the membrane-associated/insoluble 
protein fractions, implying that sequences within the C-terminal region could 
be involved in protein-membrane or protein-protein interactions.  The 
proteolytic degradation of His-REP-V5 at 4 °C and in the presence of 
protease inhibitors also suggests that the recombinant protein is not likely to 
be present in insoluble aggregates, since aggregated proteins tend to be 
protected, to some degree, from proteolytic degradation (Kane and Hartley, 
1988).  
 
4.4 DISCUSSION 
 
Previous attempts at detecting the replicase expressed in transfected tissue 
culture cells in western blots had been unsuccessful, primarily due to low 
transfection efficiencies of the plasmids encoding the full length HaSV 
replicase-EGFP fusion proteins, especially in mammalian cells.  As a result, 
the expression of sufficient replicase for biochemical fractionation studies 
was achieved using baculovirus-mediated expression of His-REP-V5 in Sf9 
cells.  This system allowed for the expression of the recombinant HaSV 
replicase in a much higher proportion of cells, increasing the overall levels of 
production and enabling detection by western blot using anti-His, anti-V5 
epitope and anti-REP1-218(b) antisera.   
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Initial solubility studies showed that His-REP-V5 was predominantly 
insoluble.  Repeated attempts at solubilisation in the presence of 8M urea 
were unsuccessful and the purification of the replicase using Ni-affinity 
purification was equally ineffective (data not shown).  The frequent use of 
high concentrations of urea in the solubilisation of misfolded and aggregated 
proteins through the stabilisation of non-native polypeptide conformations 
(Bennion and Daggett, 2003) implies that the insolubility of His-REP-V5 is 
probably due to a strong, membrane-association rather than misfolding or 
aggregation. 
 
Subcellular fractionation of cells expressing the HaSV replicase was 
conducted with the aim of demonstrating the membrane-association of the 
HaSV replicase and identifying the type of interaction involved.  The full 
length His-REP-V5 remained in the membrane-associated/insoluble protein 
 
 
 
Figure 4.8:  The subcellular fractionation of His-REP-V5 in Sf9 cells infected with the 
recombinant baculovirus, JRS BV1.  Sf9 cells infected with JRS BV1 were fractionated to 
isolate subcellular protein fractions and subjected to western analysis using anti-VDAC 
(Panel A) or anti-REP1-218(b) (Panel B) antisera at dilutions of 1:500 or 1:15 000, respectively.  
Cells were fractionated into “post nuclear supernatant” (“PNS”, Lane 1), soluble (“Sol”, Lane 
2) and membrane-associated/insoluble protein fractions.  The membrane-
associated/insoluble protein fraction was further fractionated according to differential 
solubility in 100 mM NaCO3 (“pH 11.1”, Lanes 5 and 6) or buffers containing 1 M NaCl 
(Lanes 4 and 5) or 1 % Triton X-100 (Lanes 7 and 8).  Proteins released from membranes by 
each treatment were present in the solubilised membrane (“Sol Memb”) fractions (Lanes 3, 5 
and 7) while the remaining membrane-associated and insoluble proteins were present in the 
pellet (“Pel”) fractions (Lanes 4, 6 and 8).  Molecular mass standards are shown on the left of 
each blot in kDa while VDAC and His-REP-V5 are indicated on the right. 
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fractions following treatment with high salt, alkaline pH and non-ionic 
detergent.  The fractionation protocol was always performed at 4 °C in an 
attempt to prevent the proteolytic degradation of His-REP-V5 that was 
consistently observed, even in the presence of protease inhibitors.  This 
meant that the protein fractions that pelleted in the presence of Triton X-100 
would also include DRMs, naturally occurring cellular membranes that, at 
4 °C, retain their protein content even in the presence of high concentrations 
of non-ionic detergents (reviewed in Anderson and Jacobson, 2002; Zheng 
and Foster, 2009).  Attempts at further purification of DRMs by membrane 
floatation were unsuccessful and His-REP-V5 was not detected, largely due 
to the poor sensitivity of the anti-REP1-218(b) antibodies (data not shown). 
 
Analysis of the C-terminal degradation products detected by anti-REP1-218(b) 
antiserum, generated against the N-terminal 218 amino acids of the HaSV 
replicase, showed a propensity to fractionate differently to the full length 
His-REP-V5.  Notably, a significant proportion of the 110 and 90 kDa 
fragments were detected in the soluble fraction, with the remaining 90 kDa 
fragment being soluble in the presence of 1 % Triton X-100.  Analysis of the 
HaSV replicase sequence reveals that protein fragments spanning from the 
N-terminus to either side of the RdRp domain would have theoretical 
molecular masses of approximately 97 and 152 kDa respectively.  These 
data suggest that a region within the RdRp domain may be involved in the 
association of His-REP-V5 with membrane-associated/insoluble protein 
fractions. 
 
While the solubility and membrane association of both His-REP-V5 could not 
be conclusively established in the experiments described in this chapter, 
there is evidence that these proteins are not present in insoluble aggregates.  
Firstly, the precipitation of His-REP-V5 continues unaffected by incubation 
with 8 M urea, which can be successfully used in the solubilisation of most 
insoluble aggregates.  In addition, proteins present in insoluble aggregates 
and inclusion bodies tend to be protected to some degree from proteolytic 
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degradation, while His-REP-V5 shows significant and relatively rapid 
degradation during purification, even at 4 °C and in the presence of protease 
inhibitors.  Finally, His-REP-V5 degradation products were detected in 
soluble and solubilised membrane-associated fractions, meaning that 
C-terminal degradation of the replicase beyond the RdRp domain resulted in 
liberation of those polypeptides from membrane-associated/insoluble 
fractions. 
 
While the high levels of protein produced through the baculovirus-mediated 
expression of the HaSV replicase is necessary for the detection of the 
replicase using western analysis, the system inherently has significant 
shortcomings.  Most notably, the overexpression of the replicase could 
hamper proper folding and/or trafficking by overloading cellular chaperone 
and transport machinery.  The lack of any in vivo studies on the membrane-
association of the HaSV replicase and the expression of His-REP-V5 in the 
absence of any other HaSV proteins makes it difficult to determine whether 
the apparent membrane-association of the recombinant replicase is 
representative of the natural replicase-host interactions or an artefact 
generated by the experimental system.  The following chapter addresses this 
question by comparison of these results with similar data obtained from PrV-
infected MG8 cells, the only available tissue culture system for studying in 
vivo tetravirus replication, and deletion mutants expressed in both 
experimental systems. 
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5.1 INTRODUCTION 
 
The association of vRNA replication complexes with host-derived membranes 
is usually driven either by the replicase or one or more of its cleavage 
products.  In the case of HaSV, the 187 kDa replicase appears to be the only 
viral replication protein and, as a result, is thought to carry sufficient 
information for the generation and targeting of vRNA replication factories.  
This hypothesis was investigated (Chapter 3; Short et al., 2010) with the 
expression of REP1-1704-EGFP producing punctate structures in HeLa and Sf9 
cells in the absence of other viral proteins and vRNA.  Data already 
presented in this thesis imply that at least two regions may be involved in the 
localisation of the HaSV replicase.  In the first instance, the suppression of 
localisation when EGFP was fused to the N-terminus of the replicase 
(Section 3.3.1) suggested that sequences at or near the N-terminus may be 
important in localisation.  Secondly, the differential fractionation of 
His-REP-V5 degradation products implied that sequences within the RdRp 
domain were responsible for directing membrane association (Section 4.3.4).   
 
This chapter describes the characterisation of two localisation domains by 
expressing a series of EGFP-fused replicase deletion mutants in HeLa and 
BHK-21 cells.  In addition, a fluorescence microscopy-based method for the 
analysis of the membrane association of proteins in whole cells was 
developed and used to analyse the membrane interactions of a subset of 
replicase-EGFP fusion proteins in HeLa and Sf9 tissue culture cells.  Finally, 
these results were compared to data obtained from the fractionation of PrV-
infected MG8 cells, the only available in vivo tetravirus replication system. 
CHAPTER 5 
CHARACTERISATION OF THE HaSV REPLICASE 
LOCALISATION DOMAINS 
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5.2 MATERIALS AND METHODS 
 
5.2.1. Recombinant plasmids for the expression of replicase-EGFP 
 deletion mutants 
 
Restriction maps of the recombinant plasmids used in the experiments 
described in this chapter are shown in Figure 5.1 and the cloning strategies 
used to construct each plasmid are outlined in Appendix A.  A list of the 
constructs including the coordinates of HaSV replicase fragments can be 
found in Table 5.1.  Recombinant plasmid DNA was transfected into cells on 
13 mm glass coverslips as described in Section 3.2.2 and fixed within 24 
hours of transfection using 4 % paraformaldehyde (w/v) in PBS for 15 
minutes before being mounted on glass slides using Fluorescent Mounting 
Medium. 
 
5.2.2. Statistical analysis of N- and C-terminal HaSV replicase-EGFP 
 deletion mutants 
 
At least 100 fields of view were imaged using a Zeiss LSM 510 META laser 
scanning confocal microscope with a 63x objective lens and a standard 
configuration for the detection of EGFP fluorescence in cells expressing 
replicase-EGFP fusion proteins.  Cells were scored according to the 
distribution of the EGFP fluorescence into one of the three dominant 
distributions: “Cytosolic + Nuc”, a cytosolic distribution of EGFP fluorescence, 
with EGFP also present in the nucleus; “Cytosolic – Nuc”, cytosolic EGFP 
fluorescence excluded from the nucleus; and “Punctate”, a punctate cytosolic 
pattern with little to no cytosolic EGFP fluorescence.  This analysis was 
repeated in duplicate by two “double-blind” analysts, who had no knowledge 
of which dataset represented which deletion mutant.  The percentage of cells 
falling into each distribution from all three analyses over three repeats were 
summed, averaged and the standard deviation calculated. 
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5.2.3. Bioinformatic and deletion analysis of the HaSV replicase 
 N-terminus 
 
The N-terminal 100 amino acids of the alpha-like tetravirus replicases, 
namely HaSV, DpTV and NβV (GenBank accession numbers EU345431, 
NP_048059 and YP_025094, respectively), were aligned using T-COFFEE 
(www.tcoffee.org, accessed 27 February 2010) with all parameters set at 
their default values.  The same sequences were also subjected to secondary 
structure prediction using J-pred 3 (www.compbio.dundee.ac.uk/www-jpred/, 
accessed 27 February 2010).  The results from the secondary structure 
prediction were superimposed onto the primary sequence alignment to 
produce an alignment of the predicted secondary structures. 
Table 5.1:  Plasmids used for the expression of HaSV replicase-EGFP fusion proteins. 
 
Plasmid Promoter EGFP Fusion Expressed Protein Description of Construction 
 pEGFP-N1 CMV - EGFP ClonTech 
 pJRS7 CMV C-terminal REP1-1704-EGFP A.5 
 pJRS7 N44Δ CMV C-terminal REP45-1704-EGFP A.9 
 pJRS12 CMV C-terminal REP1-100-EGFP A.10 
 pJRS15 CMV C-terminal REP1-1368-EGFP A.11 
 pJRS34 CMV C-terminal REP1-1304-EGFP A.14 
 pJRS32 CMV C-terminal REP1-1241-EGFP A.13 
 pJRS16 CMV C-terminal REP1-1159-EGFP A.12 
 pJRS8 CMV N-terminal EGFP-REP1-1704 A.6 
 pJRS4 CMV N-terminal EGFP-REP1-541 A.6 
 pCW56 hr/AcMNPV (insect) - EGFP Walter, 2008 
 pJRS26 hr/AcMNPV (insect) C-terminal REP1-1704-EGFP A.7 
 pJRS26 2A hr/AcMNPV (insect) C-terminal* REP1-1704-2A-EGFP A.15 
 
EGFP fusions are N- or C-terminal in relation to the replicase. “*” indicates that the EGFP 
fusion is preceded by the 2A-like cleavage site from equine rhinitis A virus (ERAV). 
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Figure 5.1 (Here and pages 96 and 97):  Plasmid maps of the recombinant expression 
vectors for the expression of HaSV replicase-EGFP deletion mutants in tissue culture 
cells. Amp R: β-lactamase, CMV Promoter: Human cytomegalovirus immediate early 
promoter, EGFP: enhanced green fluorescent protein, ERAV 2A-like sequence: “2A-like” co-
translational processing site derived from equine rhinitis A virus (ERAV), hr/AcMNPV 
Promoter: hybrid insect promoter, Kan/Neo R: neomycin phosphotransferase. 
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A series of N-terminal deletion mutants, each having various predicted 
secondary structure elements disrupted or deleted, were produced by 
reverse PCR as described in Appendix A.16.  An additional N-terminal 
domain-swap, replacing the HaSV N-terminus with the corresponding 
 
Figure 5.1 Continued: Figure legend on page 95. 
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sequence from NβV (pJRS7 N-NBV), was also produced (Appendix A.17).  
The analysis of cells transfected with each of these plasmids was performed 
using 50 images of transfected cells, representative of at least three 
experiments.  Cells were scored according to three dominant distributions.  
Both “Cytosolic – Nuc” and “Punctate” were as defined in Section 5.2.2 while 
the third grouping was called “Mixed” and comprised cells displaying an 
incomplete localisation of EGFP fluorescence to the punctate structures (i.e. 
a noticeable punctate distribution with residual cytosolic EGFP fluorescence).  
The images were analysed by one “double-blind” analyst and the average 
percentages for the dominant distribution calculated. 
Figure 5.1 Continued: Figure legend on page 95. 
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5.2.4. Subcellular fractionation and western analysis 
 
Transfected HeLa and baculovirus-infected Sf9 cells were fractionated as 
outlined in Section 4.2.6.  The membrane-associated pellet obtained from 
transfected HeLa cells was treated with 1 % Triton X-100 to produce 
solubilised membrane (supernatant) and insoluble (pellet) fractions.  In the 
western analyses, EGFP was detected using monoclonal mouse anti-EGFP 
antibodies (Sigma, G6539) and PrV p40 was detected in fractionated MG8 
cells using polyclonal rabbit anti-p40 antiserum (Walter, 2008).  In an attempt 
to determine whether the replicase was associated with DRMs when the 
fractionation was carried out at 4 °C, the purification protocol was also carried 
out at room temperature. 
 
5.2.5. Subcellular fractionation using laser scanning confocal 
 microscopy 
 
HeLa and Sf9 cells were transfected with the purified plasmid DNA as 
indicated in Section 3.2.2 while PrV-infected MG8 cells were seeded onto 
coverslips.  Approximately 20 hours after transfection cells were incubated in 
PBS (pH 7.4), 1 M NaCl (in PBS), 100 mM NaCO3 (pH 11.1) or 1 % Triton 
X-100 (in PBS) for 15 minutes with gentle agitation before fixation using 4 % 
paraformaldehyde.  Samples were subjected to immunofluorescence staining 
for the detection of CD63 or PrV p40 (Section 3.2.3) before mounting onto 
glass slides with Fluorescent Mounting Medium. 
 
5.2.6. Construction of the recombinant baculovirus JRS BV2 for the 
 production of  His-ΔREP-V5 
 
The plasmid pJRS42 N83Δ, which is derived from the pFastBacTM Dual 
vector, was constructed as described in Appendix A.18 and is identical to 
pJRS42 except that the sequence encoding the N-terminal 83 amino acids of 
HaSV replicase localisation domains 
99 
 
the HaSV replicase are deleted for the production of the replicase deletion 
mutant, His-ΔREP-V5.  The recombinant baculovirus for the expression of 
His-ΔREP-V5, JRS BV2, was generated, purified and optimised as described 
in Sections 4.2.1 to 4.2.4. 
 
5.3 RESULTS 
 
5.3.1. The role of N- and C-terminal regions on the localisation of 
replicase-EGFP fusion proteins 
 
In order to determine which regions of the HaSV replicase were responsible 
for the development of the punctate structures observed in cells expressing 
REP1-1704-EGFP, N- and C-terminal deletions were introduced into the 
replicase sequence and the truncated proteins expressed as EGFP fusions in 
HeLa and BHK-21 cells (Figure 5.2).  The expression of the deletion mutants 
revealed three distinct distributions of EGFP fluorescence within cells from 
both cell lines (Figure 5.2, Panel A).  Firstly, fluorescence from untagged 
EGFP was distributed throughout the cytoplasm and appeared to concentrate 
within the nucleus (labelled “Cytosolic + Nuc”).  A cytosolic, extra-nuclear 
distribution was observed for a number of the deletion mutants (designated 
“Cytosolic – Nuc”) as was the “Punctate” localised distribution, previously 
observed for REP1-1704-EGFP.  The proportion of cells displaying each 
dominant distribution, expressed as a percentage of the total number of cells 
counted, is shown in Figure 5.2 (Panel B).  
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Figure 5.2:  Distribution of HaSV replicase deletion mutants fused to EGFP.  The 
dominant distributions of EGFP fluorescence observed are shown in Panel A (HeLa cells) 
with “Cytosolic + Nuc” referring to a cellular distribution similar to that observed for EGFP.  
The distributions indicated by “Cytosolic – Nuc” and “Punctate” represent cytosolic EGFP 
fluorescence that is excluded from the nucleus and small localised structures distributed 
throughout the cytosol respectively.  Panel B contains schematic diagrams of the HaSV 
replicase deletion mutants with the positioning of their respective EGFP fusions (left) as well 
as the dominant distribution observed for each (centre) and the percentage of cells counted 
with the dominant distribution (right).  MT: methyltransferase, Hel: helicase, RdRp: RNA-
dependent RNA polymerase, ND: not determined.  Scale bar = 10 μm. 
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As expected, native EGFP displayed a “Cytosolic + Nuc” distribution in over 
97% of the cells scored, while the distribution of REP1-1704-EGFP 
fluorescence was predominantly “Punctate” as observed before (Section 
3.3.1).  Deletion of the N-terminal 44 amino acids (REP45-1704-EGFP) resulted 
in a “Cytosolic – Nuc” distribution, similar to that observed for 
EGFP-REP1-1704, indicating that the N-terminus of the protein may be 
required for localisation.  The observation that the N-terminal 100 amino 
acids alone were insufficient for localisation (REP1-100-EGFP), suggested that 
there were other regions involved in replicase targeting.  In an attempt to 
identify these regions, a series of C-terminal deletions were expressed and 
analysed as above. When 336 amino acids were removed (REP1-1368-EGFP), 
the distribution of the protein was still predominantly “Punctate”, indicating 
that all the requirements for targeting were still present.  However, deletion of 
a further 64 amino acids from the C-terminus of the replicase 
(REP1-1304-EGFP) resulted in a “Cytosolic – Nuc” pattern in the majority of 
cells scored (similar results were also obtained for REP1-1241-EGFP and 
REP1-1159-EGFP).  These data strongly imply the presence of at least two 
regions, one at the N-terminus and the other at the C-terminus of the RdRp 
domain, between residues K1304 and P1368, that may be responsible for the 
targeting of the HaSV replicase.  Similar results were observed in BHK-21 
cells (Figure 5.2, Panel B).  It is unclear whether the loss of localisation in the 
C-terminal deletion mutants was due to the deletion/disruption of the 
targeting domain or the disturbance of secondary, tertiary or even quaternary 
structures. 
 
5.3.2. Identification of potential targeting domains in the HaSV 
 replicase N-terminus 
 
A further analysis of the N-terminal region immediately upstream of the MT 
domain was undertaken to identify potential domains that might function in 
localisation of the HaSV replicase.  Two α-helices, separated by a conserved 
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LDF tripeptide motif in a well conserved “linker region”, were predicted within 
the first 45 amino acids of all three replicase sequences (HaSV, DpTV and 
NβV) (Figure 5.3).  In addition, 20 amino acid positions showed conservation 
of charge.  These consisted of eight charged (DERKH), two aromatic (YFW) 
and ten non-polar (AGVLIPMC) amino acids and were evenly spread across 
the three regions with eight present in “Helix I” and six in each the “linker 
region” and “Helix II”.  The conservation of charge across the N-terminal 
region and the significant similarity between the predicted secondary 
structures suggest the possibility of a common localisation mechanism for the 
alpha-like tetravirus replicases, which may require functions associated with 
this helix-linker-helix region.  
 
 
 
5.3.3. The effects of the disruption of predicted N-terminal 
 secondary structures on localisation 
 
In order to further assess the role of each of the putative N-terminal structural 
elements on the targeting of the replicase to the punctate structures, a series 
of five deletion mutants was generated.  The requirement of a free N-
terminus was analysed through the addition of an N-terminal 6xHis tag.  In 
 
Figure 5.3:  Primary amino acid sequence alignment of the alpha-like tetravirus 
replicases displaying predicted secondary structures.  Predicted α-helices are 
highlighted in yellow with the conserved tripeptide (LDF) within the “linker region” in green.  
“*”: exact match of aligned amino acids, “:”: conserved amino acids, “.”: semi-conserved 
amino acids, HaSV: Helicoverpa armigera stunt virus, DpTV: Dendrolimus punctatus 
tetravirus, NβV: Nudaurelia capensis β virus. 
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addition, a “domain-swap” chimeric protein was produced in which the 
N-terminal region from HaSV was substituted with the corresponding region 
from NβV (pJRS7 N-NBV) (Figure 5.4, Panel A). 
 
HeLa cells expressing the EGFP-fused N-terminal deletion mutants displayed 
both the “Cytosolic – Nuc” distribution (Section 5.3.1) and a “Mixed” 
distribution where punctate structures were obvious but a significant amount 
of cytosolic fluorescence was also detected (Figure 5.4, Panel B, right).  All of 
the N-terminal deletion mutants exhibited a decrease in localisation 
efficiency, displaying either the “Mixed” or “Cytosolic – Nuc” distributions.  
The first N-terminal deletion mutant (pJRS7 RPCR1) had helix I removed   
(Figure 5.4, Panel A) and displayed a “Mixed” EGFP fluorescence distribution 
in 60 % of the cells scored (Figure 5.4, Panel B).  A partial helix I deletion was 
generated in the replicase CDS of pJRS7 RPCR2 (Figure 5.4, Panel A).   
HeLa cells expressing this N-terminal deletion mutant exhibited “Cytosolic – 
Nuc” EGFP fluorescence in 84 % of cells (Figure 5.4, Panel B).  Similar 
results were obtained for the other three N-terminal deletion mutants.  In 
88 % of the cells expressing the EGFP fusion proteins expressed from 
pJRS7 RPCR3 and pJRS7 RPCR4, which encoded full or partial helix I 
deletions respectively in addition to the deletion of the full linker region and 
part of helix II (Figure 5.4, Panel A),  the “Cytosolic – Nuc” distribution was 
observed (Figure 5.4, Panel B).  Finally, the deletion mutant in which only the 
linker region and part of helix II was deleted (pJRS7 RPCR5) (Figure 5.4, 
Panel A) showed cytosolic EGFP fluorescence that was excluded from the 
nucleus (Cytosolic – Nuc) in 92 % of the cells counted (Figure 5.4, Panel B).   
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The fusion of a 6xHis tag to the N-terminus of the HaSV replicase CDS 
(pJRS7 N-His) (Figure 5.4, Panel A) also resulted in a decrease in 
localisation of efficiency and produced a “Mixed” distribution in 67 % of the 
cells scored (Figure 5.4, Panel B).   Interestingly, even though the predicted 
secondary structure elements were consistent between the HaSV and NβV 
sequences, the NβV sequence was not able to direct the targeting of the 
chimeric replicase, with the chimeric NβV/HaSV replicase sequence 
Figure 5.4:  Distribution of N-terminal HaSV replicase mutants fused to EGFP.  Panel A 
contains an alignment of the various N-terminal mutants generated while Panel B shows 
schematic representations of the respective mutants (left), the dominant distribution 
observed for each mutant (centre) along with the percentages of cells exhibiting each of the 
dominant distributions (right).  Amino acids within the predicted α-helices of the alpha-like 
tetravirus replicases are highlighted in yellow and the conserved “linker region” tripeptide is 
highlighted in green.  The single Q to S point mutation introduced in the cloning process is 
highlighted in purple.  In Panel B the predicted helices are represented by grey boxes while 
the “linker region” is represented by the bent arrow between the helices.  Scale bar = 10 μm. 
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(pJRS7 N-NBV) (Figure 5.4, Panel A) producing “Cytosolic – Nuc” EGFP 
fluorescence in 92 % of the cells counted (Figure 5.4, Panel B).  It is worth 
noting that the two proteins displaying the “Mixed” distribution produced 
significantly lower percentages of their dominant distribution (60 and 67 % as 
compared to 84 to 92 % for the other mutants).  This was interpreted as a 
decrease in localisation efficiency in these proteins rather than the complete 
abrogation of targeting as in the other mutants.  Another interesting 
observation was that the partial removal of helix I (pJRS7 RPCR2) resulted in 
a “Cytosolic – Nuc” distribution while the complete removal of the same helix 
(an additional 14 amino acids)  resulted in an apparent increase in targeting 
efficiency, possibly due to poor presentation of the remaining structural 
elements caused by the partial helix I. 
 
The linker region appears to be required for the localisation of the replicase 
to the punctate structures although the partial deletion of helix I seems to 
inhibit its function, possibly through steric hindrances produced by the 
modification of the predicted secondary structure.  The relative importance of 
the secondary structures, and the specific sequences contained within each 
of them, remains unclear and requires further investigation, although helix I 
may be dispensable.  The data related to the importance of a free N-terminus 
are inconclusive and the effect of the small 6xHis tag may be indicative of a 
minor, complementary role although the decrease in targeting efficiency could 
simply be due to the introduction of charge into the region. 
 
5.3.4. The subcellular distribution of replicase-EGFP fusion proteins 
 in transfected tissue culture cells 
 
Initial attempts at determining the type and degree of membrane association 
of the deletion mutants were made using the biochemical fractionation 
protocol described in Chapter 4.  However, both anti-REP1-218(b) and 
monoclonal anti-EGFP antibodies were unable to detect REP1-1704-EGFP in 
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transfected HeLa cells (Figure 5.5, data not shown).  The most likely reason 
for this was the low transfection efficiencies associated with the large 
plasmids used for the expression of the replicase-EGFP fusion proteins, 
especially in HeLa cells (Section 3.3.1). 
 
Therefore, it was decided to characterise the membrane association of the 
deletion mutants using a fluorescence microscopy-based protocol modified 
and expanded from Matthews et al. (2009).  Transfected HeLa cells were 
incubated in the presence of buffer containing high salt (1 M NaCl), alkaline 
pH (11.1) or 1 % Triton X-100 (Figure 5.6).  The cellular membrane-
associated protein CD63 (Metzelaar et al., 1991), the fluorescent tagged 
 
 
Figure 5.5:  Distribution of EGFP in subcellular fractions of transfected HeLa cells.  
Western analysis of soluble (“Sol”), membrane associated (“Memb”), solubilised membrane 
(“S Memb”) and insoluble (“Pel”) fractions of HeLa cells transfected with either pJRS7 
(Panels A and C) or pEGFP-N1 (Panels B and D).  EGFP and VDAC were detected using 
anti-EGFP (Panels A and B) or anti-VDAC (Panels C and D) respectively, both at dilutions of 
1:500.  Molecular mass standards are indicated on the left in kDa while EGFP and VDAC are 
indicated on the right. 
 
Figure 5.6:  Differential solubilisation of proteins from transfected HeLa cells using 
high salt, alkaline pH or Triton X-100.  HeLa cells were transfected with plasmids encoding 
EGFP (h to j), REP1-1704-EGFP (k to n), EGFP-REP1-1704 (s to v), REP45-1704-EGFP (o to r) or 
a mitochondrial-targeted DsRed variant (DsRed 2-Mito) (e to g) before being fractionated 
and prepared for imaging using confocal fluorescence microscopy.  The late endosome 
marker protein CD63 was detected by immunofluorescence microscopy using monoclonal 
mo se anti-CD63 antibodi s (a t  d), which were detected using Alexa Fluor 546-conjugated 
goat anti-mouse secondary antibodies.  PBS: phosphate buffered saline, 1 M NaCl: PBS + 
1 M NaCl, pH 11.1: 100 mM NaCO3 (pH 11.1), 1% Triton: PBS + 1 % Triton X-100.  “Not 
Detected” indicates samples were no fluorescence signal associated with the appropriate 
fluorophore was observed across an entire coverslip in both experiments.  Scale bars = 
10 μm. 
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mitochondrial marker DsRed2-Mito (carrying the mitochondrial targeting 
signal from subunit VIII of human cytochrome c oxidase) (ClonTech) and 
cytosolic EGFP were used for validation of the fractionation system 
(Figure 5.6, Images a to j).  The cytosolic control (EGFP) showed that 
incubation of cells in high salt and high pH buffers was insufficient for the 
disruption of the plasma membrane and therefore did not result in the release 
of the cytosolic content into the extracellular environment (Figure 5.6, 
Images i and j).  The addition of Triton X-100 however, resulted in disruption 
of the plasma membrane and the release of EGFP.  Neither the high salt nor 
alkaline pH buffers had any effect on the distribution of the membrane-
associated controls, CD63 or DsRed2-Mito (Figure 5.6, Images b, c, f and g).  
However, following the addition of Triton X-100, DsRed2-Mito was no longer 
detectable and the amount of CD63 present in the punctate structures was 
significantly, but not entirely diminished (Figure 5.6, Image d).   This result is 
consistent with reports that CD63 is a member of the tetraspannins, a group 
of proteins that are often detected in DRMs (Section 1.5.2; Metzellar et al., 
1991; Maeker et al., 1997; Berditchevski, 2001; Claas et al., 2001; Levy and 
Shoham, 2005; Zheng and Foster, 2009). 
 
The fractionation profile of REP1-1704-EGFP resembled that of CD63, with the 
distribution remaining unchanged in the presence of high salt or alkaline pH 
but being diminished in the presence of Triton X-100 (Figure 5.6, Images k 
to n).  For both CD63 and REP1-1704-EGFP, treatment with the non-ionic 
detergents resulted in a concentration of the remaining fluorescence in 
regions close to the nucleus in all the cells in which fluorescence was 
detected (Figure 5.6, Images d and n), indicating that REP1-1704-EGFP may 
be associating with DRMs similar to those associated with CD63.    The loss 
of cell volume due to the permeabilisation of the plasma membrane could 
also account for the apparent condensation of fluorescence-labelled 
structures.   
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Figure 5.6: Figure legend on pg 109. 
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Both the deletion mutant and the N-terminal EGFP fusion that were tested 
(REP45-1704-EGFP and EGFP-REP1-1704) displayed the typical “Cytosolic – 
Nuc” distribution, which was unaffected by the presence of high salt or 
alkaline pH, consistent with a soluble cytosolic distribution similar to that of 
EGFP (Figure 5.6, Images o to q and s to u).  Treatment with 1 % Triton 
X-100 resulted in the loss of the cytosolic fluorescence (Figure 5.6, Images r 
and v) suggesting that the majority of each deletion mutant was present in 
the cell as a soluble cytoplasmic protein, released from the cell when the 
plasma membrane was permeabilised.  However, a small amount of 
fluorescence was detected in punctate structures similar to those observed 
for REP1-1704-EGFP and CD63 (Figure 5.6, Images d, n, r and v).  While 
interpretation of this data is limited because the percentage of transfected 
cells in which this phenotype was observed could not be determined, the 
data does indicate that deletion mutants previously thought of as cytosolic 
(“Cytosolic – Nuc”) may, in fact, be able to localise to the punctate structures, 
albeit either at a far slower rate or with a significantly lower affinity.  
 
This experiment was repeated using Sf9 cells, but the lack of suitable 
antibodies directed against cellular membrane-associated protein markers 
meant that validation of the protocol as was done for HeLa cells, was not 
possible.  As was the case for HeLa cells, EGFP was liberated in Sf9 cells 
transfected with pCW56 only after treatment with Triton X-100 (Figure 5.7, 
Images a to c).  Similarly, REP1-1704-EGFP behaved as in HeLa cells and 
Figure 5.6 (pg 108):  Differential solubilisation of proteins from transfected HeLa cells 
using high salt, alkaline pH or Triton X-100.  HeLa cells were transfected with plasmids 
encoding EGFP (h to j), REP1-1704-EGFP (k to n), EGFP-REP1-1704 (s to v), REP45-1704-EGFP 
(o to r) or a mitochondrial-targeted DsRed variant (DsRed 2-Mito) (e to g) before being 
fractionated and prepared for imaging using confocal fluorescence microscopy.  The late 
endosome marker protein CD63 was detected by immunofluorescence microscopy using 
monoclonal mouse anti-CD63 antibodies (a to d), which were visualised using Alexa Fluor 
546-conjugated goat anti-mouse secondary antibodies.  PBS: phosphate buffered saline, 
1 M NaCl: PBS + 1 M NaCl, pH 11.1: 100 mM NaCO3 (pH 11.1), 1% Triton: PBS + 1 % Triton 
X-100.  “Not Detected” indicates samples where no fluorescence signal associated with the 
appropriate fluorophore was observed across an entire coverslip in both experiments.  Scale 
bars = 10 μm. 
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remained unaffected by both the high salt and alkaline pH treatments only to 
be partially released by treatment with Triton X-100 (Figure 5.7, Images d 
to g).  Cells expressing REP1-1704-2A-EGFP were also analysed.  
REP1-1704-2A-EGFP consists of the HaSV replicase and EGFP sequences 
separated by the “2A-like” processing site from Equine rhinitis A virus 
(ERAV).  This consensus sequence has been shown to cleave with an 
efficiency of >99 % in a reporter-based system and to produce very low 
levels of the full length product (<5 %) (Donnelly et al., 2001a, 2001b).  The 
processed EGFP, which would thus be expected to represent approximately 
99 % of the expressed EGFP, behaved similarly to untagged EGFP and was 
released in the presence of 1 % Triton X-100.  The remaining, uncleaved 
EGFP was detectable in some cells in a similar distribution to that observed 
for REP1-1704-EGFP (Figure 5.7, Images g and k).  
 
 
 
Figure 5.7:  Legend on pg 111. 
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5.3.5. Subcellular fractionation of Sf9 cells infected with the 
 recombinant baculovirus JRS BV2 
 
The data presented in Section 5.3.1 showed that deletion of the N-terminus 
of the replicase resulted in loss of targeting ability in HeLa cells expressing 
replicase-EGFP fusion proteins, i.e. the removal of the N-terminal 44 amino 
acids from the replicase resulted in abrogation of the punctate distribution of 
EGFP fluorescence  (Figure 5.2, Panel B).  This raised the possibility that an 
N-terminal replicase deletion mutant might result in a soluble recombinant 
polypeptide that could be used for antibody production.  Accordingly, the 
recombinant baculovirus, JRS BV2, expressing a replicase CDS with the 
N-terminal 83 amino acids replaced with a 6xHis tag and a V5 epitope tag 
fused to the C-terminus (His-ΔREP-V5), was constructed.  The expression of 
the recombinant replicase deletion mutant was confirmed and optimised as 
for JRS BV1 (Sections 4.2.1 and 4.2.2) and was found to behave similarly, 
with maximum protein production occurring when cells were infected at an 
MOI of 5 for a period of four days (data not shown).   
 
Western analysis of fractions generated from Sf9 cells infected with 
JRS BV2, using anti-REP1-218(b) antiserum, revealed that the subcellular 
distribution of His-ΔREP-V5 was similar to that of the wild-type protein 
His-REP-V5 (compare Figure 5.8, Panel B with Figure 4.8, Panel B in Section 
4.3.4).  In addition, a similar degradation product profile was observed for 
both His-ΔREP-V5 and His-REP-V5 although additional minor degradation 
products were detected at approximately 150 and 120 kDa (Figure 5.8, 
Figure 5.7 (pg110):  Differential solubilisation of proteins from transfected Sf9 cells 
using salt, alkaline pH or Triton X-100.  Sf9 cells were transfected with plasmids encoding 
EGFP (a to c), REP1-1704-EGFP (d to g) or REP1-1704-2A-EGFP (h to k) before being 
fractionated and prepared for imaging using confocal fluorescence microscopy.  PBS: 
phosphate buffered saline, 1 M NaCl: PBS + 1 M NaCl, pH 11.1: 100 mM NaCO3 (pH 11.1), 
1% Triton: PBS + 1 % Triton X-100.  “Not Detected” indicates samples were no EGFP 
fluorescence was observed across an entire coverslip in both experiments.  Scale bars = 
10 μm. 
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Panel B).  The majority of His-ΔREP-V5 was present in pellet fractions 
following the treatment of membrane-associated/insoluble fractions with high 
salt or alkaline pH and in the presence of Triton X-100, which was 
unexpected (Figure 5.8, Panel B, Lanes 4, 6 and 8).  The anti-REP1-218(b) 
antibodies were only able to detect small amounts of the His-ΔREP-V5 
degradation products in both the post nuclear supernatant and soluble 
protein fractions, likely due to a greater degree of proteolytic degradation of 
the deletion mutant (Figure 5.8, Panel B, Lanes 1 and 2).  Interestingly, the 
full length His-ΔREP-V5 was not the major protein band detected in any of 
the fractions, with the 150 and 90 kDa degradation products appearing in 
greater abundance.   
 
 
 
 
 
Figure 5.8:  Subcellular fractionation of His-ΔREP-V5 performed at 4 °C.  Western 
analysis of fractionated Sf9 cells expressing His-ΔREP-V5 using anti-VDAC (Panel A) or 
anti-REP1-218(b) (Panel B) antiserum at dilutions of 1:500 and 1:15 000 respectively.  Cells 
were fractionated into “post nuclear supernatant” (“PNS”, Lane 1), soluble (“Sol”, Lane 2) 
and membrane-associated/insoluble protein fractions.  The latter was further fractionated 
according to differential solubility in 100 mM NaCO3 (“pH 11.1”, Lanes 5 and 6) or buffers 
containing 1 M NaCl (Lanes 4 and 5) or 1 % Triton X-100 (Lanes 7 and 8).  Proteins released 
from membranes by each treatment were present in the solubilised membrane (“Sol Memb”) 
fractions (Lanes 3, 5 and 7) while the remaining membrane-associated and insoluble 
proteins were present in the pellet (“Pel”) fractions (Lanes 4, 6 and 8).  Molecular mass 
standards are shown on the left of each blot in kDa while VDAC and His-ΔREP-V5 are 
indicated on the right. 
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Since the fractionation procedure was performed at 4 °C and would therefore 
facilitate the purification of DRMs, it was decided to repeat the fractionation 
experiments at room temperature to determine whether an increase in 
temperature might have an effect on solubilisation of His-ΔREP-V5 by Triton 
X-100.  There was no change in the fractionation profile of His-ΔREP-V5, 
although the 90 kDa degradation product was detected in the detergent-
solubilised fraction (Figure 5.9, Panel B, Lane 7).  The 90 kDa polypeptide 
was the major protein detected, suggesting increased proteolytic degradation 
of the recombinant protein at the higher temperature. 
 
 
 
 
 
 
 
Figure 5.9:  Subcellular fractionation of His-ΔREP-V5 performed at room temperature.  
Western analysis of fractionated Sf9 cells expressing His-ΔREP-V5 using anti-VDAC (Panel 
A) or anti-REP1-218(b) (Panel B) antiserum at dilutions of 1:500 and 1:15 000 respectively.  
Cells were fractionated into “post nuclear supernatant” (“PNS”, Lane 1), soluble (“Sol”, Lane 
2) and membrane-associated/insoluble protein fractions.  The latter was further fractionated 
according to differential solubility in 100 mM NaCO3 (“pH 11.1”, Lanes 5 and 6) or buffers 
containing 1 M NaCl (Lanes 4 and 5) or 1 % Triton X-100 (Lanes 7 and 8).  Proteins released 
from membranes by each treatment were present in the solubilised membrane (“Sol Memb”) 
fractions (Lanes 3, 5 and 7) while the remaining membrane-associated and insoluble 
proteins were present in the pellet (“Pel”) fractions (Lanes 4, 6 and 8).  Molecular mass 
standards are shown on the left of each blot in kDa while VDAC and His-ΔREP-V5 are 
indicated on the right. 
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5.3.6. Subcellular localisation of the PrV replicase 
 
Given that HaSV does not replicate in tissue culture, it was not possible to 
correlate data obtained using the recombinant HaSV replicase with the 
localisation of native replicase in HaSV-infected cells.  Currently the only 
tetravirus known to replicate in tissue culture is PrV (Pringle et al., 2003), but 
as discussed in Section 1.3.5, there are significant differences between PrV 
and HaSV.  Most important is the fact that the PrV encodes a carmo-like 
replicase and is expressed as a major (p40) and minor (p104) translation 
product via the activity of a read-through stop codon.   
 
For the purposes of this study, an important question was whether the PrV 
replicase was also associated with DRMs in infected cells.  MG8 cells, which 
are persistently infected with PrV, were subjected to the same subcellular 
fractionation procedures as had been used for the recombinant HaSV 
replicase (Sections 4.2.6 and 5.2.5) and the PrV replicase (p40/p104) was 
detected using anti-p40 rabbit polyclonal antiserum.  As was the case for 
His-REP-V5, PrV p40 remained in membrane-associated/insoluble fractions 
even in the presence of 1 % Triton X-100 (Figure 5.10, Panel B, Lane 8).  
Differential fractionation of the various degradation products (approximately 
25 to 37 kDa in size) was also observed with the largest product being 
predominanty solubilised by the non-ionic detergent and partially soluble at 
alkaline pH (Figure 5.10, Panel B, Lanes 5 and 7).  The large (minor) 
translation product (p104) was not detected.   
 
Interestingly, a significant size difference was noted between the VDAC 
encoded by the Sf9 and MG8 cells (compare Figure 5.9, Panel A and 
Figure 5.10, Panel A).  While the mammalian anti-VDAC antibodies detected 
a protein co-migrating at approximately 35 kDa in Sf9 cells, the 
corresponding protein in MG8 cells was present at approximately 20 kDa.  
This is not unexpected since VDAC homologues in various organisms range 
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significantly in size from rat VDAC at 30 kDa in size to some human isoforms 
as small as 16 kDa (Genbank accession numbers:  AAH60558 and 
EAW66284.1 respectively).  
 
Finally, the subcellular distribution of p40 in PrV-infected MG8 cells was 
analysed using the fluorescence microscopy-based fractionation protocol 
using anti-p40 antiserum for the detection of wild-type p40.  This antiserum 
would also detect the full length PrV replicase, p104, although p40 is 
hypothesised to be produced in 10-fold excess in infected MG8 cells (Walter 
et al., 2010).  The effects of high salt concentrations and alkaline pH could 
not be determined since immunofluorescence using the anti-p40 antibodies 
was inhibited by these treatments.  However, as was the case for Sf9 cells 
expressing REP1-1704-EGFP, incubation of MG8 cells in buffer containing 1 % 
 
 
 
 
Figure 5.10:  Subcellular fractionation of PrV-infected MG8 cells.  Western analysis of 
fractionated MG8 cells using anti-VDAC (A) or anti-p40 (B) antiserum at dilutions of 1:500 
and 1:75 000 respectively.  Cells were fractionated into “post nuclear supernatant” (“PNS”, 
Lane 1), soluble (“Sol”, Lane 2) and membrane-associated/insoluble protein fractions.  The 
latter was further fractionated according to differential solubility in 100 mM NaCO3 (“pH 11.1”, 
Lanes 5 and 6) or buffers containing 1 M NaCl (Lanes 4 and 5) or 1 % Triton X-100 (Lanes 7 
and 8).  Proteins released from membranes by each treatment were present in the 
solubilised membrane (“Sol Memb”) fractions (Lanes 3, 5 and 7) while the remaining 
membrane-associated and insoluble proteins were present in the pellet (“Pel”) fractions 
(Lanes 4, 6 and 8).  Molecular mass standards are shown on the left of each blot in kDa 
while VDAC and PrV p40 are indicated on the right. 
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Triton X-100 did not completely liberate p40 (Figure 5.11), indicating like the 
HaSV replicase, the PrV replicase-associated structures were robust and 
also likely be associated with DRMs. 
 
 
 
5.4 DISCUSSION 
 
The primary aim of the experiments described in this chapter was to 
characterise the regions of the HaSV replicase required for the punctate 
distribution observed in REP1-1704-EGFP-expressing cells.  As such, a set of 
deletion mutants was used to identify two regions, one at the amino terminus 
and a second within the C-terminal region of the RdRp domain, both of which 
are required for efficient targeting of the replicase, in the absence of other 
viral proteins. 
 
Several lines of evidence support a role for the N-terminus in subcellular 
localisation of the HaSV replicase to punctate structures.  First, the addition 
of EGFP to the N-terminus of the replicase results in a loss of localisation, 
 
Figure 5.11:  Differential solubilisation of p40 from MG8 cells infected with PrV using 
high salt, alkaline pH or Triton X-100.  Persistently infected MG8 cells were fractionated 
and prepared for imaging using confocal fluorescence microscopy.  PrV p40 was detected by 
immunofluorescence microscopy using rabbit anti-p40 antiserum, in turn detected using 
FITC-conjugated goat anti-rabbit secondary antibodies.  PBS: phosphate buffered saline, 
1 M NaCl: PBS + 1 M NaCl, pH 11.1: 100 mM NaCO3 (pH 11.1), 1% Triton: PBS + 1 % Triton 
X-100.  “Not Detected*” indicates where p40 was not detectable, possibly due to disturbance 
of the antibody-p40 interactions following incubation in the high salt and high pH buffers.  
Scale bars = 10 μm. 
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while the addition of a 6xHis tag results in a decrease in targeting efficiency.  
Although the loss of localisation might be simply due to interference resulting 
from the large size (EGFP) or the positive charge (6xHis tag) of the fusion 
peptides, a free N-terminus could play a minor role in localisation but is most 
likely not an absolute requirement for localisation.  Second, deletion of the N-
terminal 44 amino acids of the replicase results in a largely soluble cytosolic 
fusion protein when expressed in HeLa cells.  However, the N-terminal region 
is insufficient for the localisation.  This is evidenced by the fact that the N-
terminal 100 replicase amino acid residues are unable to target EGFP to the 
punctate structures. 
 
Bioinformatic analysis of the putative N-terminal targeting domain revealed 
two predicted α-helices separated by eleven amino acids.  Analysis of the 
N-termini of the other two available alpha-like tetravirus replicases, together 
with multiple alignment of the respective sequences, identified similar 
predicted secondary structures and charge distribution in the N-termini of 
both DpTV and NβV.  In all three replicases, the two putative helices are 
separated by 11 to 13 amino acids, with each “linker region” containing an 
invariant LDF tripeptide.  Deletion analysis of the three structural elements 
(the two helices and the “linker region”) suggested that the entire sequence 
was important for efficient localisation.  Although further investigation is still 
needed, helix I may only contribute to targeting efficiency and is probably not 
an absolute requirement for localisation in HeLa cells.  Despite the notable 
similarities between the N-terminal sequences the NβV N-terminal domain 
was unable to substitute for the equivalent HaSV region, suggesting that 
structural elements alone are insufficient for targeting and that HaSV-specific 
sequences are required.  Further analysis would be required to determine the 
role of specific amino acids in targeting efficiency and the importance of the 
predicted secondary structures. 
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A series of C-terminal deletion mutants demonstrated that a second region 
within the RdRp domain was also required for punctate distribution of the 
replicase.  This was supported by the observation that the degradation 
products of the recombinant replicase expressed in Sf9 cells infected with 
recombinant baculoviruses JRS BV1 or JRS BV2 were present in different 
fractions depending on whether the polypeptide contained the RdRp domain.  
The 90 kDa degradation product consistently detected by the anti-REP1-218(b) 
antiserum (directed against the replicase N-terminus), is predicted to include 
the N-terminal half of the replicase, excluding the RdRp domain.  While the 
exact location and sequence of the targeting domain remains to be 
determined, it appears that this internal localisation region is responsible for 
the strong association with detergent resistant structures in both transfected 
and infected tissue culture cells. 
 
Further insight into the role of the replicase localisation domains was gained 
through the subcellular fractionation of cells expressing replicase-EGFP 
fusion proteins.  Both the control proteins, CD63 and DsRed2-Mito, are 
integral membrane proteins, with CD63 being a member of the multiple pass 
tetraspannin family often associated with DRMs (Section 1.5.2).  Both CD63 
and DsRed2-Mito retained their normal cellular distribution following 
incubation in high salt and alkaline pH buffers and were released only by 
treatment with 1 % Triton X-100.  A proportion of CD63 remained after 
detergent treatment, which is consistent with the reported association of a 
sub-population of CD63 with DRMs. The REP1-1704-EGFP fusion protein 
exhibited a similar fractionation pattern as CD63, with a proportion of the 
EGFP fluorescence remaining associated with punctate structures even in 
the presence of Triton X-100.  Strikingly, the deletion mutant REP45-1704-EGFP 
and EGFP-REP1-1704, that appeared to be cytosolic and soluble in previous 
experiments (Sections 3.3.1), were found to include a sub-population of 
protein that was associated with similar detergent-resistant structures.  These 
data suggest that the “Cytosolic – Nuc” distributions observed for many of the 
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deletion mutants do not necessarily represent a complete loss of targeting 
ability, but rather a significant decrease in the efficiency with which the 
localisation to the punctate structures occurs.  Since both the N-terminal 
fusion protein (EGFP-REP1-1704) and the N-terminal deletion mutant 
(REP45-1704-EGFP) displayed this phenotype, the implication is that the 
localisation domain present within the C-terminal region of the RdRp domain 
(or another as yet unidentified region) is sufficient for localisation to 
detergent-resistant structures similar to those associated with CD63.  The 
absence of the N-terminal domain results in localisation that is less efficient, 
either due to a lower rate of association or because of a decrease in affinity 
for the structures.  The N-terminal domain could then function either in the 
stabilisation of the interaction or as an activator, increasing the rate of 
association.   
 
This hypothesis is supported by data from baculoviral expression of 
His-ΔREP-V5 in Sf9 cells.  Here, deletion of the N-terminal localisation 
domain appeared to have little effect on the association of the protein with 
DRMs.  The strong association with detergent-resistant fractions of the 
baculovirus-expressed His-ΔREP-V5 could also be due to the long period of 
time allowed for expression (96 hours as opposed 24 hours in transfected 
cells).    HeLa and BHK-21 cells were harvested 20 hours after transfection 
and observations made in live cells (Section 3.3.4) suggest that prolonged 
expression results in an increased accumulation of the punctate structures 
(through homotypic fusion) into larger structures that are less mobile.  The 
increased time required for baculovirus expression in Sf9 cells may result in 
the development of similar aggregated structures that could represent 
misfolded protein but are more likely to be replicase-induced structures that 
are resistant to detergent solubilisation.  Alternatively the replicase could 
have a higher affinity for protein and/or membrane host factors present in 
insect cells or that host factors involved in the stabilisation of the 
replicase-membrane association in HaSV-infected cells are present in Sf9 
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cells and absent in mammalian cells.  These factors could strengthen the 
interaction to the point that the N-terminal domain is unnecessary in insect 
cells.   
 
The heterologous expression of the HaSV replicase in the absence of other 
viral proteins raised the possibility that the membrane-association and 
subcellular distribution were experimental artefacts.  In the absence of 
experimental systems for the analysis of wild-type HaSV replication 
complexes, the subcellular fractionation data was compared with data 
similarly obtained from tissue culture cells persistently infected with PrV.  The 
consistency with which both the recombinant HaSV replicase and the wild-
type PrV p40 were present in detergent-resistant fractions suggests that both 
associate with DRMs in vivo and that the punctate structures observed in 
cells expressing REP1-1704-EGFP are most likely the result of replicase-
directed membrane-association rather than the aggregation of misfolded 
proteins.  Since the interaction of the HaSV replicase with membranes occurs 
in the absence of other viral proteins, the targeting signals present within the 
replicase CDS appear to be sufficient for localisation.  In addition, even 
though the PrV and HaSV replicases differ significantly in terms of amino acid 
sequence, similarities observed in the distribution and membrane-association 
suggest that the subcellular location of tetravirus replication complexes may 
be consistent throughout the family. 
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While there is a significant body of literature on the assembly and maturation 
of tetravirus particles, very little progress has been made towards a 
fundamental understanding of the molecular mechanisms of tetravirus 
replication.  The study of virus-host interactions among the tetraviruses has 
been hampered by the absence of suitable in vivo (tissue culture) replication 
systems.  The overall aim of this study was to develop experimental systems 
for the study of the replication biology of the omegatetravirus, HaSV, which is 
the only tetravirus for which the cDNAs have been shown to be infectious 
(Gordon et al., 2001).  The focus of the research was on the subcellular 
location of recombinant HaSV replicase in mammalian and insect tissue 
culture cells.   
 
6.1 PRODUCTION OF ANTI-REPLICASE ANTIBODIES 
 
The first objective was to generate antibodies that could be used to detect 
the replicase in cell-free extracts (by western analysis) and in whole cells (by 
immunofluorescence microscopy).  During the course of this study, two sets 
of polyclonal antibodies were produced using an N-terminal replicase 
polypeptide fragment expressed in E. coli (Chapter 2).  There were problems 
with the solubility of all the polypeptides used, probably due to misfolding of 
the recombinant protein. Both antisera generated had poor sensitivity and 
were unable to detect the replicase in HaSV-infected midgut extracts by 
western analysis or in transfected tissue culture cells by immunofluorescence 
microscopy.  The increased expression levels via recombinant baculoviruses 
(See Section 6.2 below) did however produce sufficient replicase for 
detection using the anti-replicase antibodies. 
CHAPTER 6 
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The poor sensitivity of the anti-replicase antiserum when used in the 
detection of the native replicase was likely due to a combination of low 
antigenicity, possibly due to misfolding, and the relatively small size of the 
recombinant polypeptide (25 kDa) as compared to the full length replicase 
(180 kDa).  While every attempt was made to select the region of the 
replicase sequence with the highest degree of hydrophilicity, the polypeptide 
fragments were consistently present as insoluble aggregates in the E. coli 
expression system used for their production.  The low sensitivity of the 
antiserum was further compounded by the difficulties of working with HaSV-
infected larvae.  Since HaSV preferentially infects early instar H. armigera 
and stunting is induced in infected insects, the isolation of sufficient quantities 
of infected larval midgut cells is prohibitive due to their small size and 
flaccidity.  As the midgut cannot be readily separated from the body wall, this 
essentially results in the dilution of infected cells with the uninfected tissue, 
which makes up the vast majority of each larva.  These observations suggest 
that the sensitivity of the anti-replicase antiserum would be increased by the 
expression of larger replicase fragments with a greater number of potential 
antigenic sites and the expression of such polypeptides in experimental 
systems capable of overexpressing larger protein such as Sf9 cells, derived 
from S. frugiperda (Order: Lepidoptera, Family: Noctuidae), which is closely 
related to H. armigera. 
 
The observation that the N-terminal deletion mutant REP45-1704-EGFP 
produced a cytosolic distribution in transfected mammalian cells (Section 
5.3.1) suggested that a similar deletion mutant expressed in Sf9 cells would 
generate a polypeptide well suited to the generation of anti-replicase 
antiserum with enhanced sensitivity.  Further analysis of localisation 
mechanisms of the replicase in both mammalian and Sf9 cells (Sections 
5.3.4 and 5.3.5) however, demonstrated that the localisation domain within 
the C-terminal region of the RdRp domain was likely to be responsible for the 
tight membrane association of the replicase with host cellular membranes.  
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The expression of a replicase fragment containing the full N-terminus of the 
replicase up to and including the full HEL domain, similar to the 90 kDa 
degradation product observed in Sf9 cells expressing both His-REP-V5 and 
His-ΔREP-V5, would therefore represent a good candidate for the production 
of anti-replicase antiserum in the future. 
 
6.2 THE SUBCELLULAR LOCALISATION OF THE HaSV 
REPLICASE 
 
6.2.1. Experimental systems 
 
Two different approaches were used to study the subcellular localisation of 
the HaSV replicase, namely fluorescence microscopy on fixed and live cells 
and biochemical fractionation of cell-free extracts.  In the absence of 
replicase-specific antibodies suitable for immunofluorescence microscopy, 
the replicase was expressed as an EGFP fusion protein.  This system 
allowed for the detection of the protein of interest expressed in mammalian 
and insect cells by confocal fluorescence microscopy as live or fixed cells 
and subcellular localisation by live cell staining and immunofluorescence 
microscopy.  An added advantage was the potential of analysing the 
membrane association of proteins through biochemical fractionation of whole 
cells with proteins being detected by fluorescence microscopy.  A 
disadvantage of the experimental system, however, was the low transfection 
frequencies leading to low levels of overall protein expression preventing the 
detection of the replicase by western analysis using anti-replicase or 
anti-EGFP antibodies.  As a result, a second experimental system based on 
the baculovirus-mediated expression of replicase fusion proteins was also 
developed.  The infection of Sf9 cells with recombinant baculoviruses led to 
an increase in the number of cells expressing the replicase and an overall 
increase in recombinant protein production that allowed for the detection of 
the replicase by western analysis using anti-replicase, anti-His or anti-V5 
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epitope antisera.  This allowed for further biochemical analysis of the 
intracellular membrane interactions of recombinant HaSV replicase. 
 
One of the major questions that remains unanswered is what factors are 
responsible for the narrow host range and tissue tropism exhibited among the 
tetraviruses. In addition to the further analysis of the association of the HaSV 
replicase with DRMs, the expression of the replicase-fusion proteins in Sf9 
cells presents the possibility of identifying host factors associated with viral 
replication complexes in Sf9 cells.  The recombinant replicase could be 
purified either by the Ni-affinity chromatography or by co-immunoprecipitation 
– if suitable antiserum can be generated.  Stable transfectants generated in 
both mammalian and insect tissue culture cells could be used to identify and 
analyse the elements required for vRNA replication.  Transfection of cells 
expressing the viral replicase with vRNA or vRNA:protein complexes could 
help to identify the function of structural proteins or RNA sequence elements 
in the initiation of vRNA replication.  
 
6.2.2. The HaSV replicase is targeted to membranes derived from 
endocytic compartments 
 
Transient expression of the C-terminal HaSV replicase-EGFP fusion protein 
(REP1-1704-EGFP) in mammalian and insect tissue culture cells resulted in the 
localisation of EGFP fluorescence to small punctate structures distributed 
throughout the cytoplasm.  Immunofluorescence co-localisation studies 
showed a partial overlap between the replicase-EGFP fusion protein and the 
late endosome marker CD63 16 to 18 hours after transfection, but no overlap 
had been observed with endocytosed dextran used as a marker for the 
classical endocytic pathway (Sections 3.3.2 and 3.3.3).  Time-lapse confocal 
microscopy of live cells showed that the punctate structures underwent 
fusion, fission and “kiss-and-run” events as well as what appeared to be 
directed transport, all of which are characteristics of endocytic organelles 
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(Gruenberg et al., 1989; Bright et al., 2005).  These data suggests that the 
punctate structures are either derived from organelles that are similar to (but 
not part of) the classical endocytic pathway or that the accumulating 
replicase possesses a mechanism for excluding soluble, luminal endocytic 
contents (such as dextran) and/or membrane associated marker proteins 
(like CD63).   
 
6.2.3. Association of the HaSV replicase with DRMs derived from 
non-classical endocytic organelles 
 
Biochemical fractionation of mammalian and insect cells showed that 
REP1-1704-EGFP-containing punctate structures displayed characteristics 
typical of an association with DRMs (Section 5.3.4). Interestingly, the late 
endosomal marker, CD63, also appeared to interact with similar membranes 
in HeLa cells, further evidence supporting the hypothesis that the HaSV 
replicase is targeted to membranes derived from endocytic organelles.  This 
data presents three possible mechanisms for the subcellular localisation of 
the replicase.  First, the replicase may be targeted to a subset of late 
endosomes with fluid phase endocytic contents and host marker proteins 
being excluded by an unknown replicase-dependent mechanism.  Second, 
the replicase might associate with a subset of CD63-positive organelles that 
do not necessarily form part of the classical endocytic pathway.  Although 
CD63 accumulates primarily in multivesicular late endosomes, it has been 
shown to cycle between endocytic and secretory pathways in some cell types 
(Kobayashi et al., 2000).  Finally, the punctate structures could represent an 
unidentified structure that interacts, through fusion or “kiss-and-run” events, 
with CD63-positive late endosomes.  The partial overlap between CD63 
immunofluorescence and REP-EGFP fluorescence 16 to 18 hours after 
transfection could therefore represent hybrid organelles generated by the 
mixing of membranes between these structures.  In this case, the lack of 
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overlap at later time points would imply that the accumulation of the HaSV 
replicase resulted either in an inhibition of fusion and membrane cycling or an 
active exclusion of at least some host proteins, such as CD63.  Comparison 
of the data obtained from transfected Sf9 and HeLa cells demonstrates that 
the endocytic organelles targeted by the replicase are common to both cell 
types. 
 
A further survey of the available literature has highlighted the relatively recent 
discovery of alternate endocytic pathways (reviewed in Nichols and 
Lippincott-Schwartz, 2001; Johannes and Lamaze, 2002; Pelkmans and 
Helenius, 2003; Mayor and Pagano, 2007).  The HaSV replicase may be 
associated with membranes derived from one of these pathways.  This 
hypothesis is especially tempting since DRMs appear to be important 
constituents of a number of these alternative pathways (See Section 1.5.2).  
In addition, endocytic organelles that function in parallel to the classical 
endosomes have been identified.  These alternate endocytic organelles can 
be identical to classical endocytic organelles in terms of subcellular 
distribution, transport and maturation, differing only in protein content, with 
some being devoid of typical endosomal markers such as EEA1, Rab4 and 
Rab5 (Kalia et al., 2006).  Although the majority of endocytosed material is 
ultimately delivered to classical early endosomes (Hansen et al., 1993; Mayor 
and Pagano, 2007), the partial overlap of the punctate structures with late 
endosomes could represent the merging of an alternate endocytic pathway 
with classical late endosomes.   
 
The complete lack of overlap between endocytosed dextran and replicase-
associated punctate structures, even at the earlier time points (16 to 18 
hours), suggests that the replicase is not associating with classical late 
endosomes.  A more likely hypothesis is that the temporary overlap with 
CD63-positive organelles demonstrates that the punctate structures fuse with 
late endosomes until this reaction is inhibited by a replicase-dependent 
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mechanism.  Although further investigation is necessary, the most likely site 
for the localisation of the HaSV replicase is therefore alternate endocytic 
organelles that usually merge with classical endosomes.   
 
These data are strikingly similar to recent studies on the subcellular 
interactions of the RV replication complex in infected cells (Matthews et al., 
2009, 2010) suggesting that these viruses may share a common site for 
vRNA replication and that they may make use of a similar mechanism for 
membrane association.  The authors noted that the both replicating vRNA 
and viral replication complexes only partially overlapped with the late 
endosome/lysosomal marker protein LAMP2, even though the distributions 
appeared to be similar especially during the early stages of infection.  The 
vast majority of the RV replication protein, P150, was also found to remain 
associated with detergent-resistant fractions both during infection and when 
expressed alone in transfected cells, leading the authors to suggest a strong 
association between P150 and membranes.  Subsequently, Matthews et al. 
(2010) showed that the RV replication proteins associate with microtubules 
during the formation of unique intracellular fibres and although neither the 
fibres nor microtubules are required for vRNA replication, they may facilitate 
the cell-to-cell spread of RV without the need for infectious virus particles.   
 
DRMs are thought to be present in distinct membrane microdomains in a 
number, if not all, cellular membranes and are likely to function in the 
concentration of cellular factors (proteins, co-factors, etc.) to specific areas in 
order to generate localised reaction sites (discussed in detail in 
Section 1.5.2).  It is possible that the association of the viral replicase to such 
sites could aid in the concentration of vRNA replication factories and the 
assembly of vRNA replication complexes.  This could parallel or further 
enhance the function of replicase-induced spherules analogous to those 
observed for many other viruses.  The similarities exhibited by these viruses 
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could be indicative of common viral replication strategies that, with further 
study, could further the understanding (+ve) RNA virus replication in general. 
 
6.3 Localisation of the HaSV replicase is directed by two 
targeting domains 
 
Since HaSV (and the other known alpha-like tetraviruses) carries a single 
replication protein, the information required for the development of in vivo 
replication complexes, and the punctate structures observed in transfected 
cells, is likely to be encoded by the replicase CDS. In addition to the analysis 
of the subcellular location of the HaSV replicase, this study provided an 
opportunity to identify and characterise the targeting domains. 
 
Bioinformatic analysis of the HaSV replicase amino acid sequence did not 
detect any similarities to any known targeting motifs and, as a result, deletion 
mutagenesis was used to identify the regions required for targeting.  This 
analysis revealed two putative targeting regions.  Deletion mutants lacking 
either the N-terminal 44 amino acids or the C-terminus of the replicase up to 
P1368 in the RdRp domain displayed cytosolic distributions suggesting that 
both were essential for the localisation of the replicase. 
 
The role of these domains was investigated by biochemical fractionation of 
Sf9 cells expressing either full length (His-REP-V5) or N-terminal deletion 
mutant (His-ΔREP-V5) replicase fusion proteins.  The replicase was strongly 
associated with DRM fractions in both cases.  Analysis of the degradation 
products detected by antiserum directed against the N-terminus of the 
replicase demonstrated that degradation products missing the C-terminal 
region of the replicase including the RdRp domain were either soluble or 
released from DRM fractions in the presence of Triton X-100 (Sections 4.3.4 
and 5.3.5).  This implied that the N-terminal region was not required for 
membrane association in insect tissue culture cells and that the sole region 
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required for efficient targeting in this system was present within the RdRp 
domain.  Interestingly, incubation of cells expressing REP45-1704-EGFP in the 
presence of Triton X-100 resulted in a significant proportion of EGFP 
fluorescence remaining in structures similar to those observed for both the 
full length replicase-EGFP fusion and CD63.  This suggested that, while the 
majority of this polypeptide was present within the cell as a cytosolic protein, 
a significant proportion was associated with cellular DRMs.   
 
Time-lapse imaging of live cells suggest that prolonged expression of 
REP1-1704-EGFP in HeLa and Sf9 cells results in the accumulation of punctate 
structures into larger and less mobile structures.  It is possible that the 
prolonged expression of the replicase in the baculovirus-mediated expression 
system results in the association of a greater proportion of the replicase with 
DRM fractions.  Alternatively, the difference could be due to host factors that 
influence the membrane association of the replicase, either positively in Sf9 
cells or negatively in HeLa cells.  Although further investigation is required, it 
is more likely to be the presence of activating host factors in Sf9 cells since 
they are relatively closely related to H. armigera, the natural host for HaSV.  
Replicase-host interactions could therefore result in an increase in targeting 
efficiency meaning that the single, internal domain is sufficient for 
localisation.  While the N-terminal domain is not capable of targeting EGFP in 
mammalian cells, it could stimulate membrane-association of the replicase by 
other regions, giving the impression that it is required for localisation when it 
is rather increasing the rate of association or stabilising the interaction.   
 
In an attempt to further understand the role of the N-terminal region in the 
membrane association of the viral replicase, bioinformatic analysis was done 
on the N-terminal regions of all three of the alpha-like tetravirus replicases 
sequenced to date (HaSV, DpTV and NβV).  The presence of conserved 
predicted secondary structural elements in this region, along with the 
distribution of a series of N-terminal deletion mutants, suggested that the 
Discussion and conclusion 
130 
structure was important in localisation.  However, the lack of 
complementation between the two N-terminal regions demonstrates that the 
function of the N-terminal domain in the activation of replicase localisation is 
most likely due to a combination of structural and virus-specific sequence 
elements. 
 
6.4 Tetravirus replicases-host interactions:  a comparison 
between HaSV and PrV 
 
Although the PrV and HaSV replicases differ significantly in terms of their 
functional organisation, their RdRp domains and the expression strategies 
used, two interesting similarities have been highlighted during the course of 
this study.  First, while the subcellular location of PrV replication proteins has 
not been thoroughly analysed, the distribution of p40 in persistently infected 
MG8 cells is remarkably similar to the distribution of HaSV replicase-EGFP 
fusion proteins expressed in both HeLa and Sf9 cells, indicating that a 
common subcellular location may be targeted as vRNA replication sites by 
both viruses.  This may be due to the fact that both infect similar host tissues 
i.e. the midgut cells with specialised endocytic functions.  Secondly, both the 
HaSV replicase and PrV p40 displayed a similar association with DRMs 
suggesting that the strength and type of association could be consistent 
between the replicases.  It is possible that even though the replicases are 
classified into different superfamilies in terms of their amino acid sequence, 
there could be a common mechanism for the localisation of replication. 
 
6.5 The role of the viral replicase in the induction of apoptosis in 
tetravirus-infected cells 
 
The association of the HaSV replicase with acidic organelles, such as 
lysosomes, was originally hypothesised by Tomasicchio et al. (2007).  In vitro 
maturation of VLPs is induced under acidic pH (<5.5) conditions (Canady et 
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al., 2000, 2001; Taylor et al., 2002) and the induction of apoptosis in yeast 
cells expressing the HaSV capsid protein precursor results in the 
spontaneous maturation of VLPs (Tomasicchio et al., 2007).  The cytosolic 
acidification that occurs as a result of apoptosis is therefore thought to be 
important in the maturation of infectious tetravirus particles in vivo 
(Tomasicchio et al., 2007).  This hypothesis was further supported by the 
increased incidence of apoptosis observed in HaSV-infected H. armigera 
midgut cells (Brooks et al., 2002).   
 
The data presented in this thesis suggest that the HaSV replicase (and 
perhaps the PrV replicase) associates with organelles from an alternate 
endocytic pathway that overlaps in part with the classical endocytic pathway 
through the late endosomes.  At no point was there any indication that the 
HaSV replicase expressed in either experimental system resulted in an 
increase in the incidence of apoptosis, suggesting that the association with 
endocytic organelles was not the source of the apoptosis observed by Brooks 
et al. (2002).  While the role of the replicase in the induction of apoptosis in 
infected cells cannot be discounted since these data were obtained in cells 
expressing the replicase in isolation of other viral proteins and vRNA, a more 
likely hypothesis is that apoptosis is induced by the host in response to viral 
infection and may be exploited by tetraviruses for capsid maturation. 
 
6.6 A model for the association of HaSV replicase with host 
endosome-derived membranes and the viral life cycle 
 
As hypothesised by Munshi et al. (1996), HaSV is thought to bind to the 
surface of cells containing permissive surface receptors and enter the cell via 
endocytosis.  As is the case with a number of viruses, including the 
structurally-related FHV, the low pH of the endosomal lumen would then 
induce the translocation of vRNA in a reaction dependent on the pentameric 
bundles generated by the autoproteolytic cleavage of the capsid precursor 
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protein upon particle maturation.  Once within the cytosol, expression of the 
viral replicase would be initiated by host ribosomes and the replicase 
targeted to endosomes by an unknown localisation signal.  Here it associates 
with DRMs through the localisation domain present within the C-terminus of 
the RdRp domain.  The rate at which the replicase associates with host 
membranes and generation of vRNA replication factories is likely to be 
enhanced by the N-terminal domain in a sequence- and structure-dependent 
manner, probably through inter- and/or intra-replicase as well as replicase-
host interactions.  Once replication complexes are established, the replication 
of vRNA proceeds with RNA1 being preferentially reproduced during the 
initial stages of infection (Bawden et al., 1999).  Once sufficient RNA1 and/or 
viral replicase has been generated, a switch is made and the production of 
RNA2 (Bawden et al., 1999) and the viral structural proteins is prioritised with 
the resulting assembly of HaSV provirions containing both RNAs and 
uncleaved capsid protein precursors.  Whether cytosolic acidification is 
required for the maturation of virus particles in vivo remains to be 
determined, but the maturation of virus particles could be induced as a result 
of apoptosis that is directed either by the host cell itself or by an unknown 
virus-dependent mechanism. 
 
6.7 Concluding remarks 
 
The absence of suitable experimental systems has severely hindered the 
study of tetravirus replication biology.  In an attempt to gain insight into this 
area of the tetravirus lifecycle, two experimental systems were developed 
and used to analyse the subcellular localisation and membrane association 
of the HaSV replicase, the first study of its kind on a tetravirus.  The exact 
subcellular location of the replicase remains to be conclusively demonstrated 
and the role that DRMs play in the viral life cycle is still unclear.  The 
generation of suitable antiserum for the detection of the replicase in infected 
insects remains a significant challenge, but replicase-specific antibodies will 
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provide an opportunity to compare the data obtained here with the virus-host 
interactions in vivo.  While the observations made using the experimental 
systems developed during the course of this research are limited by the 
absence of other virus proteins and vRNA, they do present an important 
opportunity to investigate the role of other viral proteins in vRNA replication 
and to identify the factors required for the generation of ex vivo tetravirus 
replication systems.  
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All PCR reactions were performed using the Expand High Fidelity PCR 
system (Roche Applied Biosystems) and reverse PCR (RPCR) reactions 
were carried out using Pfu DNA Polymerase (Promega), both in accordance 
with manufacturers' instructions.  HaSV replicase RNA1-derived sequences 
were either PCR amplified or sub-cloned from pAV13HC G+ (called pAV13 
throughout the text) or pMLY1 (Venter, 2001) both of which were generated 
using the HaSV RNA1 sequence from pDVHStuR1HC (GenBank Acc. No. 
EU345431) obtained from T. Hanzlik and K. Gordon (CSIRO).  Finally, PCR 
products were all ligated into pGEM T-easy (Promega) according to the 
manufacturer's instructions using 25 ng pGEM T-easy per reaction.  Ligations 
were done using 3 U T4 DNA ligase (Promega) in a final volume of 10 μl, at 
4 °C overnight or for 3 hours at room temperature.  Characteristics of the 
plasmids used in this study are summarised in Table A.1 below and their 
construction is described in detail below. 
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Table A.1:  Plasmids used in this study (Key on pg 156) 
Plasmid Vector Backbone 
Antibiotic 
resistance Host(s) Comments Chapter Appendix Reference 
pCW56 N/A Kan/Amp B, I EGFP-fusion expression vector 3  Walter, 2008 
pEGFP-C1 N/A Kan B, M EGFP-fusion expression vector N/A  ClonTech 
pEGFP-N1 N/A Kan B, M EGFP-fusion expression vector 3  ClonTech 
pFastBacTM DUAL N/A Amp/ Gent B, I (Bac) Recombinant bacmid shuttle vector 4  Invitrogen 
pGEX-4T-2 N/A Amp B E. coli expression vector N/A  GE Healthcare 
pJRS4 pEGFP-C1 Kan B, M REP1-541-EGFP expression vector 5 A.5 Constructed in this study 
pJRS7 pEGFP-N1 Kan B, M REP1-1704-EGFP expression vector 3 A.4 Constructed in this study 
pJRS7 N44Δ pEGFP-N1 Kan B, M REP45-1704-EGFP expression vector 5 A.8 Constructed in this study 
pJRS7 N-His pEGFP-N1 Kan B, M His-REP1-1704-EGFP expression vector 5 A.15 Constructed in this study 
pJRS7 N-NBV pEGFP-N1 Kan B, M Replicase N-terminal domain swap expression vector 5 A.17 Constructed in this study 
pJRS7 RPCR1 pEGFP-N1 Kan B, M Replicase N-terminal deletion mutant expression vector 5 A.16 Constructed in this study 
pJRS7 RPCR2 pEGFP-N1 Kan B, M Replicase N-terminal deletion mutant expression vector 5 A.16 Constructed in this study 
pJRS7 RPCR3 pEGFP-N1 Kan B, M Replicase N-terminal deletion mutant expression vector 5 A.16 Constructed in this study 
pJRS7 RPCR4 pEGFP-N1 Kan B, M Replicase N-terminal deletion mutant expression vector 5 A.16 Constructed in this study 
pJRS7 RPCR5 pEGFP-N1 Kan B, M Replicase N-terminal deletion mutant expression vector 5 A.16 Constructed in this study 
pJRS8 pEGFP-C1 Kan B, M EGFP-REP1-1704 expression vector 3 A.4 Constructed in this study 
pJRS12 pEGFP-N1 Kan B, M REP1-100-EGFP expression vector 5 A.9 Constructed in this study 
pJRS15 pEGFP-N1 Kan B, M REP1-1368-EGFP expression vector 5 A.10 Constructed in this study 
pJRS16 pEGFP-N1 Kan B, M REP1-1159-EGFP expression vector 5 A.11 Constructed in this study 
pJRS17 pT7-7_6xHis Amp B His-REP1-150 expression vector 2 A.1 Constructed in this study 
pJRS19 pT7-7_6xHis Amp B His-REP1-218 expression vector 2 A.2 Constructed in this study 
pJRS23 pGEX-4T-2 Amp B GST-REP1140-1704 expression vector 2 A.3 Constructed in this study 
pJRS26 pCW56 Kan/Amp B, I REP1-1704-EGFP expression vector 3 A.6 Constructed in this study 
pJRS26 2A pCW56 Kan/Amp B, I REP1-1704-2A-EGFP expression vector 5 A.14 Constructed in this study 
pJRS32 pEGFP-N1 Kan B, M REP1-1241-EGFP expression vector 5 A.12 Constructed in this study 
pJRS34 pEGFP-N1 Kan B, M REP1-1304-EGFP expression vector 5 A.13 Constructed in this study 
pJRS42 pFastBacTM DUAL Amp/ Gent B, I (Bac) Recombinant shuttle vector for generating JRS BV1 (His-REP-V5) 4 
A.7 Constructed in this study 
pJRS42 N83Δ pFastBacTM DUAL Amp/ Gent B, I (Bac) Recombinant shuttle vector for generating JRS BV1 (His-ΔREP-V5) 5 
A.18 Constructed in this study 
pT7-7_6xHis pT7-7 Amp B E. coli expression vector 2  Constructed in this study 
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Key to Table A.1:  Antibiotic Resistance – Amp: Ampicillin, Kan: Kanamycin, Gent: 
Gentamicin.  Hosts – B: Bacteria (E. coli), I: Insect (Sf9), I (Bac): Insect (Baculovirus 
mediated expression), M: Mammalian (HeLa, BHK-21).  “Chapter” – chapter in which the 
respective plasmid is first mentioned.  “Appendix” – Appendix entry describing construction 
of the plasmid. 
 
A.1 pJRS17 
 
Firstly, the 5' region of the HaSV replicase CDS, up to and including the wild-
type KpnI site, was PCR amplified, using the primers JRS6F and JRS5R, 
which included an additional 5' NdeI site.  The PCR product was ligated into 
pGEM T-easy to produce pJRS11F.  To allow for the restriction of the XbaI 
site, pJRS11F was transformed into E. coli JM110 (rpsL (Strr) thr leu thi-1 
lacY galK galT ara tonA tsx dam dcm supE44 Δ(lac-proAB) [F´ traD36 proAB 
lacIqZΔM15]) cells (Stratagene).  The sequence coding for the amino-terminal 
150 amino acids of the HaSV replicase was removed from pJRS11F using 
NdeI and XbaI.  The production of pJRS17 was completed by ligating this 
fragment into the similarly restricted expression vector pT7-7 6xHis, which 
contains an inducible T7 RNA polymerase promoter, ribosome binding site 
(RBS) and a hexahistidine (6xHis) sequence followed by a multiple cloning 
cassette for the overexpression of N-terminal 6xHis-tagged proteins (Figure 
A.1). 
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Figure A.1: The construction of pJRS17.  Amp R: β-lactamase, T7 Promoter: T7 
bacteriophage RNA polymerase promoter. 
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A.2 pJRS19 
 
Approximately 660 bp from the 5’ end of the HaSV replicase CDS was PCR 
amplified from pJRS8 (Section A.5) using the primers JRS6F and JRS18R, 
introducing 5' NdeI and 3' HindIII sites to the PCR product, before it was 
ligated into pGEM T-easy to produce pJRS18F.  The smaller NdeI and HindIII 
fragment from pJRS18F was then ligated into pT7-7 6xHis, also restricted 
with NdeI and HindIII to create pJRS19 (Figure A.2).  
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Figure A.2: The construction of pJRS19.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, Kan/Neo R: neomycin phosphotransferase, T7 
Promoter: T7 bacteriophage RNA polymerase promoter. 
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A.3 pJRS23 
 
pJRS8 (Section A.5) was used as the template in the PCR amplification of 
approximately 1750 bp from the 3' of the HaSV replicase CDS using the 
primers JRS21F and JRS22R, introducing a 5' BamHI and a 3' ClaI site into 
the PCR product.  The PCR product was then ligated into pGEM T-easy to 
create pJRS21 (BamHI-ClaI) R, which was subsequently restricted with 
BamHI and NotI.  The resulting insert was ligated into pGEX-4T-2 (GE 
Healthcare) also digested with BamHI and NotI, producing pJRS23 (Figure 
A.3). 
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Figure A.3: The construction of pJRS23. Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
GST: glutathione S-transferase, Kan/Neo R: neomycin phosphotransferase, tac Promoter: 
hybrid bacterial promoter. 
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A.4 pJRS7 
 
The REP1-1704-EGFP expression vector was constructed in a two step 
process starting with the restriction of pMLY1 with BamHI and HindIII and 
ligation of the resulting fragment into pEGFP-N1 restricted with BglII and 
HindIII, producing pJRS5.  The remaining 3' 251 bp of the HaSV replicase 
CDS was PCR amplified using the primers JRS2 and LMR2 (designed by 
Lindsay Murray) and ligated into pGEM-T easy, generating pJRS6.  The PCR 
product included the internal HindIII site and an engineered 3' BamHI site 
downstream of the mutated opal stop codon that produced an in-frame fusion 
with the EGFP coding sequence in pEGFP-N1.  Finally, both pJRS5 and 
pJRS6 were digested with HindIII and BamHI and the respective fragments 
ligated (Figure A.4).  
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Figure A.4: The construction of pJRS7.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.5 pJRS8 
 
pMLY1 was restricted with HindIII and KpnI and the 1682 bp fragment gel 
purified before ligating it into pEGFP-C1, also restricted with HindIII and KpnI 
to produce pJRS4.  The remaining fragment of the HaSV replicase CDS was 
obtained by the restriction of pMLY1 with KpnI and ligated into KpnI-digested 
pJRS4 (Figure A.5).  
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Figure A.5: The construction of pJRS8.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.6 pJRS26 
 
The restriction of pJRS6 with BamHI and HindIII produced a fragment 
containing the 3' 251 bp of the HaSV replicase cDNA.  This was ligated into 
pCW56 also digested with BamHI and HindIII to create pJRS25.  The 
remaining portion of the HaSV replicase CDS was added to pJRS25 by 
restricting pMLY1 with HindIII (cutting at two sites) and ligating the resulting 
fragment into HindIII digested pJRS26 (Figure A.6). 
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Figure A.6: The construction of pJRS26.  Amp R: β-lactamase, EGFP: enhanced green 
fluorescent protein, hr/AcMNPV Promoter: hybrid insect promoter, Kan/Neo R: neomycin 
phosphotransferase. 
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A.7 pJRS 42 
 
The V5 epitope (derived from Simian virus 5) CDS was PCR amplified using 
the primers JRS30F and JRS31R and ligated into pGEM T-easy to create 
pJRS40F.  This vector was digested with BamHI and NotI to produce an 
insert containing the V5 epitope CDS that was ligated into similarly restricted 
pJRS7.  This produced the mammalian expression vector pJRS7 C-V5, 
which contained the sequence coding for the expression of a C-terminal full-
length HaSV replicase-V5 fusion protein.  Both pJRS7 C-V5 and pJRS39 
(Section A.15), were restricted with NdeI and KpnI and the resulting 
fragments were gel purified and ligated to create pJRS41.  The sequence 
coding for the full-length HaSV replicase with N-terminal 6xHis and C-
terminal V5 epitope tags was removed from pJRS41 by restriction with BglII 
and NotI and ligated into pFastBacTM DUAL (Invitrogen), also digested with 
these enzymes, producing the baculovirus expression vector pJRS42 (Figure 
A.7). 
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Figure A.7 (Here and page 170):  The construction of pJRS42. The PCR product of the 
V5 epitope CDS is indicated at the top of the image with the primer sequences in bold and 
italics.  The introduced BamHI site is displayed above the sequence. Amp R: β-lactamase, 
CMV Promoter: Human Cytomegalovirus immediate early promoter, EGFP: enhanced green 
fluorescent protein, Gent R: gentamicin acetyl transferase, Kan/Neo R: neomycin 
phosphotransferase, PohH Promoter: AcMNPV polyhedrin promoter. 
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Figure A.7:  Figure legend on page 169 
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A.8 pJRS7 N44Δ 
 
The HaSV replicase CDS nts 134 to 1658 were PCR amplified using the 
primers JRS4F and JRS5R, which introduced a HindIII site, an engineered 
start codon at the 5' end and included the internal HaSV replicase KpnI site 
at the 3' end.  This product was ligated into pGEM T-easy to create pJRS9F.  
This was restricted with HindIII and KpnI and the resulting fragment inserted 
into pEGFP-N1, also restricted with the same restriction enzymes, producing 
pJRS10.  Both pJRS10 and pJRS7 were then digested with BamHI and KpnI 
and the resulting fragments ligated together to make pJRS7 N44Δ (Figure 
A.8).  
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Figure A.8: The construction of pJRS7N44Δ.  Amp R: β-lactamase, CMV Promoter: 
Human Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent 
protein, Kan/Neo R: neomycin phosphotransferase. 
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A.9 pJRS12 
 
Approximately 300 nts of the 5’ of the HaSV replicase were PCR amplified 
using JRS14F and JRS13R, which introduced 5' HindIII and 3' BamHI sites 
into the PCR product, and ligated into pGEM T-easy to created pJRS13F.  
The 5' replicase amplicon was then removed from pJRS13F by restriction 
using HindIII and BamHI and ligated into similarly digested pEGFP-N1 
(Figure A.9). 
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Figure A.9: The construction of pJRS12.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.10 pJRS15 
 
The region of the replicase CDS from the internal KpnI site up to the 5' end of 
the sequence encoding the RdRp domain were PCR amplified using the 
primers JRS7F and JRS17R.  This PCR product was ligated into 
pGEM T-easy to produce pJRS14R.  Both pJRS14R and pJRS7 were in turn 
digested with KpnI and BamHI and the respective fragments ligated together 
to generate pJRS15 (Figure A.10). 
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Figure A.10: The construction of pJRS15.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.11 pJRS16 
 
pEGFP-N1 was digested with BglII and SmaI and the HaSV replicase CDS 
fragment, obtained from pMLY1 restricted with BamHI and PvuII, was ligated 
into the pEGFP-N1 backbone to produce pJRS16 (Figure A.11). 
 
 
 
 
 
 
 
 
 
 
 
Figure A.11: The construction of pJRS16.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.12 pJRS32 
 
A fragment of the HaSV replicase spanning from the internal SmaI site to a 
region within the RdRp domain of the CDS was PCR amplified using the 
primers JRS23F and JRS24R, which introduced a BamHI site at the 3' end of 
the amplicon.  The PCR product was ligated into pGEM T-easy to generate 
pJRS31F.  Both pJRS16 and pJRS31F were digested with SmaI and BamHI 
and the respective fragments gel-purified and ligated together to form 
pJRS32 (Figure A.12). 
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Figure A.12: The construction of pJRS32.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.13 pJRS34 
 
A replicase fragment from the internal SmaI site of the replicase CDS to a 
region within the RdRp domain was PCR amplified using the primers JRS23F 
and JRS25R, introducing a BamHI site at the 3' end of the PCR product. This 
was ligated into pGEM T-easy to generate pJRS33F.  pJRS34 was then 
generated by digesting pJRS33F and pJRS16 with SmaI and BamHI and 
ligating the gel-purified products together (Figure A.13). 
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Figure A.13: The construction of pJRS34.  Amp R: β-lactamase, CMV Promoter: Human 
Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent protein, 
Kan/Neo R: neomycin phosphotransferase. 
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A.14 pJRS26 2A 
 
A ds oligonucleotide containing partial BamHI sites and the entire CDS of the 
ERAV 2A-like sequence was produced as follows.  Forward and reverse 
primers (JRS33F and JRS34R) (50 nmol of each) were phosphorylated in the 
presence of 1.875 mM ATP, 1 x polynucleotide kinase buffer and 7.5 U T4 
polynucleotide kinase (Promega) (in a total of 20 μl) at 37 °C for 30 minutes.  
The phosphorylated primers were then purified by adding 130 μl 
phenol:chloroform:isoamyl alcohol (25:24:1) (PCI), mixing vigorously and 
centrifuging at 14 000 rpm in a benchtop microcentrifuge at 4 °C for 2 
minutes.  The aqueous phase was then re-extracted under the same 
conditions.  To the retained aqueous phase, 15 μl 3 M NaAc and 300 μl 96 % 
ethanol was added and the sample placed at -80 °C for 1 hour.  The 
precipitated DNA was collected by centrifugation at 14 000 rpm at 4 °C for 5 
minutes and air dried after the excess ethanol was removed.  The pellet was 
resuspended in 35 μl ddH2O, 5 μl 1 M MgCl2 and 10 μl 1 M Tris (pH 7.6) and 
the primers annealed by incubation in boiling water for 2 minutes and slow 
cooling to room temperature.  The ds oligonucleotide was then ligated into 
pJRS25 (Section A.6) restricted with BamHI to generate pJRS25 2A.  The 
remaining HaSV replicase CDS was removed from pJRS26 (Section A.6) 
using HindIII, gel purified and ligated into pJRS25 2A, also digested with 
HindIII, to produce pJRS26 2A (Figure A.14). 
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Figure A.14: The construction of pJRS26 2A.  The ds oligonucleotide generated by 
annealing JRS33F and JRS34R is displayed at the top of the image. BamHI-complimentary 
overhangs are indicated in bold while the sequence for recreating the BamHI site is 
designated above the sequence.  Amp R: β-lactamase, EGFP: enhanced green fluorescent 
protein, hr/AcMNPV Promoter: hybrid insect promoter, Kan/Neo R: neomycin 
phosphotransferase. 
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A.15 pJRS7 N-His 
 
A ds oligonucleotide including 5' HindIII and BamHI sites, the CDS for a 
6xHis tag and partial KpnI and NdeI sites at the 5' and 3' ends respectively, 
was produced from the primers JRS28F and JRS29R as described in section 
A.14.  This was inserted into pJRS17 (Section A.1) digested with KpnI and 
NdeI to produce pJRS37.  The 5' end of the 6xHis tagged replicase CDS 
fragment was then removed from pJRS37, using HindIII and XhoI, and 
ligated into pJRS9F (Section A.8), also digested with these enzymes, 
generating pJRS38.  BglII and KpnI digestion of pJRS38 produced an N-
terminal 6xHis tagged replicase CDS fragment that was inserted into the 
similarly digested pEGFP-N1 backbone (pJRS39).  Finally, pJRS7 N-His was 
generated by digesting both pJRS7 (Section A.4) and pJRS39 with BamHI 
and KpnI and ligating the 3' end of the replicase CDS into pJRS39 
(Figure A.15). 
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Figure A.15 (Here and pg 186): The construction of pJRS7 N-His.  The ds 
oligonucleotide generated by annealing JRS28F and JRS29R is displayed at the top of the 
image. Full restriction sites are shown above the sequence while sequences complimentary 
to, but not capable of reforming KpnI and NdeI sites are shown below the sequence.  The 
6xHis tag CDS is also displayed below the sequence. Amp R: β-lactamase, CMV Promoter: 
Human Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent 
protein, Kan/Neo R: neomycin phosphotransferase, T7 Promoter: T7 bacteriophage RNA 
polymerase promoter. 
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Figure A.15:  Figure legend on pg 185 
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A.16 pJRS7 RPCR1-5 
 
The 5' end of the HaSV replicase CDS, including the wild-type HaSV 
replicase Kozak sequence, was PCR amplified using the primers JRS45F 
and JRS5R, introducing a 5' BglII site and including the native KpnI site.  This 
PCR product was ligated into pGEM T-easy to generate pJRS48F.  Five 
different primer sets (JRS49R and JRS52F, JRS50R and JRS52F, JRS49R 
and JRS53F, JRS50R and JRS53F, JRS51R and JRS53F) were then used in 
RPCR reactions, using pJRS48F as a template.  The RPCR products were 
then phosphorylated with polynucleotide kinase (Promega) (as described in 
Section A.14) and re-ligated to produce pJRS48 RPCR1-5 (Figure A.16a). 
Four of the RPCR products (1, 2, 3 and 5) were then restricted with BglII and 
SpeI and the resulting inserts ligated into pJRS7 N-His (Section A.15), also 
digested with BglII and SpeI resulting in pJRS7 RPCR1, -2, -3 and -5, 
respectively (Figure A.16b).  Due to the presence of a second internal BglII 
site in the 5' of the HaSV replicase sequence of pJRS48 RPCR4, an 
alternate process for the production of pJRS7 RPCR4 was necessary.  
pJRS7 N-His and pJRS48 RPCR4 were restricted with BglII and NcoI, 
respectively, before being “filled in” using Klenow DNA polymerase  
(Promega).  Thereafter they were digested with SpeI and the resulting 
fragments ligated together to form pJRS7 RPCR4 (Figure A.16c).  
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Figure A.16a: The construction of pJRS48F RPCR1-5.  Amp R: β-lactamase, T7 
Promoter: T7 bacteriophage RNA polymerase promoter. 
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Figure A.16b: The construction of pJRS7 RPCR3.  Amp R: β-lactamase, CMV Promoter: 
Human Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent 
protein, Kan/Neo R: neomycin phosphotransferase. 
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Figure A.16c: The construction of pJRS7 RPCR4.  Amp R: β-lactamase, CMV Promoter: 
Human Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent 
protein, Kan/Neo R: neomycin phosphotransferase. 
 
Appendix A: Construction of recombinant plasmids 
 
193 
A.17 pJRS7 N-NBV 
 
The 5' region of the NβV replicase CDS was PCR amplified from pGEM6625 
(Luke, 2001) using JRS47F and JRS48R and ligated into pGEM T-easy to 
generate pJRS49.  The HaSV replicase 5' sequence was replaced by the 235 
nts encoding the NβV replicase N-terminus by digesting both pJRS48F and 
pJRS49 with NcoI and XhoI and ligating the products together to form 
pJRS48 NBV.  The NβV/HaSV replicase chimeric 5' sequence (removed from 
pJRS48 NBV using BamHI and SpeI) was then used to replace the existing 5' 
sequence of the HaSV replicase in pJRS7 N-His (section A.15) (digested with 
BglII and SpeI), resulting in pJRS7 N-NBV (Figure A.17). 
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Figure A.17: The construction of pJRS7 N-NβV.  Amp R: β-lactamase, CMV Promoter: 
Human Cytomegalovirus immediate early promoter, EGFP: enhanced green fluorescent 
protein, Kan/Neo R: neomycin phosphotransferase. 
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A.18 pJRS42 N83Δ 
 
Primers JRS43F and JRS44R were used to generate a ds oligonucleotide 
containing the CDS for a 6xHis tag and partial BglII and XhoI sites (5' and 3' 
respectively) as described in section A.14.  This ds oligonucleotide was then 
ligated into pJRS10 (section A.8) digested first with BglII and then XhoI, 
generating a 256 nt deletion of the HaSV replicase CDS with an N-terminal 
6xHis tag (pJRS46).  The truncated 5' sequence was then transferred to 
pJRS41 by digesting both plasmids with BglII and KpnI and ligating the 
resulting fragments to create pJRS41 N83Δ.  The replicase CDS was then 
inserted into pFastBacTM DUAL (Invitrogen) by restricting both with BamHI 
and NotI and subsequently ligating the appropriate fragments to produce 
pJRS42 N83Δ (Figure A.18). 
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Figure A.18: The construction of pJRS42N83Δ. The ds oligonucleotide generated by 
annealing JRS43F and JRS44R is displayed above.  Also shown are the BglII and XhoI half-
sites and the 6xHis CDS. Amp R: β-lactamase, CMV Promoter: Human Cytomegalovirus 
immediate early promoter, EGFP: enhanced green fluorescent protein, Gent R: gentamicin 
acetyl transferase, hr/AcMNPV Promoter: hybrid insect promoter, Kan/Neo R: neomycin 
phosphotransferase, PohH Promoter: AcMNPV polyhedrin promoter. 
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Name Sequence Description Ref. 
JRS2 5'GTGGAAGGGCGTGACCGG'3  A.4 
JRS4F 5'GAAGCTTGAACATGTACTATCCGCTGCGCTTC'3 HindIII A.8 
JRS5R 5'GCTGCTTGACGTCGGTGTTGAGACC'3  A.1, A.8, A.16 
JRS6F 5'CATATGTACGCGAAAGCGACAGACG'3 NdeI A.1, A.2 
JRS7F 5'CGAACGTCCGGTACCTTCCACTCC'3 KpnI A.10 
JRS13R 5'GGATCCCCATGTAGCTTAAGTGCG'3 BamHI A.9 
JRS14F 5'GAAGCTTAACAATGTACGCGAAAGCG'3 HindIII A.9 
JRS17R 5'GGATCCGGATACGTGCTGCTGTAAGC'3 BamHI A.10 
JRS18R 5'AAGCTTAGCCGAGCTCGGCATTAACCACG'3 HindIII A.2 
JRS21F 5'GGATCCCACAATAACACGAGTGAGCTG'3 BamHI A.3 
JRS22R 5'CATCGATCCTTCATGCGCTCTTGCTGATC'3 ClaI A.3 
JRS23F 5'GTACCCCGGGTGCACAACCAC'3 SmaI A.12, A.13 
JRS24R 5'CTATGGATCCATGTGAAGGCGGCTAGCG'3 BamHI A.12 
JRS25R 5'CTATGGATCCTTGGTGATGTCTCTCACAGCC'3 BamHI A.13 
JRS28F 
JRS29R 
    5'AAGCTTAGATCTACAATGCATCATCATCACCATCATGG'3 
3'CATGTTCGAATCTAGATGTTACGTAGTAGTAGTGGTAGTACCAT'5 
 
ds oligonucleotide 
KpnI, NdeI, 
HindIII, BglII, NsiI, 
6xHis tag 
A.15 
JRS30F 5'GGATCCGGTAAGCCTATCCCTAACCCTC'3 BamHI A.7 
JRS31R 5'GTCGACTTAACCGGTACGCGTAGAATC'3  A.7 
JRS33F 
JRS34R 
5'GATCCACAGTGTACTAATTATGCTCTCTTGAAATTGGCTGGAGATG'3 
                                   3'CCGACCTCTAC 
AACTCTCGTTGGGGCCCGGGCTAG'5 
ds oligonucleotide 
HindIII, ERAV 
2A-like sequence 
A.14 
JRS43F 
JRS44R 
5'GATCTACAATGCATCATCATCACCATCATC'3 
    3'ATGTTACGTAGTAGTAGTAGTGGTAGAGCT'5 
ds oligonucleotide 
BglII, XhoI, 6xHis 
tag 
A.18 
JRS45F 5'CCATGGAGATCTAACAATGTACGCGAAAGCG'3 BglII A.16 
JRS47F 5'GGATCCAACAATGGAAGACGCAAGCAAG'3 BamHI A.17 
JRS48R 5'CTCGAGCACTGTCGGTACATTCTTAACGTGC'3 XhoI A.17 
JRS49R 5'TACATTGTTAGATCTCCATGGAATCGAATTC'3 BglII A.16 
JRS50R 5'TCTGCCGCGGCGTAGACAC'3  A.16 
JRS51R 5'GCTCTCTGCTGCAGTACGTTCGC'3 PstI A.16 
JRS52F 5'CCTGAGCCAGAGAGCAGTCAAGTTG'3 Bpu10I A.16 
JRS53F 5'TCTAGAAACCCTCCACAGACTGTACTATCC'3 XbaI A.16 
LMR2 5'CCCGGATCCCCGGGTGCAGGGATGTCTGTAAAC'3 BamHI A.4 
M13F 5’CCCAGTCACGACGTTGTAAAACG’3  Section 4.2.1 
M13R 5’AGCGGATAACAATTTCACACAGG’3  Section 4.2.1 
 
Key:  Complete restriction sites are in bold and underlined, partial restriction sites are in bold 
and ds oligonucleotide sequences complimentary to overhangs generated by restriction with 
specific enzymes but do not regenerate the recognition sequence are in bold and italics. 
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HeLa S3 immortalised human cervical cancer cell line ECACC 93021013 
(HeLa cells) (Gey et al., 1952) and Baby Hamster Kidney cell line IZSBS BS 
CL21 (BHK-21 cells) (Macpherson and Stoker, 1962) were maintained in 
buffered Dulbecco's modified Eagle medium (Lonza) supplemented with 
10 % heat-inactivated foetal calf serum (Invitrogen), 100 U ml-1 penicillin, 
10 mg ml-1 streptomycin and 25 μg ml-1 FungizoneTM (Lonza) at 37 °C in 10% 
CO2.   
 
Spodoptera frugiperda pupal ovarian (Sf9) cells (cell line 9 CRL 1711) 
(Vaughn et al., 1977) were maintained in TC100 insect medium (Lonza) or 
Grace's insect medium supplemented with 10 % foetal calf serum 
(Invitrogen), 100 U ml-1 penicillin and 10 mg ml-1 streptomycin (Lonza) at 
28 °C without CO2.  H. zea midgut cells (cell line BCIRL-HZ-MG8, referred to 
as MG8 cells in text) (Pringle et al., 2003), were grown in ExCell 420 
complete insect medium containing 100 U ml-1 penicillin and 10 mg ml-1 
streptomycin at 28 °C without CO2 or foetal calf serum. 
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